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SUMMARY
The underlying mechanisms controlling the complicated process of bone remodelling 
are complex and poorly understood. One of the many potentially important interactions 
is that between the cell and its extracellular matrix, various components of which have 
been shown to exert a number of effects in non bone cell types. Apart from these direct 
effects, the extracellular matrix is also concerned with the presentation of cytokines and 
growth factors to neighbouring cells.
Cellular interactions with the extracellular matrix are mediated by specific families of 
receptor, one of the most well studied of which are the integrins. By binding to 
different ligands, the cell surface expression of integrin subunits determines the 
microenvironment immediately surrounding the cell. Through specific cytoskeletal 
associations, integrin subunits potentially determine the way in which a cell responds to 
its external environment. In addition to this fairly passive role, the activities of many 
integrin molecules can be radically modulated by cells, and they in turn, can modulate 
cell activities in ways that extend far beyond adhesion.
The aim of this Ph.D was to examine the cell surface expression of integrin subunits by 
human bone cells and to assess their regulation by cytokines and extracellular matrix 
components. Any modulation of integrin subunit expression was compared with other 
phenotypic effects elicited by these agents and the significance of any correlations was 
assessed.
Osteoblasts and osteoclasts expressed different integrin subunits which potentially 
adhere to different ligands within the bone matrix. Osteoblasts primarily expressed a l, 
a3 and pi subunits whilst osteoclasts expressed a2, pi, aV and p3. Staining patterns 
observed in situ for cells of the osteoblastic lineage were maintained in culture but there 
was increased expression of a2, and aV subunits were weakly positive.
Expression of the major integrin subunits detected on cultured human osteoblast-like 
cells was regulated by interleukin 1 beta (IL-lp), transforming growth factor beta 
(TGFp) and to a lesser extent by 1,25-dihydroxyvitamin D3 (1,25D). However, 
changes in expression of a l ,  a2, a3 and pi subunits could not be correlated with 
proliferation, alkaline phosphatase activity or 1,25D induced osteocalcin release. IL-lp 
and TGFp also modulated the expression of these subunits in MG-63 cells. Attachment 
assays were developed using this osteosarcoma cell line but treatment of MG-63 cells 
with IL-lp and TGFp did not affect cell adhesion.
Growth of human osteoblast-like cells on fibronectin, laminin, collagen I film and 
collagen I gel affected cell proliferation, alkaline phosphatase activity and 1,25D 
induced osteocalcin release. These changes in differentiated osteoblast phenotype could 
not be correlated with integrin subunit expression. However, when cultured on a 
collagen I gel, osteoblast-like cells exhibited a different morphology which was 
accompanied by gel contraction and a 3.5 fold increase in expression of a2 subunits. 
This data suggests that signals transmitted though the type and level of integrin subunits 
expressed can influence phenotypic behaviour and hence bone remodelling.
CHAPTER 1. 
INTRODUCTION
1.1 THE ULTRASTRUCTURE OF BONE
(reviewed by Baron, 1990 and Teitelbaum, 1990)
The characteristics and structure of bone
Bone and cartilage are specialised connective tissues which together make up the 
skeletal system. Bone is a highly vascular, mineralised connective tissue which 
provides structural support and protects the vital organs and bone marrow. Cartilage 
covers the extremities of bones and provides a smooth articular surface permitting 
frictionless movement of the joint. In addition to its mechanical and protective roles, 
bone also serves as a reservoir for ions such as calcium and magnesium in mineral 
homeostasis.
Bone can be divided into three types. Cortical (compact) and trabecular (spongy) bone 
together make up lamellar bone and are the major types found in the adult skeleton. 
Woven bone is primarily associated with the foetus.
Cortical bone
Cortical bone makes up about 80% of the total skeleton and is composed of Haversian 
systems. An Haversian system (Fig 1.1) consists of plates of bone called lamellae, 
arranged around a central Haversian canal which contains blood vessels, nerves and 
lymphatics. Between the lamellae are spaces known as lacunae which contain bone 
cells (osteocytes) and lymph: the cells communicate via fine channels termed canaliculi 
which run between the lacunae. Between the Haversian systems there are tiny circular 
plates of bone called interstitial lamellae (Armstrong and Jackson, 1972).
Cortical bone is found on all external surfaces of all bones. It is thickest in the shaft 
(diaphysis) of long bones where it encloses the medullary cavity which contains the 
haemopoietic bone marrow. The functions of cortical bone are mainly structural and 
protective, its relatively slow turnover suggesting that it does not play a role in mineral 
homeostasis.
Trabecular bone
Trabecular bone makes up about 20% of the total skeleton and has less well defined 
Haversian systems. It consists of trabeculae surrounded by stromal spaces containing 
haemopoietic bone maiTow. The surfaces of all trabeculae are generally covered by
3three different types of bone cells. These include the lining cells which are found in 
metabolically quiescent areas, the osteoblasts in areas of active bone formation and the 
osteoclasts in areas of active bone resorption.
Trabecular bone is typically found at the ends of long bones and in the vertebral bodies. 
It is more cellular and vascular than cortical bone and is more metabolically active. 
Because of its higher rate of turnover, the trabecular bone plays an important role in 
mineral homeostasis.
Woven bone
Woven bone is the first type of bone to appear in the developing foetus. Here the 
collagen fibres are orientated randomly as irregular bundles and calcification occurs in 
disorganised patches. This is an immature form of bone and is mechanically inefficient 
as a structural unit. It is normally resorbed and replaced by the more organised lamellar 
bone during development. Woven bone may also appear during fracture healing and in 
certain pathological conditions such as metabolic bone diseases and tumours.








There are two distinct types of bones found in the skeleton, flat bones and long bones. 
Flat bones which include the skull, scapula, mandible and ileum are derived from 
intramembranous bone formation. Long bones which include the tibia, fibula and 
humerus are derived from both endochondral and intramembranous bone formation.
The main difference between these is the presence (endochondral) or absence 
(intramembranous) of a cartilage phase.
Intramembranous ossification
Intramembranous bone formation is characterised by the growth of bone from a cluster 
of ossification centres in the absence of a cartilage template. At these centres, groups of 
mesenchymal cells differentiate directly into preosteoblasts and then osteoblasts. These 
osteoblasts secrete a matrix of type I collagen, proteoglycans and glycoproteins and this 
subsequently becomes mineralised. This initial trabeculum, lined by osteoblasts, 
branches into other trabeculae by apposition. As these widen, osteoblasts are 
incorporated into the matrix and become osteocytes. The early woven bone is resorbed 
by osteoclasts and later replaced by mature lamellar bone. Those trabeculae destined to 
form cortical bone continue to expand, incorporating blood vessels into Haversian 
systems.
Endochondral ossification
In endochondral bone formation (Fig. 1.2), mesenchymal cells proliferate and 
differentiate into chondroblasts which sit in lacunae and secrete large amounts of 
cartilaginous matrix. As synthesis continues, cells become embedded in the matrix and 
form chondrocytes. At the external surface (perichondrium), mesenchymal cells 
continue to proliferate and differentiate and this allows cartilage to expand by 
apposition. Chondrocytes embedded in matrix continue to divide and interstitial growth 
takes place as a result of new matrix synthesis. In the growth plate, chondrocytes 
appear in regular columns known as isogenous groups. These proliferate and expand 
the plate interstitially until they enter the hypertrophic zone. Here, hypertrophic 
chondrocytes enlarge, polarise and produce alkaline phosphatase which is thought to 
promote subsequent cartilage mineralisation. When formed, the calcified cartilage is 
partially resorbed by osteoclasts and invaded by blood vessels. A layer of woven bone
5is then formed on top of the remaining calcified cartilage. This is remodelled at a later 
stage to produce mature lamellar bone.












Structure of long bones
A typical long bone consists of a central shaft (diaphysis), an intermediate area 
(metaphysis) and two ends (epiphyses). The diaphysis consists of dense cortical bone 
and encloses the medullary cavity which is filled with haemopoietic bone marrow. The 
epiphyses contain a thinner outer layer of cortical bone and an internal cavity which is 
filled with bone marrow. There are two surfaces where the bone is in contact with soft 
tissues; an external (periosteal) surface and an internal endosteal surface. Both these 
surfaces are lined with osteogenic cells organised in layers to form the periosteum and 
endosteum respectively. During growth, the metaphysis and epiphysis are separated by 
a layer of epiphyseal cartilage which makes up the growth plate.
1.2 STRUCTURE OF THE BONE MATRIX
Most of the structure of bone consists of extracellular matrix which has both organic 
and inorganic components. The organic component is largely responsible for the 
tensile strength of bone whilst the inorganic component contributes to its compressive 
strength and rigidity. The organic matrix is composed chiefly of type I collagen but 
there are also many noncollagenous proteins which may function as instigators and/or 
regulators of bone remodelling and mineralisation: the properties of some of these will 
be described below. The inorganic component consists mainly of crystals of 
hydroxyapatite [Caio(PC>4 )6 (OH2)] which are organised in the same direction as the 
collagen fibres.
1.2.1 Collagen
Collagen is the most abundant component of the bone matrix, comprising 85-90% of 
total bone protein. It consists of three polypeptide a  chains characterised by unique 
repeating sequences of the three amino acids Gly-X-Y. X and Y are often proline or its 
derivative hydroxyproline and it is this sequence which allows the polypeptide chains to 
form an extremely stable, semi-rigid triple helix. More than ten types of collagen have 
now been identified, but to date, the collagen found in bone is almost exclusively type 
I. The type I collagen molecule consists of two identical al(I) chains and one a2(I) 
chain wound together in a triple helix to form a collagen fibril. The three constituent a 
chains of collagen I are synthesised simultaneously and assembled into a helical 
structure intracellularly. In the matrix, collagen molecules associate head to tail 
longitudinally and laterally in a one quarter molecule-staggered array. This collagenous
scaffolding then becomes stabilised by the formation of covalent cross links (Gehron 
Robey, 1989)
1.2.2 Noncollagenous proteins 
Osteocalcin
Osteocalcin (bone Gla protein) was the first of the noncollagenous bone matrix proteins 
to be identified and was discovered by two groups almost simultaneously (Hauschka et 
al.1975; Price et al.1976). It has a molecular weight of 5.3 Kd, contains one 
intramolecular disulphide bond and is characterised by three to five residues of y  
carboxyglutamic acid (Gla). This modified amino acid is dependent on vitamin K for 
its synthesis and has been implicated in calcium binding. Northern blot analysis of 
extracted mRNA and immunocytochemical studies demonstrate that osteocalcin is 
mineralised-tissue specific and occurs in young osteoblasts and odontoblasts 
(Bronckers et al.1985; Bronckers et al.1987). Several osteosarcoma cell lines and non­
transformed cultures of osteoblast-like cells synthesise osteocalcin and its production is 
transcriptionally regulated by 1,25-dihydroxyvitamin D3 (Price and Baukol, 1980; 
Beresford et al. 1984b). The function of this protein is unknown but it is a potent 
inhibitor of hydroxy apatite crystal growth in vitro (Romberg et al.1986).
Furthermore, rats treated with the vitamin K antagonist warfarin, exhibit low bone 
levels of osteocalcin (less than 2  % of normal) and display an excessive mineralisation 
disorder characterised by a loss of longitudinal growth and a densely calcified growth 
plate (Price et al.1982). Taken together these findings suggest that osteocalcin serves 
as a regulator of mineralisation in vivo by inhibiting crystal growth. However, 
osteocalcin has been shown to exhibit chemotactic activity for two osteoblastic rat 
osteosarcoma cell lines (Lucas et al.1988) which implies that it may also be important 
for bone cell recruitment during the process of bone remodelling. A small fraction of 
osteocalcin is present in the circulation and measurement of serum levels are used as an 
index of bone turnover.
Osteonectin
Osteonectin is an abundant noncollagenous protein in bone. It is a 32 Kd 
phosphoprotein which has numerous disulphide bonds and can interact with both 
collagen and hydroxyapatite (Marks and Popoff, 1988). Osteonectin is not bone 
specific but levels are typically 1000-10,000 times higher than in other tissues (Gehron 
Robey, 1989). Immunohistochemical studies have localised this protein in
preosteoblasts, osteoblasts, newly formed osteoid, mineralised matrix and osteocytes 
(Jundt et al.1987; Bianco et al.1988). It is particularly abundant in developing bone 
and tends to be found in cells and tissues undergoing rapid proliferation and 
remodelling. A structurally and immunologically distinct form of osteonectin has also 
been observed in the a  granules of platelets (Malaval et al. 1991): its function is unclear 
but Clezardin et al.(1991) have postulated a role in the maintenance of platelet 
aggregation. The function of osteonectin in bone is also unknown but its strong 
binding to hydroxyapatite indicates a possible regulatory function in hydroxapatite 
crystal growth (Sodek et al.1986).
Osteopontin
Osteopontin is an acidic phosphorylated glycoprotein (44 Kd) which is rich in cysteine 
residues and contains several disulphide bonds. It binds tightly to hydroxyapatite and 
contains the functional attachment sequence Arg-Gly-Asp (RGD) (Oldberg et al.1986). 
Osteopontin has been localised in the extracellular matrix of woven bone and has been 
found in preosteoblasts, osteoblasts, osteocytes and osteoclasts (Mark et al.1987; Mark 
et al.1988). More recently, osteopontin mRNA has been detected in osteoclasts (Merry 
et al.1992; Tezuka et al.1992), indicating that this protein is synthesised by osteoclasts 
and not purely absorbed from the matrix. This protein is not unique to bone but has 
also been demonstrated in other tissues including kidney, brain and ear (Nomura et 
al.1992). Osteopontin is a major secretory product of the rat osteosarcoma cell line 
ROS 17/2.8. Synthesis is increased by 1,25-dihydroxyvitamin D3  (Prince and Butler, 
1987) and transforming growth factor p (Noda et al.1988) and decreased by 
parathyroid hormone and other agents which increase intracellular levels of cAMP 
(Noda and Rodan, 1989).
The function of osteopontin is unknown but the presence of the peptide Arg-Gly-Asp 
(RGD) suggests that it may play a role in adhesion. In support of this, high levels of 
osteopontin have been demonstrated in the bone matrix underlying resorbing 
osteoclasts in the rat, as demonstrated by light microscopy (Mark et al.1987) and 
immunoelectronmicroscopy (Reinholt et al.1990) (see Chapter 4 discussion).
Thrombospondin
Thrombospondin is a trimeric glycoprotein composed of identical subunits (150 Kd) 
which are linked by disulphide bonds. The molecule has an RGD sequence (Lawler 
and Hynes, 1986) which suggests that it is capable of promoting cell attachment but it
was initially found in platelet a  granules where it specifically interacts with osteonectin 
(Clezardin et al.1988). It is now known to be a product of many connective tissue cells 
and in general is present during stages of proliferation, migration and intracellular 
adhesion (O'Shea and Dixit, 1988). Thrombospondin is synthesised and secreted by 
osteoblasts (Clezardin et al.1989; Gehron Robey et al.1989) and osteosarcoma cells 
(Clezardin et al.1989) and in vitro studies have demonstrated that it mediates cell 
attachment but not spreading (Clezardin et al.1989; Gehron Robey et al.1989). 
However this effect is dependent on cell type as primary human osteoblast-like cells 
adhered well but attachment of two osteosarcoma cell lines was inhibited (Clezardin et 
al.1989). The physiological significance of the RGD sequence is therefore not yet 
clear. The proposed functions for this molecule range from mediating platelet 
aggregation, organising extracellular matrix components and acting as an autocrine 
growth factor (Gehron Robey, 1989).
Bone sialoprotein
Bone sialoprotein (BSP) is an acidic glycoprotein (70-80 Kd) containing no cysteine 
residues or disulphide bonds (Fisher et al.1990); expression is not regulated by 1,25 - 
dihydroxyvitamin D3 (Gehron Robey and Fisher, 1987). In situ hybridisation and 
immunocytochemistry has localised BSP in osteoblasts, osteocytes and in some 
hypertrophic cartilage of developing long bones and calvariae (Bianco et al.1991). 
Northern blot analysis originally showed that BSP was fairly bone specific (Fisher et 
al.1990) but it has since been localised in placenta (Bianco et al.1991). Like 
osteopontin, there is an RGD attachment sequence which possibly binds to the 
vitronectin receptor (Oldberg et al.1988; Fisher et al.1990). However, osteopontin is 
active at lower concentrations and attachment is maintained for longer periods of time in 
the absence of protein synthesis (Somerman et al.1988).
Fibronectin
Fibronectin consists of a dimer composed of two similar but not identical subunits 
(each of which is 250 Kd) held together by disulphide bonds. Each subunit contains at 
least nine functional domains each of which is composed of three types of homologous 
repeat: the third type of repeat contains the cell attachment sequence Gly-Arg-Gly-Asp- 
Ser (GRGDS). The role of fibronectin in bone metabolism has not been extensively 
investigated. However, it is synthesised during bone development and is present 
around osteoblasts during osteogenesis (Weiss and Reddi, 1980; Weiss and Reddi, 
1981). In vitro, osteoblasts can use fibronectin as an attachment protein which
suggests that it may play a similar role in vivo especially as binding to collagen is 
sometimes mediated through fibronectin (Kleinman et al.1981). It has also been shown 
that osteoblasts synthesize fibronectin in culture and that synthesis is stimulated by 
transforming growth factor p (Wrana et al.1988).
Proteoglycans
Proteoglycans are large molecules that form the ground substance of connective tissues 
and bone. There are 2 major classes of proteoglycans present in developing 
subperiosteal bone and these constitute 1 0 % of the noncollagenous bone matrix 
proteins. Both molecules are composed of a protein core to which there is covalent 
attachment of long chains of repeating disaccharide units, termed glycosaminoglycans. 
The large proteoglycan (600 Kd) is removed prior to mineralisation and the small 
proteoglycan, like all bone matrix proteins, becomes degraded with age. The smaller 
molecular weight proteoglycan consists of two products, PG-1 (350 Kd) and PG-2 
(200 Kd), named biglycan and decorin respectively. Proteoglycans are synthesised by 
human osteoblast-like cells in vitro (Beresford et al.1987) but are not unique to bone. 
They have also been detected in articular cartilage (Rosenberg et al.1985), nasal 
cartilage, skin, tendon, sclera, cornea and aorta (Heinegard et al.1985). The function 
of proteoglycans in developing and mature bone is unknown but it is thought that they 
interact with growing collagen fibres to regulate the organisation of the extracellular 
matrix (Gehron Robey, 1989). However, more recent studies have shown that these 
molecules also bind to and regulate growth factor activity (see below).
1.2.3 Matrix mineralisation
(reviewed by Gehron Robey, 1989 and Marks and Popoff, 1988)
The process of mineralisation is not understood but it results from the combined 
influences of cells and the extracellular matrix that they produce. Two mechanisms for 
bone mineralisation have been described. One of these occurs in calcified cartilage and 
woven bone and the other in lamellar bone. The key events in mineralisation of 
cartilage matrix appear to be as follows: During matrix synthesis, hypertrophic 
chondrocytes undergo apoptosis to produce matrix vesicles containing concentrated 
enzyme activity. Phospholipids within the plasma membrane of these vesicles 
sequester calcium and this leads to the appearance of the first mineral crystals and the 
activation of alkaline phosphatase. Crystallisation proceeds at a rate which seems to 
depend on the presence of inhibitors e.g. pyrophosphates and acidic noncollagenous 
proteins. Eventually the vesicle ruptures and the newly formed crystals serve as foci
for the propagation of mineralisation. Noncollagenous proteins may bind to these 
precursors and regulate the direction of growth and final crystal shape. Mineralisation 
of adjacent collagen initially occurs within fibrils and subsequently between them, 
producing crystals orientated parallel to the collagen fibres. In lamellar bone, there are 
less matrix vesicles which are not localised to mineralising sites. Here, mineralisation 
is initiated in the hole regions, where newly synthesised phosphoproteins are located. 
This suggests that phosphoproteins may be sufficient initiators of the mineralisation 
process. Possible roles of these and other noncollagenous proteins in controlling 
mineralisation are currently being investigated.
1.3 THE CELLS OF BONE
Lining cells
In the adult, the majority of bone surfaces are covered by a layer of flattened inactive 
lining cells. The function of these cells is unknown but they may serve as nutritional 
support for osteocytes via gap junctions between cell processes (Stanka, 1975).
Osteoblasts
Osteoblasts are cuboidal, polar, basophilic cells which line the bone matrix at sites of 
bone remodelling. They are highly metabolically active and form gap junctions which 
serve as a communication link between adjoining cells and osteocytes (Jeansonne et 
al.1979; Doty, 1981). They also express high levels of alkaline phosphatase (Fritsch et 
al.1985), the function of which is unknown. However, in the genetic disorder 
hypophosphatasia, this enzyme is deficient and patients develop severe osteomalacia, 
implying that alkaline phosphatase is essential for mineralisation (Whyte, 1990). The 
function of osteoblasts is to produce calcified bone matrix. Therefore, they synthesise 
collagen I, osteocalcin, osteonectin, sialoproteins and proteoglycans (Beresford et 
al. 1984a; Gehron Robey, 1989). They also function in the process of mineralisation 
although their precise role is not yet understood. In addition to their bone forming 
activities, osteoblasts are also thought to be concerned with regulating some of the 
actions of osteoclasts.
Osteocytes
Osteocytes are the end cells of the osteogenic lineage and are derived from osteoblasts 
which have become enclosed within lacunae in the bone matrix. These cells are much
smaller than osteoblasts and are not as metabolically active; features which become 
more pronounced deeper within the bone matrix. Osteocytes are linked to each other 
and to osteoblasts through long cytoplasmic processes which extend through canaliculi 
permeating the bone matrix (Jeansonne et al-1979; Doty et al, 1981; Nejweide et 
al.1981). The function of these cells is unknown although the viability of bone 
depends on their presence. There is some data to suggest that they are involved in 
transducing signals and responding to stress, since a variety of enzymes and RNA 
synthesis are increased in bones subjected to a stress regime (Skerry et al. 1989).
Osteoclasts
(reviewed by Peck and Woods, 1988 and Vaes, 1988)
Osteoclasts are large, differentiated, multinucleated cells which have the capacity to 
resorb bone and cartilage. They are not commonly seen on quiescent bone surfaces but 
are often found at sites of active bone remodelling such as in the metaphysis of growing 
bones. They have also been observed in some pathological conditions, for example 
adjacent to collections of tumour cells.
Osteoclasts are giant cells derived from fusion of mononuclear precursor cells. They 
vary greatly in size, but the average number of nuclei per cell ranges from 1 0  to 2 0  
(Mundy, 1990). One of the unique ultrastructural characteristics of this cell type is the 
presence of a ruffled border which has numerous folds and invaginations and allows 
intimate contact with the bone surface. The ruffled border is surrounded by a clear 
zone which is rich in actin filaments. This so called 'sealing zone' is closely apposed to 
the bone surface and mediates attachment of the osteoclast to the bone matrix, sealing 
off a resorption compartment. The rest of the cytoplasm contains large numbers of 
lysosomes, mitochondria and golgi complexes. There are also many vesicles, thought 
to contain apatite crystals and collagen fibres derived from recently resorbed matrix. 
Osteoclasts express a large number of enzymes including tartrate resistant acid 
phosphatase (TRAP), acid hydrolase, cysteine proteases and carbonic anhydrase n. 
TRAP and the hormone receptor for calcitonin are the main markers used to identify 
this cell type.
Resorption occurs at the ruffled border and is a two step process involving 
demineralisation followed by degradation of the extracellular matrix. Demineralisation 
results from an acidic environment created between the ruffled border of the osteoclast 
and the bone surface. The high concentration of H+ ions is formed from the action of 
carbonic anhydrase and is pumped out of the cell by an ATP dependent proton pump.
The acidic environment also facilitates subsequent degradation of the extracellular 
matrix. This is thought to result mainly from the actions of cysteine proteases such as 
cathepsins L, B and N.
Bone marrow
There are two types of bone marrow found in the adult skeleton. Red marrow is 
located in trabecular bone and contains an abundance of erythrocytes and blood vessels. 
The surrounding tissue of red marrow consists of reticular fibres which support various 
types of progenitor cell and mature leukocytes, and it is therefore a primary site of 
haemopoiesis. Yellow marrow is found in the medullary cavity of long bones. Like 
red marrow, it consists of fat and blood cells, but is not so rich in blood supply or 
erythrocytes (Armstrong and Jackson, 1972).
The osteoblast lineage
Cells of the osteoblastic lineage are considered to arise from a fibroblast colony- 
forming cell (CFU-F) isolated from the haemopoietic bone marrow (reviewed by 
Owen, 1988; Beresford, 1989). CFU-F is capable of proliferating and differentiating 
into fibroblastic, reticular, adipocytic and osteogenic stromal cell lines depending on the 
culture conditions. The stages of osteoblastic differentiation, from a committed 
progenitor to the mature osteoblast have not yet been elucidated owing to a lack of 
suitable biochemical or cell surface markers.
The osteoclast lineage
Osteoclasts are thought to arise from haemopoietic mononuclear cells in the bone 
marrow (Roodman et al.1985). These precursor cells circulate in the blood and, at sites 
destined to be remodelled, they proliferate, differentiate and finally fuse to form 
multinucleated osteoclasts which subsequently resorb bone. The regulation and 
mechanisms of osteoclast formation are poorly understood but local factors produced 
by osteoblasts can stimulate both the proliferation and differentiation of osteoclast 
progenitors. The cell of origin for the osteoclast within the bone marrow is still under 
debate and currently there are three theories regarding the osteoclast lineage (reviewed 
by Nijweide et al.1986; Marks and Popoff, 1988). The weight of evidence to date, 
suggests that the progenitor is a pluripotent stem cell (CFU-GM) which has the 
capacity, in response to certain stimuli, to differentiate into a granulocyte, monocyte or 
osteoclast.
1.4 THE BONE REMODELLING CYCLE 
(reviewed by Parfitt, 1988)
Bone remodelling consists of a tightly controlled sequence of events occurring at 
discrete sites in the skeleton. It involves the co-ordinated action of a range of cell 
types, many of which have still not been fully identified. These include osteoclasts, 
osteoblasts, osteocytes and possibly haematopoietic, immune and endothelial cells. 
Bone remodelling occurs mostly at the endosteal surface and its main functions are to 
replace effete bone and to maintain mineral homeostasis. The remodelling process has 
been divided into a number of stages as shown in Figure 1.3.
(i) Quiescence
Quiescent bone is covered by a layer of thin, apparently inactive lining cells thought to 
be primarily of the osteoblast lineage. However, this cell population is undoubtedly 
heterogeneous and also contains osteoblast and osteoclast precursors, and cells which 
help to regulate bone remodelling by transmitting signals between cell types.
(ii) Activation
The first observable event during bone remodelling is an increase in the number of 
mononuclear precursor cells around the resorption site. These activated mononuclear 
cells insert long pseudopodia down between the flattened lining cells. It is thought that 
the lining cells may facilitate this process by digesting the endosteal membrane and 
retracting to expose the bone surface. On reaching the bone surface the precursor cells 
undergo proliferation, differentiation and finally fusion to form multi-nucleated 
osteoclasts.
(iii) Resorption
The newly formed osteoclasts, now attached to the bone surface resorb a defined 
quantum of bone forming a resorption pit or Howship’s lacuna approximately 50 pm 
deep.
(iv) Reversal
Resorption is followed by a reversal phase, when osteoclasts are replaced by TRAP 
positive mononuclear cells. The identity of these cells is not known but it has been 
suggested that they are the products of osteoclast fission. During this phase a cement 
line is laid down consisting of glycoproteins, glycosaminoglycans and acid 
phosphatase. This is thought to act as a chemoattractant for osteoblast precursors
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which proliferate and differentiate at the resorption site. The release of cytokines into 
the microenvironment of resorption lacunae and the bone matrix are two other factors 
which may contribute to the coupling of bone resorption and subsequent formation.
(v) Formation
Newly formed osteoblasts synthesise bone matrix (osteoid) above the cement line. 
This process continues until the resorption site has been completely replaced. As the 
osteoid matures it subsequently becomes mineralised.






1.5 SOLUBLE FACTORS AFFECTING BONE REMODELLING
Bone cells are intimately associated with neighbouring cells and extracellular matrix. 
During the process of bone remodelling, osteoblasts and osteoclasts are regulated by a 
whole plethora of soluble and insoluble mediators. Systemic hormones, cytokines and 
prostaglandins are some of the soluble factors which have been shown to affect bone 
cells and the characteristics and actions of some of these are described below.
However, each mediator should not strictly be considered in isolation; it is the interplay 
between many different local and systemic factors which regulate bone cell metabolism.
1.5.1 Systemic factors
Parathyroid hormone
Parathyroid hormone (PTH) is an 84 amino acid peptide which, after secretion, 
becomes cleaved between amino acids 33 and 34. The amino terminal fragment retains 
full biological activity but the carboxy terminal fragment is inactive. The synthesis and 
secretion of PTH is regulated by serum concentrations of calcium and phosphate and its 
function is to maintain mineral homeostasis. It is produced in response to decreased 
calcium concentrations and its major sites of action are in the bone, kidneys and 
gastrointestinal tract.
In bone, PTH is a potent stimulator of osteoclast mediated bone resorption both in vivo 
and in vitro. This effect is achieved by activation of pre-existing osteoclasts (Holtrop 
and Raisz, 1979; Raisz and Lorenzo, 1980) and by fusion of pre-existing osteoclast 
precursors (Nijweide et al.1978; Krieger et al.1982; Lorenzo et al.1983). The effects 
of PTH on bone resorption are indirect (Nijweide et al.1986) as no receptors have been 
identified on osteoclasts (Silve et al.1982; Rouleau et al.1986) and moreover, PTH 
does not influence the behaviour of these cells in isolation (Chambers and Dunn, 1982; 
Chambers et al.1984). It has been speculated that activation of pre-existing osteoclasts 
occurs via the osteoblast, which expresses PTH receptors (Silve et al.1982; Rouleau et 
al.1986) and responds both morphogenetically (Jones and Boyde, 1976) and 
functionally (Kream et al. 1980) to PTH in vitro . However, it is also possible that 
osteoclast precursor cells express PTH receptors and that increased cell fusion 
following PTH administration is a direct effect.
PTH also exerts a number of effects on osteoblasts which can both potentiate bone 
resorption and affect bone formation. Matrix degradation can be increased by the
release of collagenase (Sakamoto and Sakamoto, 1985) and plasminogen activators 
(Hamilton et al.1985) which occur in response to PTH administration. In addition, 
PTH also causes cytoplasmic contraction in osteoblasts, resulting in exposure of 
underlying matrix for subsequent invasion by osteoclasts (Jones and Boyde, 1976). 
The effects of this hormone on bone formation are rather more complex. It has been 
shown to decrease proliferation (Reid et al.1988), collagen synthesis (Dietrich et 
al.1976; Kream et al.1980) and osteocalcin production (Beresford et al. 1984b) but to 
increase synthesis of prostaglandin E (MacDonald et al.1984). Some of these effects 
may be mediated through adenylate cyclase or changes in intracellular calcium as 
concentrations of 3',5'-adenosine monophosphate and Ca2+ are increased following 
addition of PTH (Chase and Aurbach, 1970; Dziak and Stem, 1975).
Calcitonin
Calcitonin is a 32 amino acid peptide secreted by cells from the thyroid in response to 
increased levels of serum Ca2+. Its main biological effect is to inhibit osteoclastic bone 
resorption (see Austin and Heath, 1981 for review). However, there are also studies to 
suggests that it promotes bone formation by stimulating the proliferation, collagen 
synthesis and alkaline phosphatase activity of osteoblasts (Farley et al.1988; 1991).
Calcitonin receptors have been identified on osteoclasts (Warshawsky et al.1980) and 
there is every reason to believe that this hormone is a direct-acting inhibitor of 
osteoclast function. Isolated osteoclasts have been shown to respond to calcitonin 
within minutes, and pseudopod retraction, cell rounding, reduced motility and 
cytoskeletal rearrangements are typical morphological changes which occur (Chambers 
and Magnus, 1982; Chambers and Moore, 1983; Chambers et al.1984). 
Administration of calcitonin in vivo rapidly causes osteoclasts to detach from the bone 
surface and to lose their ruffled borders (Lucht, 1973). There is also a reduction in the 
number of osteoclasts and some authors have concluded that calcitonin acts by causing 
fission of pre-existing osteoclasts into ill-defined mononucleated cells (Baron and 
Vignery, 1982). Others have detected a change in the localisation of carbonic 
anhydrase II, and have suggested that this may represent a mechanism of calcitonin- 
mediated inhibition of bone resorption (Anderson et al.1982). In vitro, calcitonin has 
been shown to transiently inhibit augmented resorption caused by PTH (Feldman et 
al.1980). This transient effect is reproducible and termed 'escape', but the 
phenomenon is not understood.
1,25-dihydroxyvitamin D3
1,25-dihydroxyvitamin D3 (1,25D) is the major active metabolite of vitamin D and is 
important in calcium homeostasis. It is produced in response to decreased Ca2+ 
concentrations and its primary sites of action are in the gut, the kidney and bone.
The most striking effect of 1,25D on bone in vivo and in vitro is the stimulation of 
osteoclast mediated bone resorption (Raisz et al.1972; Herrmann-Erlee and Gaillard, 
1978; Marie and Travers, 1983). This results from an increase in osteoclast number 
and activity, and is considered to be independent of PTH (Reynolds et al. 1976;
Holtrop et al.1981). As with PTH, most of the actions of 1,25D on osteoclasts appear 
to be indirect, implying the involvement of another cell type such as the osteoblast. In 
support of this, isolated osteoclasts do not respond to 1,25D (Chambers and Dunn, 
1982) and receptors have been identified on preosteoblasts and osteoblasts but not on 
osteoclasts and osteocytes (Narbaitz et al, 1983). It is also possible that 1,25D 
promotes the differentiation of osteoclast precursors within the bone maiTOw. This is 
supported by results obtained from long term cultures of mononuclear cells isolated 
from feline (Ibbotson et al.1984) and human (MacDonald et al.1987) marrow: in these 
studies, administration of 1,25D increased the number of multinucleated cells which 
exhibited several features typical of osteoclasts. Differentiation of other haemopoietic 
cells is known to occur in response to 1,25D (Bar-Shavit et al.1983; Amento et 
al.1984; Rigby et al.1985) and this could also stimulate bone resorption through 
increased secretion of appropriate cytokines.
1,25D also affects mineralisation and bone formation. In vivoy it has been shown to 
promote calcification of bone matrix but inhibit new bone formation, a phenomenon 
which leads to growth retardation (Reynolds et al.1976; Marie et al.1985). In vitro data 
are often conflicting and the responses of cells seem to depend on variables such as 
species differences, cell density and stage of differentiation (Rodan and Rodan, 1984). 
In human trabecular-derived bone cells, 1,25D has been reported to decrease 
proliferation but to increase collagen I synthesis, alkaline phosphatase activity 
(Beresford et al 1986) and osteocalcin production (Beresford et al. 1984b; Skjodt et 
al. 1985). 1,25D also stimulates collagen I synthesis in the human osteosarcoma cell 
line MG-63 (Franceschi et al.1988). In ROS 17/2.8 cells, alkaline phosphatase 
activity (Manolagas et al.1981) and production of osteopontin (Prince and Butler,
1987) are increased, but collagen synthesis is inhibited (Kream et al.1986).
Oestrogen
Oestrogen and androgens stimulate skeletal maturation at puberty and can prevent loss 
of bone mass in adults. Oestrogen deficiency is clearly central to the development of 
post menopausal osteoporosis and similarly, androgen deficiency due to the decline of 
gonadal function in the elderly may be equally important in men.
The mode of action of oestrogen is not understood. Some reports favour an indirect 
mechanism whereby oestrogen increases serum Ca2+ concentrations by enhancing 
levels of PTH and 1,25D (Riggs et al.1972; Gallagher et al.1980). Others have 
suggested that oestrogens and other sex steroids affect bone metabolism via the 
immunomodulatory system (Grossman, 1984). Another possibility is that oestrogen 
coordinates the production of locally produced cytokines and thereby controls the 
process of bone remodelling. In support of this, Ernst et al.(1989) demonstrated that 
oestradiol, in addition to PTH and growth hormone increased the proliferation of rat 
osteoblasts in vitro by increasing insulin-like growth factor I gene transcription. Also, 
it has been demonstrated that oestrogen decreases bone resorption by inhibiting the 
production of interleukin-6 , a cytokine which is required for haemopoiesis and 
osteoclastogenesis (Girasole et al.1992; Jilka et al.1992).
There have been numerous studies in vitro to investigate any direct effects of 
oestrogens on osteoblasts. Unfortunately results from these studies appear to be 
dependent on the cell type and species of origin. For example, in rat cultures, 
oestradiol has been shown to stimulate osteoblast proliferation in primary cultures 
(Ernst et al.1988; Ernst et al.1989) but to inhibit proliferation in the osteogenic cell line 
UMR-106 (Gray et al.1987; Bankson et al.1989). In primary human osteoblast-like 
cells, treatment with oestrogen appeared to exert no effect (Keeting et al.1991) but in a 
clonal human osteoblast-like cell line, a l (I)-procollagen mRNA was increased (Benz 
et al.1991 a). In rat cultures oestrogen also appears to promote a more differentiated 
osteoblast phenotype as it has been shown to increase expression of alkaline 
phosphatase (Gray et al.1987), osteocalcin, osteonectin (Glibert et al.1989) and 
collagen (Ernst et al.1988; 1989).
Despite the well documented effects of oestrogen in vitro, localisation of oestrogen 
receptors in bone has proved difficult. However, specific binding sites have now been 
detected both in primary human osteoblast-like cells (Eriksen et al.1988) and in rat 
(ROS 17/2.8) and human osteosarcoma (HOS TE85) cell lines (Komm et al.1988). 
Primary cultures expressed approximately 1600 binding sites per cell but only 200 sites
were detected in osteosarcoma cell lines. Both values were lower than those observed 
in cells from the uterus which were shown to express several thousand receptor sites 
per cell. More recently, oestrogen receptors have also been localised in osteoclasts 
(Oursler et al.1991; 1992).
1.5.2 Local factors
It is unlikely that systemic hormones alone regulate the tighdy controlled and highly 
localised process of bone remodelling. However, local mediators could provide the 
necessary site and cell specific signals for recruitment and proliferation of appropriate 
precursors at the right time. Cytokines and cellular interactions with the extracellular 
matrix are two local factors which, in combination with systemic hormones, could 
potentially fulfil these criteria.
1.5.2.1 Cytokines
The first direct evidence that cytokines could affect bone cells was provided by Horton 
et al. (1972) who demonstrated bone resorbing activity in conditioned medium from 
human peripheral blood mononuclear cells. This activity was named osteoclast 
activating factor (OAF) and has since been shown to result from at least 10 different 
cytokines some of which are described below (see Gowen, 1991 for review).
Interleukin-1
Interleukin-1 (IL-1) exists as two related proteins with virtually identical actions on a 
wide range of cellular targets. IL-1 a  and IL-ip are the products of separate genes but 
are structurally related. Both are translated as a 31 Kd precursor polypeptide which is 
subsequently cleaved from the C-terminal portion to form 17 Kd mature forms. There 
is only 26 % amino acid homology and both precursors have no leader sequence 
suggesting an ’abnormal' route of 'export'. IL-ip is often produced in great excess of 
IL-1 a  and is the major secreted form; IL-1 a  remains cell associated as a membrane 
bound active form (Gowen, 1992b).
Both IL-1 a and IL-lp interact with the same plasma membrane receptor which consists 
of an 80 Kd glycoprotein. There are approximately 1000 receptor sites per cell and 
these are of high and low affinity. When IL-1 binds to its receptor, the resulting 
complex is rapidly internalised (probably by receptor mediated endocytosis) and later 
dissociated in lysosomes. Once inside the cell, the mechanism of action of IL-1 is
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unknown; there is no obvious mechanism of signal transduction but some reports have 
suggested that it is translocated to the nucleus where it regulates transcription directly 
(see Martin and Resch, 1988 for review)
IL-1, the first candidate to be identified as an OAF, is a potent stimulator of osteoclastic 
bone resorption in vivo (Boyce et al.1989; Konig et al.1989) and in vitro (Gowen et 
al.1983; Dewhirst et al.1985; Heath et al.1985). EL-1 is active in isolation at 1 pM 
(Gowen, 1992a) and when present at suboptimal concentrations, acts synergistically 
with other agents such as tumour necrosis factor a, tumour necrosis factor p 
(Stashenko et al.l987a) and PTH (Dewhirst et al.1987). This makes IL-1 a  and IL-ip 
the most potent, known stimulators of bone resorption in vitro (Gowen, 1992a). Cell 
culture studies suggest that this is achieved by the increased proliferation of osteoclast 
precursors (Gowen and Mundy, 1986) a finding which correlates with results obtained 
from long term bone marrow culture experiments (Pfeilschbacher et al.1989).
However, there have also been some reports suggesting that the effects of IL-1 are 
mediated by osteoblasts. For example, Thomson et al.(1986) showed that IL-1 
increased bone resorption only when osteoclasts were co-cultured with rat calvarial 
cells or UMR-106 cells (a rat osteosarcoma cell line): this did not result from the 
production of prostaglandins, another potent stimulator of bone resorption, as the 
addition of indomethacin had no effect.
IL-1 also has powerful effects on bone formation. In vitro, it stimulates proliferation of 
human osteoblast-like cells (Gowen et al.1985; Gowen, 1988) and increases DNA 
synthesis in rat calvarial cells (Canalis, 1986; Smith et al.1987). It also decreases type 
I collagen synthesis (Beresford et al. 1984a; Canalis, 1986) and inhibits alkaline 
phosphatase activity and 1,25D induced osteocalcin production (Stashenko et al. 1987b; 
Evans et al.1989) suggesting an overall reduction in formation of mineralised bone 
matrix. In addition, it increases synthesis of prostaglandins and plasminogen activator 
(Gowen, 1988; Evans et al.1989), two factors which potentially increase the rate of 
bone resorption.
Most of the literature quoted on the effects of IL-1 on osteoblasts is obtained from 
studies using normal 'untransformed' bone cell cultures, and it should be noted that 
findings observed in cell lines are often different. For example, in MG-63 cells (a 
human osteosarcoma cell line) and in MC3T3-E1 cells (a mouse clonal cell line), IL-1 
inhibits proliferation but stimulates alkaline phosphatase activity (Hanazawa et al.1986; 
Ohmori et al.1988; Dedhar, 1989). This highlights the importance of interpreting in
vitro studies with care, and of choosing model systems which are as close as possible 
to the actual cell of interest.
IL-1 is produced by osteoblast-like cells in culture (Hanazawa et al.1987; Amano et 
al.1988) and IL-1 {3 mRNA has been detected at specific stages of bone remodelling 
using in situ hybridisation (Dodds et al.1992). The fact that IL-1 is synthesised locally 
and affects both osteoblasts and osteoclasts suggests that it may play an important role 
in coupling bone resorption with subsequent formation at individual remodelling sites.
T um our necrosis factor
Tumour necrosis factor (TNF) exists as a family of two related peptides (a and p) 
which share approximately 30% homology and are products of separate genes. Like 
IL-1, TNFa and TNFp are potent stimulators of bone resorption (Bertolini et al.1985; 
Tashjian et al.1987). Generally, TNFa elicits a stronger response than TNFp, but both 
cytokines are typically between 100-and 1000- fold less potent than IL-1, the active 
concentration range being 10'9 -10 7 M (Bertolini et al.1985). The effects of TNFa and 
TNFp on bone formation are also similar to those observed with IL-1, although again, 
higher concentrations of TNF are generally required to elicit a similar response. Thus, 
TNF (10-7 -10-1 0M) has been shown to stimulate proliferation (Centrella et al.1988; 
Gowen, 1988; Gowen et al. 1988) and to inhibit collagen synthesis (Canalis, 1987; 
Smith et al.1987; Centrella et al.1988), alkaline phosphatase activity (Canalis, 1987; 
Centrella et al.1988) and 1,25D induced osteocalcin production (Gowen et al.1988) in 
human osteoblast-like cells.
T ransform ing growth factor p
Transforming growth factor p (TGFp) is a 25 Kd dimeric peptide which exerts 
numerous effects in a wide variety of normal and malignant cells. It is synthesised as a 
larger precursor molecule which is subsequently cleaved and secreted as a biologically 
inactive form. This latent protein consists of a complex containing the mature dimeric 
TGFp together with the 'precursor remainder' and a third component. The active 
TGFp dimer can be released by transient acidification, or by the action of exogenous 
proteases such as plasmin and cathepsin D. Following activation, TGFp binds to 
specific cell receptors which are expressed by most cell types ( 1 0 0 - 1 0  0 0 0  sites/cell). 
However, the intracellular mechanisms by which it exerts its effects are unknown, 
since, unlike other growth factor receptors, no associated tyrosine kinase activity has 
been identified (see Spom et al.1986; Spom et al.1987; Massague, 1987 for reviews).
TGFp exists in three forms, designated TGFpi, TGFp2 and TGFp 1.2 (Cheifetz et 
al.1987). It is present at highest concentrations in platelets but is also very abundant in 
bone (Spom et al.1987). TGFp is particularly prevalent in developing bone which 
suggests that it may play a role in the regulation of ossification during endochondral 
bone development (Carrington et al. 1988). It is synthesised by bone cells in vitro 
(Gehron Robey et al.1987) and receptors for TGFp have been identified on primary 
cultures of human osteoblast-like cells (Gehron Robey et al.1987). Furthermore, its 
production is increased by the systemic hormones PTH and 1,25D (Pfeilschifter and 
Mundy, 1987; Merry and Gowen, 1992) so it seems likely that TGFp could play an 
important role in the local control of bone cell activity.
In vitro studies suggest that TGFp modulates the actions of both osteoblasts and 
osteoclasts. It stimulates cell replication in normal osteoblast-like cells (Centrella et 
al.1987) but inhibits DNA synthesis in osteosarcoma cell lines (Pfeilschifter et 
al.1987). TGFp also stimulates collagen synthesis and alkaline phosphatase activity in 
some (Centrella et al.1987; Pfeilschifter et al.1987) but not all (Centrella et al.1986) 
experimental models. The effects of TGFp on bone resorption are more complex. It 
stimulates bone resorption in newborn mouse calvarial cultures by a prostaglandin 
synthesis-dependent mechanism (Tashjian et al.1985). However, in foetal rat long 
bones, bone resorption is inhibited (Pfeilschifter et al.1988). This inhibitory action of 
TGFp may result from decreased osteoclast formation, a finding which is observed 
when TGFp is added to bone marrow cultures (Chenu et al.1988).
The mechanism of action of TGFp in bone is still a matter of controversy. There is 
some evidence to suggest that the proliferative effects are mediated by proto-oncogenes 
such as c-sisy c-fos and c-myc (Loef et al.1986; Sandberg et al.1988). Other 
phenotypic responses may result from a modulation of receptor binding of calcitropic 
hormones (Merry and Gowen, 1992; Schneider et al.1992), but it has also been 
suggested that changes in cell-matrix interactions are responsible for the pluripotent 
effects (Roberts et al.1992).
Insulin-like growth factors
Insulin-like growth factors (IGF-I and IGF-II), have been shown to stimulate the 
proliferation (Canalis, 1980; Schmid et al.1983) and the production of collagen type I 
(Canalis, 1980; McCarthy et al.1989; Schmid et al.1989) by osteoblasts in vitro. Their 
biological activities are modulated at least in part by a series of specific high affinity
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binding proteins which are synthesised by osteoblasts (Mohan and Baylink, 1991). 
There is some evidence to suggest that IGF-I mediates the effects of oestrogens. For 
example Ernst et al.(1989) have shown that IGF-I is produced by bone cells stimulated 
with oestrogen, and the actions of oestrogen similar to those of IGF-I, can be abated by 
the addition of anu-IGF-I antibody. Furthermore, the production of IGF binding 
proteins is also modulated by systemic hormones such as growth hormone (Ernst et 
al.1990).
Other cytokines
There are a large number of other cytokines active in in vitro model systems. Interferon 
gamma (IFNy) selectively inhibits cytokine (IL-1, TNF) but not hormone induced bone 
resorption in vitro (Gowen and Mundy, 1986). It also antagonises IL-1 and TNF 
actions on osteoblasts, in that it inhibits proliferation and stimulates some (alkaline 
phosphatase and osteocalcin) (Gowen and Mundy, 1986) but not all (collagen) (Smith 
et al.1987) aspects of differentiated cell function. Bone morphogenetic proteins 
(BMP’s) 1-7 (Wang et al.1988) and osteoinductive factor (OIF) (Bentz et al.1989) are 
examples of matrix derived cytokines. The BMP's are all members of the TGFp 
superfamily but OIF is similar in structure to the bone proteoglycans and therefore has 
no growth promoting activity of its own. In view of the ability of decorin to bind 
TGFp, it has been proposed that OIF may serve as a binding protein for the BMP's and 
that bone proteoglycans may act as a store for cytokines in bone (Seyedin and Rosen, 
1990). Granulocyte-colony stimulating factor (G-CSF) (Felix et al.1988) and 
granulocyte-macrophage colony stimulating factor (GM-CSF) (Felix et al.1988; 
Horowitz et al.1989) have been shown to be produced by osteoblasts in culture and are 
considered to regulate the proliferation and differentiation of haemopoietic precursors. 
Interleukin- 6  (EL-6 ) and leukaemia inhibitory factor (LIF) are also considered to 
stimulate osteoclast precursor proliferation (Reid et al.1989; Brandt et al.1990) and 
overexpression of LIF in transgenic animals leads to elevated bone remodelling and 
ectopic calcification (Metcalf and Gearing, 1989).
1.5.2.2 Prostaglandins
Prostaglandins (PG's) are a diverse group of unsaturated oxygenated fatty acids whose 
synthesis is inhibited by indomethacin. They exist in a variety of different tissues and 
have limited, localised biological activity before being rapidly degraded (Hinman,
1972): the major types localised in bone are PGEi, PGE2  and PGI2 .
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PG's are potent stimulators of bone resorption (Klein and Raisz, 1970) and some 
evidence suggests that this results from direct actions on osteoclasts (Chambers and 
Dunn, 1982; Chambers and Ali, 1983). However, data obtained from studies using 
mouse foetal long bones (Akatsu et al.1991), suggest that PG’s also stimulate 
osteoclast formation at an early stage of development. In addition to its effects on bone 
resorption, PGE2  enhances bone formation by stimulating the replication and 
differentiation of osteoblast progenitors (Chyun and Raisz, 1984).
1.6 TH E EXTRACELLULAR MATRIX
Signals from the extracellular matrix (ECM) can exert as much control over the 
behaviour of cells as hormones, cytokines and other soluble mediators. The main 
difference is that the ECM is insoluble and therefore exerts its effects over a short 
range. Contact with the ECM is fundamental to many biological processes including 
embryonic development, tissue remodelling, wound healing, inflammation and 
metastasis (von der Mark et al.1992). Very little information is available concerning the 
role of of the ECM in regulating bone cell function. However, the process of bone 
remodelling must be regulated by highly site and cell specific signals which allow 
recruitment and proliferation of the appropriate cells at the right time. The ECM of 
bone fulfils all these criteria and as over 90% of bone is composed of matrix, it seems 
likely that this insoluble local mediator plays an important role in controlling bone cell 
function.
ECM's are chiefly composed of collagen(s), proteoglycans and glycoproteins. Its 
major functions are to provide anchorage and support, cues for migration and signals 
for growth and differentiation. Adhesive and migratory properties of the ECM have 
been illustrated in vitro: if mesenchymal cells are plated onto a surface coated with 
limiting concentrations of ECM protein applied as a gradient, cells adhere and 
subsequently move towards the higher concentration (Basara et al.1985). The 
importance of the ECM in expression of a differentiated cell phenotype can also be 
observed in vitro using chondrocytes. When these cells are cultured on agar or in 
agarose, they exhibit a rounded morphology and express collagen type II and 
chondroitin sulphate proteoglycan. If however they are cultured on tissue culture 
plastic or on glass, they spread out, develop stress fibres and focal contacts, and 
synthesize type I collagen and non cartilage-type proteoglycans. Under the latter 
conditions, chondrocytes have become 'fibroblastic' or 'de-differentiated' whereas 
when cultured on agar or in agarose they express markers characteristic of the 
differentiated chondrocyte phenotype (reviewed by von der Mark et al.1986).
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The importance of the extracellular matrix in expression of a differentiated cell 
phenotype can also be observed using primary cultures of mouse mammary epithelial 
cells. When these cells are cultured on plastic or on flat collagen gels, they rapidly lose 
their ability to synthesize and secrete most milk proteins, even in the presence of 
lactogenic hormones. If however, they are cultured on 'released' (or floating) type I 
collagen gels or on a reconstituted basement membrane derived from the Engelbreth- 
Holmes-Swarm tumour (EHS), there is increased expression of [3-casein and transferrin 
mRNA and enhanced rates of milk protein secretion (Emerman and Pitelka, 1977; Lee 
et al.1984; 1985; 1987; Li et al.1987). This induction is accompanied by profound 
morphological changes: cells cultured on plastic or on flat collagen gels display short 
stubby microvilli on their apical surfaces, they exhibit a flattened morphology and lack 
internal polarisation and secretory apparatus. In contrast, when cultured on 'released' 
collagen I gels, cells become columnar and polar and develop tight junctions. 
Furthermore, extensive microvilli are observed over their apical surface and evidence of 
a secretory apparatus is displayed internally (Emerman and Pitelka, 1977). Cells 
grown on EHS are also morphologically differentiated and, in addition, are surrounded 
by a continual basal lamina separating them from the matrix in which they were 
embedded (Bissell and Barcellos-Hoff, 1987). These changes in cell structure are 
accompanied by changes in the organisation of cells into tissue-like forms. The most 
striking of these occurs following growth on EHS. Here, cells are oriented with their 
apices inwards and form domes and duct-like structures resembling secretory alveoli 
(Bissell and Barcellos-Hoff, 1987). This difference in morphology is accompanied by 
vectoral secretion of milk proteins into the lumen when cells are cultured in the presence 
of lactogenic hormones (Barcellos-Hoff et al.1987).
1.7 THE INTEGRINS
The integrins are a family of cell surface receptors which mediate interactions between 
cells and ECM's. Expression of these proteins is essential to many of the functions 
ascribed to the ECM. For example, integrins play an important role in tissue repair 
(Clark, 1990), gastrulation (Darribere et al.1988) and tumour cell metastasis (reviewed 
by Albeda and Buck, 1990). In addition, they are required at several stages of 
embryogenesis, namely during neural crest migration (Bonner-Fraser, 1985; Bonner- 
Fraser, 1986), neurite extension (Reichardt et al.1988) and histogenesis (Menko and 
Boettiger, 1987; Jeffredo et al.1988). Integrin subunit expression is also necessary for 
the functioning of non adherent cell types and platelets, where it influences the 
processes of inflammation, immune cell function and blood clotting (Hynes, 1992).
Integrin subunits are expressed by most cell types and defective function causes 
pathological conditions. Examples include leukocyte deficiency syndrome (Springer et 
al. 1987), which is characterised by the inability of myeloid cells to carry out 
phagocytosis and chemotaxis, and Glanzmann's thrombasthenia (Phillips and Agin, 
1977) where platelets fail to aggregate in response to activation.
1.7.1 Integrin diversity
The integrins comprise a family of membrane spanning heterodimers composed of non 
covalently linked a  (120-180 Kd) and p (90-110 Kd) subunits (reviewed by Hynes, 
1987; Ruoslahti and Pierschbacher, 1987; Albeda and Buck, 1990). 8 p subunits and 
14 a  subunits have now been identified (Table 1), and most of these have been 
sequenced at the cDNA level, with the exception of a l  and a IEL (Hynes, 1992). It 
was originally thought that the a subunits within each group bound faithfully to an 
individual p subunit, but it can be seen from Table 1.1 that alternative pairings are 
possible. For example, a4 and a6 can both associate with two p's, and aV can bind up 
to five different p subunits. When ligand-binding specificities of integrins are 
examined, two more general features are apparent. First, certain integrins such as a3pi 
and aVp3 are able to bind multiple ligands. Secondly, the same ligand may recognise 
multiple integrin receptors; for example, both fibronectin and laminin are recognised by 
six or more different integrin molecules. Yet a further level of complexity is introduced 
by the existence of alternative splicing which occurs in the cytoplasmic domains of pi, 
p3, p4, a3 and a6 subunits and in the extracellular domains of allb (summarised by 
Hynes, 1992).
1.7.2 Adhesive ligands and their binding sites
It can be seen from Table 1.1 that the vast majority of integrin molecules bind to ECM 
proteins and thereby mediate cell-matrix interactions. Other integrins bind to cell 
membrane proteins ('counter-receptors'), thereby mediating cell-cell adhesion. 
Considerable progress has been made in defining the integrin recognition sites in the 
ligands and counter-receptors listed in Table 1.1. The first binding site to be defined 
was the tripeptide Arg-Gly-Asp (RGD) which is found on many of the ECM 
components of bone. Examples include collagen, fibronectin, vitronectin, laminin, 
osteonectin, osteopontin, bone sialoprotein and thrombospondin (reviewed by 
Humphries, 1990). However, this sequence is not always responsible for mediating 
adhesion. For instance, a2pl binds Asp-Gly-Glu-Ala (DGEA) in type I collagen
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PI a l Collagens, laminin
a 2 Collagens, laminin






aV Vitronectin, fibronectin, collagen, fibrinogen, von Willebrand 
factor
P2 aL ICAM-1, ICAM-2, ICAM-3
aM C3b component of complement (inactivated), fibrinogen, factor X, 
ICAM-1
aX Fibrinogen, C3b component of complement (inactivated) ?
P3 allb Fibrinogen, fibronectin, von Willebrand factor, vitronectin, 
thrombospondin
aV Vitronectin, fibrinogen, von Willebrand factor, thrombospondin, 
fibronectin, osteopontin, collagen
P4 a 6 Laminin
P5 aV Vitronectin
p6 aV Fibronectin
p7 a4 Fibronectin, VCAM-1
(=PP?) alEL ?
P8 aV 7
(Staatz et al.1991) and a4pl binds Glu-Ile-Leu-Asp-Val (EILDV) in an alternatively 
spliced region of fibronectin (Humphries et al.1987). Other binding sites have not been 
identified as precisely although different laminin receptors recognise various parts of 
the molecule. For example, a3pi, a6pl and a7pl bind to the long arm of the laminin 
molecule, whereas a lp i and cx2pi recognise the cross region of this ECM protein 
(reviewed by Hynes, 1992).
Although the presence of cell-binding activity in short, linear peptide sequences is a 
common feature of ECM molecules, it should be noted that synthetic mimics of these 
sequences have a relatively low biological activity compared to the molecules from 
which they are derived. This may result from the three dimensional conformation of 
the active site peptide or, alternatively, adhesive proteins may contain additional regions 
that contribute to the affinity and specificity of receptor binding. In support of this, 
fibronectin, thrombospondin and von Willebrand's factor all possess cell adhesion 
domains distinct from their RGD sites (Humphries, 1990). In the case of fibronectin, 
deletion mutagenesis has been employed to identify a site which functions in synergy 
with RGDS (Obara et al.1988). This site cannot be described by a short amino acid 
sequence and probably requires precise folding of non contiguous regions of the 
polypeptide backbone for full biological activity.
1.7.3 Integrin subunit structure
(reviewed by Albeda and Buck, 1990; Hogg, 1991 and Hynes, 1992)
Integrin a  and p subunits are unrelated transmembrane glycoproteins with a large 
extracellular domain, a single hydrophobic transmembrane segment, and a short 
cytoplasmic domain (50 amino acids or less). A notable exception to this is the 
cytoplasmic domain of the p4 subunit which comprises over 1000 amino acids. Both 
subunits are required for ligand binding but only extracellular domains (>75 Kd for p 
subunit and >100 Kd for a  subunit) are required for the association of ap heterodimers. 
In support of this, truncated forms lacking transmembrane and cytoplasmic regions can 
be expressed, and do form ap heterodimers (Dana et al.1991; Bodary et al.1991). 
Electron microscopic images of several integrins show a globular head apparently 
comprising parts of both subunits, and two stalks extending through the lipid bilayer 
into the cytoplasm. A structural representation of integrin receptors is illustrated in 
Figure 1.4.
Integrin a  subunits are very heterogeneous, and only exhibit an overall 25% amino acid 
homology which increases to 45-63% between members of the same group. All a
subunits typically possess calmodulin-type divalent cation binding sites close to the 
ligand binding region in the extracellular domain. In addition, most a  subunits contain 
a proteolytic cleavage site which separates the heavy extracellular chain from the light 
transmembrane chain, and in some cases these are held together by a disulphide bond. 
Some a  subunits also contain an 180 amino acid insertion, termed the I domain, which 
is homologous to that observed in collagen binding proteins. The function of this 
domain is unknown but is considered to contribute to ligand binding. Integrin p 
subunits share an overall 37-45% amino acid homology, the greatest of which occurs in 
the cytoplasmic and transmembrane domains. These subunits have an extracellular 
cysteine-rich region, believed to be disulphide bonded. The amino terminal 40-50 Kd 
is tightly folded with intrachain disulphide bonds and this associates with the a  subunit 
to form an extracellular ligand binding domain. Divalent cations are essential for 
receptor function: the nature of the cations can affect both affinity and specificity for 
receptor-ligand interactions and furthermore, their presence is required for association 
of some a  and p subunits (Gailit and Ruoslahti, 1988; Kirchhofer et al. 1990a; 
Kirchhofer et al.1991).
The cytoplasmic domains of most integrin subunits associate with the cytoskeleton at 
focal contacts and adhesion plaques. The only known exception to this occurs with the 
integrin a6p4 which is specifically concentrated at hemidesmosomes in epithelial cells 
(Stepp et al.1990; Kurpakus et al.1991; Sonnenberg et al.1991) and interacts with 
microfilaments. The cytoplasmic domains of other integrin molecules interact with the 
actin cytoskeleton via an indirect linkage involving cytoskeletal proteins such as talin, 
vinculin and a-actinin and perhaps other cytoplasmic components. There is direct 
evidence for the involvement of the pi subunit in mediating cytoskeletal interactions 
since deletion of all or part of the pi cytoplasmic domain interferes with associations 
with focal contacts (Hayashi et al.1990; Marcantonia et al.1990; Solowska et al.1991). 
The a subunits are also considered to interact with the cytoskeleton although evidence 
for this association is less direct. It has been suggested that the a  subunits convey 
some kind of functional specificity since the cytoplasmic domains of these subunits are 
very heterogeneous. However, pi subunits must also provide some kind of specificity 
as aVpl, aVp3 and aVp5 do not all associate with the same ligands (see Table 1.1).
There is a tyrosine phosphorylation site on the cytoplasmic domain of the p subunit 
which suggests that a phosphorylation event may in some way contribute to receptor- 
cytoskeleton binding.
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Figure 1.4 A structural representation of integrin receptors (Humphries. 1990)
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1.7.4 Integrin receptor function
Integrin molecules play a structural role in mediating cell adhesion, and in addition, 
they transmit signals between the external environment and the interior of the cell. The 
cell surface expression of integrins may be a crucial determinant in the phenotypic 
behaviour of a given cell type, especially since the ECM with which many integrins 
interact is known to exert profound effects on cell phenotype. A key feature apparent 
from Table 1.1 is that there is a tremendous amount of redundancy in the ligand 
specificity of the integrins. One explanation for this redundancy is that in a given cell, a 
particular integrin may not exhibit all the specificities listed. For example, a2pi 
behaves exclusively as a collagen receptor on platelets (Staatz et al.1989), but on other 
cell types, it recognises both collagen and laminin (Elices and Hemler, 1989;
Kirchhofer et al. 1990b). Alternatively, different integrins could transduce specific 
signals to the interior of the cell, whilst interacting with the same ligand. In support of
this, different ap heterodimers exhibit different cytoskeletal associations even when 
interacting with the same ligand. For example, cx5pl is present in focal contacts 
whereas a3pi is not, even though both bind to fibronectin (Elices et al.1991).
Similarly, aVp3 is found in focal contacts, whereas aVp5 is not, even though both 
interact with the RGD site on vitronectin (Wayner et al.1991). Cytoplasmic domains of 
various a  subunits have also been shown to elicit specific functions. For example, 
Chan et al.(1992), using chimeric constructs, recently demonstrated that a2 
cytoplasmic domains mediated collagen gel contraction whereas a4 cytoplasmic 
domains promoted cell migration.
1.7.5 Mechanisms of integrin receptor function
Quantitative changes in cell-matrix interactions
Communication between the external environment and the interior of the cell could 
occur through quantitative changes in the expression of integrin receptor molecules or 
their respective ligands. It is now becoming apparent that factors known to influence 
cell phenotype in vitro also affect cell-matrix interactions. For example, IL-ip has been 
shown to modulate expression of various integrin subunits in osteosarcoma cell lines 
(see Chapter 5). In addition, IL-1 a, IL-ip and TNFa have also been shown to 
modulate collagen deposition by human dermal fibroblasts (Mauviel et al.1991). TGFp 
is another cytokine which has been shown to affect cell-matrix interactions. For 
instance, Roberts et al. (1988) and Heino et al. (1989) have demonstrated an up- 
regulation of integrin subunit expression in human lung fibroblasts. Similarly, Ignotz 
and Massague (1987) showed an increased integrin subunit expression using a variety 
of different cell types, and Ignotz et al. (1989) demonstrated increased expression of 
vitronectin receptor and LFA-1 following treatment with this cytokine. There have also 
been several reports of increased matrix deposition following addition of TGFp. For 
example, it has been shown to increase fibronectin and collagen mRNA levels in rat 
(Ignotz et al.1987) and human fibroblasts (Ishikawa et al.1990) and to increase 
vitronectin expression in Hep G2 hepatoma cells (Koli et al.1991). It has also been 
found to increase expression of chondroitin/dermatan sulphate proteoglycans in a 
variety of different cell lines (Bassols and Massague, 1988) but to up-regulate biglycan 
and down-regulate decorin in human fibroblasts (Kahari et al.1991). Similar studies 
have also been performed on osteoblast-like cells and a modulation of integrin subunit 
expression and increased ECM synthesis has typically been observed. For example, 
Heino and Massague (1989) demonstrated that TGFp affects the pattern of integrin 
subunits expressed in MG-63 osteosarcoma cells and causes a selective loss of
adhesion to laminin. Strong et al. (1991) demonstrated increased synthesis of type I 
collagen in human osteoblast-like cells isolated from explants of trabecular bone, and 
Noda et al. (1988) showed an increased production of osteopontin in ROS 17/2.8 cells.
Other agents known to modulate bone cell function have also been shown to affect 
interactions between cells and their external environment. For example, 1,25D 
increases fibronectin (Franceschi et al.1987) and collagen synthesis (Franceschi et 
al.1988), and stimulates fibronectin mediated cell adhesion in MG-63 cells (Franceschi 
et al.1987). 1,25D also increases aVp3 expression in avian osteoclast precursor cells 
isolated from marrow (Medhora et al.1993) but glucocorticoids decrease expression of 
pi in ROS 17/2.8 cells (McCarthy et al.1992). IGF-II increases collagen synthesis in 
osteoblast-like cells isolated from explants of trabecular bone (Strong et al.1991) and 
retinoic acid (lfr9 M) increases adhesion of the human osteosarcoma cell line OHS-4 to 
fibronectin (Dunlay et al.1992). In addition, retinoic acid (10 5 M) and PMA (10 nM) 
increase expression of a  1 in human endothelial cells, and costimulation with TNFa (5 
ng/ml) and PMA result in a synergistic effect (Defilippi et al.l991b). This induction of 
a l  subunit expression affected the adhesive properties of endothelial cells: attachment 
to collagen, laminin and laminin fragment PI was increased, whilst adhesion to 
fibronectin and laminin fragment E8  remained constant. In another study, TNFa (5 
ng/ml) and IFNy(100 U/ml) decreased expression of p3 which combines with aV to 
form a vitronectin receptor. This reduction in p3 subunit expression resulted in a 
decreased adhesion to vitronectin whilst adhesion to fibronectin remained unchanged 
(Defilippi et al.1991 a).
Modulation of integrin receptor affinity and specificity
(reviewed by Hynes, 1992)
Individual cells can vary their adhesive properties by regulating the specificity and 
affinity of a given integrin molecule. Both activation and de-activation of integrin 
functions have now been reported but the best understood examples are allbp3 on 
platelets and p2 integrins on neutrophils, monocytes and lymphocytes. On resting 
circulating platelets, although allbp3 can attach to surface-bound fibrinogen, it cannot 
bind to any of its soluble ligands. However, on activation by thrombin, collagen or 
other platelet agonists, allbp3 undergoes a conformational change and becomes an 
effective receptor for soluble fibrinogen and the other ligands listed in Table 1.1. The 
p2 integrins expressed on leukocytes exhibit activation phenomena that are strikingly 
similar to those exhibited by allbp3: activation of leukocytes is required for 
expression of the various ligand-binding activities of the p2 integrins (see Table 1.1).
The mechanisms by which these activation events occur are largely unknown.
However, evidence from recombinant-DNA expression experiments has suggested that 
the cytoplasmic domains of integrin subunits are targets for regulatory events.
In addition to these relatively well studied examples of integrin modulation, there are 
other cases in which intracellular events affect integrin receptor affinity. For instance, 
activation of T cells by antigen or phorbol esters leads to activation of a2pl, a4pi, 
a5JSl and <x6f31 without changes in surface levels. In contrast to these activation events, 
there are also examples in which integrins lose activity during development. This 
occurs with a5pi during the terminal differentiation of keratinocytes (Adams and Watt, 
1990) and with a 6 pl during the development of retinal neurons. As with p2 and p3 
integrins, the mechanisms by which these regulatory events occur are not understood. 
However, studies performed by Hotchin and Watt (1992) have demonstrated that loss 
of a5pl from the cell surface of keratinocytes involves changes in both transcriptional 
and post-translational control.
Mechanical transduction via the integrins
(reviewed by Ingber, 1991)
Mechanical forces play a major role in the regulation of tissue formation and function. 
Cells generate tension within their actin cytoskeleton and exert this force on their 
extracellular adhesions. At the same time, ECM substrata resist these forces and 
transmit mechanical forces into the cytoskeleton. This balance between inward and 
outward forces has been found to be critical for control of cell shape, migration, 
growth, differentiation and tissue patterning. ECM substrata convey different 
regulatory signals depending on whether or not they can resist forces from the 
cytoskeleton. For example, when fibroblasts are cultured on attached collagen gels, 
they proliferate, spread out, organise long actin bundles and secrete ECM proteins. 
However, if these gels are ’released’, cells become rounded, disrupt their actin fibres, 
decrease matrix synthesis and become quiescent within 1 hr. In mouse mammary 
epithelial cells, growth on a 'floating' collagen gel induces expression of 
differentiation-specific genes and deposition of a basement membrane (Emerman and 
Pitelka, 1977).
Integrins physically link actin-associated proteins (e.g talin, vinculin, a-actinin, 
paxillin) to ECM and to adhesion receptors on the surfaces of other cells. Therefore 
these molecules would potentially alter cell function by affecting the number, location 
or strength of the adhesive contacts that can transmit physical forces to and from the
cytoskeleton. The importance of integrin molecules in mechanical force transduction 
can be observed in vivo during wound healing. In this process, fibroblasts produce 
wound contraction and connective tissue remodelling by exerting tension on their ECM 
adhesions. Control of F-actin bundle assembly, transmembrane force transduction and 
wound organisation all appear to depend on cell surface expression of a5pl (Welch et 
al.1990).
The mechanisms by which integrin molecules transduce mechanical signals are largely 
unknown. One possibility is through force-dependent release of chemical second 
messengers, but alternatively, responses could involve changes in cytoskeletal 
organisation. Different cytoskeletal associations could affect positioning of the cell's 
metabolic machinery and/or nuclear structure.
1.8 THE ROLE OF CELL-MATRIX INTERACTIONS IN THE 
REGULATION OF HUMAN BONE CELL FUNCTION
Very little information is available concerning the role of the ECM and its 
corresponding cell surface receptors in the regulation of human bone cell function. 
However, over 90% of bone is composed of ECM and resident cell populations do not 
rely solely on cellular interactions for their phenotypic control. The potential 
importance of bone ECM can be illustrated in vivo: if devitalised and decalcified bone 
powder is implanted into syngeneic hosts, bone formation is induced (Reddi and 
Anderson, 1976). In this experimental model, bone powder is considered to promote 
an outgrowth of mesenchymal cells which differentiate into chondrocytes. Blood 
vessels subsequendy invade the area, cartilage cells are replaced by osteoblasts and 
osteoclasts, and marrow spaces containing haemopoietic cells are observed. The newly 
formed osteoblasts actively synthesize bone matrix and this later becomes mineralised.
The ECM of bone is composed of at least 200 different proteins (Delmas et al.1984) 
many of which have yet to be fully characterised. Some of these ECM proteins e.g 
collagen, fibronectin and laminin are not unique to bone and have previously been 
shown to directly affect the actions of other cell types (reviewed by von der Mark et 
al.1992). Other non-collagenous ECM proteins are more bone-specific but the precise 
functions of these molecules are largely unknown. In addition to exerting direct effects 
on cell phenotype, the ECM is also concerned with the presentation of cytokines and 
growth factors to neighbouring cells. This increases their effective local concentration 
and ensures that the appropriate cytokine is available at the right time (reviewed by 
Gowen, 1991 and Nathan and Spom, 1991). For example, GM-CSF, interleukin-3
and fibroblast growth factor bind heparan sulphate; TGFp binds to biglycan and 
decorin; BMP3 specifically binds to collagen IV and IGF-II binds tightly to 
hydroxyapatite via a specific bone matrix associated binding protein.
Attachment of cells to their ECM is mediated, at least in part, through the integrins. By 
binding to different ligands, the cell surface expression of integrin subunits determines 
the microenvironment immediately surrounding the cell. Through specific cytoskeletal 
associations, integrin subunits potentially determine the way in which a cell responds to 
its external environment. In addition to this fairly passive role, the activities of many 
integrin molecules can be radically modulated by cells, and they, in turn, can modulate 
cell activities in ways that extend far beyond adhesion.
To date, bone cell research has largely concentrated on the roles of hormones, 
cytokines and other soluble mediators in the control of bone cell function. However, 
integrin-mediated interactions between bone cells and their ECM could play an 
important role at many different stages of bone remodelling. For example, initiation of 
bone resorption requires attachment to the bone matrix and formation of multinucleated 
osteoclasts requires fusion of mononuclear precursor cells. The process of bone 
resorption requires an intimate association between the sealing zone of the osteoclast 
and its ECM. During the reversal phase, osteoclasts must detach from the bone surface 
and osteoblast precursor cells must be recruited to the resorption site and activated. 
Matrix deposition and the subsequent formation of the osteoblast-lining cells and 
osteocytes could also be influenced by mechanical and chemical signals elicted by the 
ECM. In view of the present confusion regarding the precise functions of soluble 
factors, a complementary project was proposed to investigate a possible role for the 





In this section, reagents have been divided into specific categories for quick reference. 
All unspecified chemicals were obtained from Sigma (Poole, UK).
2.1.1 Tissue Culture Reagents
Minimal Essential Medium (MEM), penicillin and streptomycin, glutamine, sodium 
bicarbonate and trypsin/EDTA were obtained from GIBCO (Paisley, UK). Foetal calf 
serum was purchased from Imperial Laboratories (Andover, UK). High grade charcoal 
(Norit GSX) used for preparing charcoal stripped serum was purchased from BDH 
(Lutterworth, UK). MG-63 cells were obtained from the European collection of animal 
cultures (Salisbury, UK) and HOS cells were purchased from the American Type 
Culture Collection (Rockville, M.D.).
2.1.2 Biochemicals
Phosphate buffered saline (PBS) was purchased from Oxoid (Bristol, UK). 
Diethanolamine, chloramine T, sodium metabisulphite, potassium iodide and acetone 
were obtained from BDH (Lutterworth, UK). Sephadex G25 (medium grade) was 
purchased from Pharmacia (Milton Keynes, UK) and protein dye binding reagent was 
obtained from Bio-rad Laboratories (Hertfordshire, UK). 125I was obtained from 
Amersham International (Amersham, UK).
2.1.3 Cytokines
Human recombinant IL-lp (specific activity 5 x 107  U/mg) was a gift from Glaxo 
Group Research (Middlesex, UK). Human TGF-p (specific activity 1-2 x 107 
U/mg) was purchased from British Biotechnology (Oxford, UK) and activated by 
acidification according to the manufacturer's instructions.
2.1.4 Monoclonal antibodies
Monoclonal antibody (mAb) T52/7 was generously donated by Dr. Hemler (Boston, 
MA) and recognises the a l  (CDw49a) subunit of integrin a lp i. MAbs raised against 
a3 (CDw49c), a 6  (CDw49f) and pi (CD29) subunits were obtained from Bioquote Ltd 
(Ilkley, UK), Serotec (Oxford, UK) and Coulter Instruments (Luton, UK) 
respectively. MAbs directed against a2 (CDw49b), a4 (CDw49d) and a5 (CDw49e),
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aL (CD1 la) and (32 (CD 18) subunits were purchased from Immunotech 
(Birmingham,UK) and a mAb directed against the aM (CD1 lb) subunit was obtained 
from Dakopatts (High Wycombe, UK). MAb 23C6 which recognises the aV (CD51) 
subunit in complex with p3 (Davies et al ,1989) was generously donated by Dr. Horton 
(London, UK) and mAb C22 which recognises the p3 subunit (CD61) was raised in 
our laboratory. All mAbs were obtained as ascites of hybridoma nu/nu mice or tissue 
culture supernatants.
2.1.5 Immunochemicals
Purified bovine osteocalcin standard and polyclonal rabbit anti-bovine osteocalcin 
antibody were obtained from Biogenesis (Bournemouth, UK). Normal rabbit serum 
was obtained from GIBCO (Paisley, UK) and goat anti-rabbit gammaglobulin was 
purchased from Calbiochem (Nottingham, UK). Diff-Quik reagents were obtained 
from Baxter Dade AG (Dudingen, Germany). Immunochemicals used for staining 
procedures employing alkaline phosphatase anti-alkaline phosphatase conjugates were 
obtained from Dakopatts (High Wycombe, UK). Human AB serum was obtained from 
GIBCO and FITC coated latex beads were purchased from Flow Cytometry Standards 
(Research Triangle Park, NC).
2.1.6 Equipment
All tissue culture plastics were obtained from Costar (Northumberland, UK) and glass 
slides were obtained from Henley Ltd (Loughton, UK). Colorimetric assays were 
quantified using a spectrophotometer (Dynatech model MR5000) and fluorimetric data 
were analysed using a Shimadzu spectrofluorimeter (model RF-540). Iodinated protein 
was monitored in LP4 tubes purchased from Luckham (Burgess Hill, UK) using an 
automatic gamma counter (LKB Wallac 1277 gammamaster). Cells were centrifuged 
onto glass slides using a Shandon cytospin, sections of osteophytic tissue were cut 
using a Bright's cryostat (Bright's Instruments Co.; Huntingdon, UK) and 
immunocytochemical studies were analysed using a Leitz microscope (Laborlux S). 
Cells prepared for FACS experiments were analysed on a Becton Dickenson Facstar 
Plus with 100 mW argon ion laser and Consort 32 computer.
2.2 TISSUE CULTURE
2.2.1 Isolation of primary human osteoblast-like cells
Trabecular bone fragments (approx. 3 mm3) were extracted from femoral heads 
obtained from orthopaedic surgery (usually above knee amputation, total hip 
replacement or fractured neck of femur). The fragments of bone were washed 
extensively in PBS to remove blood and any surrounding connective tissue and then 
incubated overnight at 37°C in serum free medium. Bone fragments were then 
transferred into 9 cm diameter tissue-culture grade petri-dishes and 10 ml medium 
containing serum was added. Explants were maintained in a humidified atmosphere of 
5% CO2 , 95% air at 37°C and old medium (10ml) was removed from the cultures and 
replaced once a week. Under these conditions confluency was usually achieved after 
4-6 weeks. Bone cell cultures were maintained in Eagles Minimal Essential medium 
(MEM) containing 10% heat inactivated foetal calf serum (FCS), 100 i.u/ml penicillin, 
100 jig/ml streptomycin and 2 mM glutamine. FCS was heat inactivated by incubation 
at 56°C for 40 min; this removes complement components which could cause cell lysis.
The cells obtained from these explant cultures have been characterised previously and 
possess an osteoblastic phenotype. This includes the synthesis of type I collagen, 
alkaline phosphatase and osteocalcin (Beresford et al. 1984b; Beresford et al.1986) and 
the production of cAMP in response to PTH (MacDonald et al.1984).
2.2.2 Culture of osteosarcoma cell lines
MG-63 and HOS TE85 cells were cultured under similar conditions to those described 
for bone-derived cells. However, culture medium was replaced every 3-4 days and 
confluency was typically achieved within a week.
2.2.3 Subculturing human osteoblast-like cells and osteosarcoma cell 
lines
Bone-derived cells were subcultured by replacing bone chips from trypsinised cells 
back into their original 9 cm diameter dishes. Fresh culture medium was added (10 ml) 
and explants were fed once a week as described. These cells could only be subcultured 
once using this method. Osteosarcoma cell lines were maintained by placing a small 
volume of a trypsinised cell suspension into 1 0  ml fresh culture medium which was
subsequently replaced every 3-4 days. The number of cell passages was noted and cell 
lines were subcultured up to about passage 30.
2.2.4 Passaging cells for experimental assay
MG-63, HOS TE85 and human osteoblast-like cells were passaged into 9 cm diameter 
tissue culture grade petri-dishes, multi-well plates or onto glass slides by trypsinisation. 
At confluency, the medium was removed, cell layers were washed with 10 ml sterile 
PBS to remove traces of serum and 2.5 ml/plate trypsin/EDTA solution (0.25% w/v 
trypsin, 0.2% w/v EDTA) was added. After 5 min at 37°C for osteosarcoma cell lines 
and 10-15 min at 37°C for bone cell cultures, cells were detached and further 
trypsinisation was prevented by the addition of 7.5 ml fresh medium containing serum. 
Cells were pelleted by centrifugation (1000 rpm/5 min), resuspended in fresh culture 
medium and counted using a haemocytometer. Cells were then seeded into assay plates 
at the required density and used for experimental purposes.
2.2.5 Detaching cells from assay plates
In order to detach cells from their ECM, medium was removed and cell layers were 
washed with PBS (1 ml/well for 24-well plates and 5 ml/plate for 9 cm dishes). 
Trypsin/EDTA solution was then added to cells grown on plastic, fibronectin, collagen 
I film and laminin (250 pl/well for 24 well plates and 2.5 ml/plate for 9 cm dishes) and 
collagenase I (0.3% w/v in serum free MEM) was added to cells grown on collagen I 
gels (the volume of collagenase added was equivalent to the volume of the gel). After 
5 min in trypsin/EDTA and 30 min in collagenase, trypsin was neutralised by the 
addition of MEM+10% FCS (750 pl/well for 24 well plates and 7.5 ml/plate for 9 cm 
dishes) and cells were collected by centrifugation ( 6  500 rpm/5 min in a microfuge or 
1000 rpm/5 min in a bench top centrifuge).
2.3 ROUTINE PREPARATIONS
2.3.1 Preparation of charcoal stripped serum (CS-FCS)
100 ml heat inactivated serum was stirred with 4 g high grade charcoal (Norit GSX) on 
ice for 1 hr. Charcoal was separated from serum by centifugation (3000 rpm/15 min) 
and filtration through 0.4 pm pre-filters. Serum was then re-sterilized using 0.2 pm 
filters and stored in aliquots at -20°C. The main function of this procedure is to remove 
steroids present in serum.
2.3.2 Preparation of rat tail collagen (Type I)
Type I collagen was prepared from rat tails using a method based on a report by Strom 
and Michalopoulos (1982). 12 rat tails were sterilised by repeatedly dipping them into 
industrial methylated spirits. Tendons were then dissected from the tails using forceps, 
transferred into 0.1% acetic acid (500-1000 ml) and stirred at 4°C for 48 hr. The 
resulting solution was filtered through absorbant gauze and separated by centrifugation 
(10 000 rpm/30 min/4°C). 1 M NaOH was then added to the supernatant in a ratio of 
1: 6  to precipitate the collagen. This collagen precipitate was collected by centrifugation 
(2500 rpm/10 min), resuspended in a minimal volume of 0.1% acetic acid and the 
concentration of collagen was determined by dry weight. Stock solutions (1 mg/ml) 
were then prepared in 0.1% acetic acid and stored at 4°C until required.
2.3.3 Preparation of collagen I gels
Collagen I gels were prepared by a method used at Glaxo Group Research. A stock 
solution of concentrated medium (see below) was added to wells containing collagen 
type I in a ratio of 1.33:1. The contents were mixed well and the plates were incubated 
at 37°C for 30 min. During this time the increased pH caused the collagen to form a gel 
which stabilised after a few hours. Gels were stored overnight at 4°C and then used 
for experimental purposes.
Preparation of concentrated medium:
10 X MEM
Penicillin (10 000 i.u/ml)/Streptomycin (10 000 pg/ml) solution 
Glutamine (200 mM)
CS-FCS
0.1 M sterile NaOH
2.4 BIOCHEMICAL AND CELLULAR ASSAYS
2.4.1 Measurement of cell proliferation
MG-63, HOS TE85 and human osteoblast-like cells were cultured under test conditions 
for the required number of days. At the end of the assay period, cells were detached by 
trypsinisation or treatment with collagenase (Method 2.2.5) and collected by
6  ml 
0.25 ml 
0.25 ml 
1 2  ml
7 ml
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centrifugation. Cell pellets were then resuspended in MEM+10% FCS, stored on ice to 
minimise cell clumping and 2  x 1 0  |d aliquots were counted in a haemocytometer.
2.4.2 Alkaline phosphatase assay
Cellular alkaline phosphatase acivity was measured colorimetrically in detached cells by 
monitoring the release of para-nitrophenol (p-nitrophenol) from disodium p-nitrophenyl 
phosphate at 37°C and pH 10.5. The reaction produces a coloured product which can 
be measured spectrophotometrically at 410 nm.
MG-63, HOS TE85 and human osteoblast-like cells were cultured under test conditions 
for up to 10 days. At the end of the treatment period, the medium was removed (and 
retained for osteocalcin assay if required) and cells were detached by trypsinisation or 
treatment with collagenase (Method 2.2.5): neither of these enzymes interfered with 
alkaline phosphatase activity (see Chapter 3). When cells were to be simultaneously 
assayed for cell number or DNA, cell suspensions were divided in a ratio of 1:2 and the 
larger aliquot was assayed for alkaline phosphatase. Cell pellets were resuspended in 
100 pi Tween 20 (0.1% in de-ionised H2O) and 3 x 25 pi aliquots were transferred into 
wells of a 96-well plate. The assay plate also contained blanks (25 pl/well 0.1% Tween 
20) and known concentrations of p-nitrophenol standard (25 pl/well). Standards were 
diluted in 0.1% Tween 20 from a 10 mM stock to give concentrations of 0.05,0.1,
0.2, 0.4, 0.6, 0.8, 1.0, 1.2, 1.4, 1.6, 1.8, 2.0 pmol/ml. 225 pi aliquots of substrate 
buffer was added to all wells (0.1 M diethanolamine, 0.5 M MgCl2 , pH 10.5 and 
46 mg/100ml 4-disodium-p-nitrophenyl phosphate) and the assay plate was incubated at 
37°C. After 30-40 min, or when colour intensities from samples were similar to those 
of the lower standards, the absorbance was recorded at 410 nm. Enzyme activity, 
expressed as pmol/ml p-nitrophenol/hr was then determined from a standard curve 
(Fig. 2.1).
2.4.3 DNA assay
A DNA assay was developed from a method used by Mates et al.(1986) in order to 
obtain an accurate measurement of cell number. In this assay, cellular DNA was 
quantified using the Hoechst stain 33258. This compound specifically intercalates with 
DNA and produces a linear increase in fluorescence with cell number. This method 
was mainly used in conjunction with the alkaline phosphatase assay so that enzyme 
activity could be related to cell number. All samples were assayed immediately as 
storage at 4°C or -20°C interferes with fluorescence values.
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2.4.3.1 Optimisation of reagent concentrations
Initially, a series of standard DNA solutions containing 0.00-1.0 pg DNA were 
prepared in TRIS buffer (10 mM TRIS, 10 mM EDTA, 10 mM NaCl, pH 7.0). 1.0 ml 
EDTA (10 mM, pH 12.3) was added to each standard followed by 100 pi KH2PO4 
(1 M): the pH of this reagent was adjusted so that when 10 pi was added to 100 pi 
EDTA, the pH was 7.0. 1 ml Hoechst 33258 (80 pg/ml in TRIS buffer) was then 
added to all standards and the fluorescence of each DNA standard was recorded over an 
excitation range of 250-500 nm. Fluorescence readings obtained from the DNA 
standards were almost identical (data not shown) implying interference from one or 
more reagents.
As a result of this finding, the emission profile of each reagent was assessed and the 
volume producing least interference was determined.
Optimised reagent volumes are shown below:
Calf thymus DNA (single stranded) 0.05-1 pg in 200 pi TRIS buffer
EDTA 100 pi
KH 2PO4  10 pi
Hoescht solution (80 pg/ml) 500 pi
TRIS buffer 1400 pi
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Excitation and emission profiles from this solution showed optimum excitation and 
emission wavelengths of 354 nm and 473 nm respectively.
A typical standard curve for DNA is shown in Figure 2.2A. The assay was linear over 
a range of 0.025-1 jig DNA which was appropriate for assessing DNA content of 
osteoblast-like cells seeded into 24-well plates.
2.4.3.2 Linearity of DNA assay with cell number
Before this procedure was used as an assessment of cell density, the linearity with cell 
number was determined using a range of concentrations of WEHI cells. This mouse 
leukaemic cell line was used in preference to human osteoblast-like cells due to their 
relative abundance. Figure 2.2B illustrates that the assay was linear over a range of 
1 250-20 000 cells. These results produced a mean value of 29 pg DNA/cell which 
agrees with data obtained previously (Mates et al.1986).
2.4.3.3 Measurement of cellular DNA
MG-63, HOS TE85 and human osteoblast-like cells were cultured in 24-well plates for 
up to 10 days. At the end of the treatment period, the medium was removed (and 
retained for osteocalcin assay if required) and cells were detached (Method 2.2.5) and 
divided in a ratio of 1:2. Cells from the smaller aliquot were then washed in PBS 
( l x l  ml) to remove any residual medium (phenol red interferes with the DNA assay) 
and lysed by the addition of 100 pi EDTA. Blanks (200 pi TRIS buffer) and standards 
(200 pi in TRIS buffer) were also placed under these conditions. Standards were 
prepared from calf thymus DNA (Type 1; stored at 4°C) to give 0.025, 0.05,0.1,0.2, 
0.4, 0.6, 0.8, 1.0. 1.2, 1.4 and 1.6 pg DNA/tube. After 20 min at 37°C, 10 pi 
KH2 PO4  was added, followed by TRIS buffer; 1600 pi to samples and 1400 pi to 
standards and blanks. Finally, 500 pi Hoechst 33258 solution (80 pg/ml in TRIS 
buffer) was added to all tubes and the fluorescence was measured in a quartz cuvette 
using a fluorimeter. The excitation and emission wavelengths were set at 354 nm and 
473 nm respectively. Fluorescence of all samples was recorded in triplicate and cellular 




















Figure 2.2. Evaluation of a DNA assay for assessment of cell number.
A typical standard curve obtained from the DNA assay (A). Linearity of
DNA assay with respect to cell number (B). A series of DNA standards prepared in
200 pi Tris buffer and dilutions of WEHI cells were incubated with EDTA
(20 mins/37°C). 10 pi KH 2PO4  was then added followed by Tris buffer (1 400 pi to
standards; 1 600 pi to cells). Finally, 500 pi Hoechst 33258 was added to all samples
and the fluorescence was recorded (excitation = 354 nm; emission = 473 nm)
2.4.4 Osteocalcin assay
Iodination of osteocalcin
Osteocalcin standard was resuspended in 40 pi PBS and transferred to a reaction vessel 
containing a magnetic flea. 10 pi of 1251 (1 mCi) was then added followed by 20 pi 
chloramine T (0.5% w/v) which started the reaction. After exactly 1 minute, the 
iodination was terminated by the addition of 2 0 0  pi sodium metabisulphite (0.016% 
w/v) followed by 400 pi KI (1% w/v). The contents of the reaction vessel were 
transferred to the top of a Sephadex G25 column (prepared by incubating 5 g Sephadex 
medium grade G25 with 100 ml PBS+1% BSA overnight at 10°C) and 1 2 5I-osteocalcin 
was eluted with PBS+1% BSA. 40 x 1 ml fractions were collected and 5 pi aliquots 
were counted in a gamma counter. The hottest fractions containing iodinated protein 
were pooled, diluted in Bent T (0.01 M TRIS pH 7.4, 0.14 M NaCl, 0.025 M EDTA, 
0.1% Tween 20,0.25% BSA) to 10 000 cpm/50 pi, and stored at -20°C until required.
Osteocalcin assay
Osteocalcin released into supernatants was measured by specific competitive 
radioimmunoassay (RIA). In this assay, radiolabelled osteocalcin (1 2 5I-osteocalcin) 
and cold osteocalcin in standards or samples compete for binding sites on a primary 
antibody (rabbit anti-bovine osteocalcin). A second antibody (goat anti-rabbit 
gammaglobulin) is then added to precipitate the osteocalcin-primary antibody complex 
and this is collected by centrifugation and counted at the end of the assay.
Supernatants were collected from human bone-derived cells or osteosarcoma cell lines 
and 3 x 50 pi aliquots were transferred into LP4 tubes. Reference tubes detecting total 
counts, non specific binding and maximum binding were then prepared in triplicate. 
Total counts (TC) were determined by the addition of 3 x 50 pi aliquots of 1 2 5I- 
osteocalcin. Non-specific binding (NSB) was detected using 3 x 50 pi aliquots of 2 % 
normal rabbit serum (NRS) diluted in Bent T. Maximum binding (MAX) was assessed 
by recording counts obtained in the absence of cold osteocalcin. A standard curve of 
purified bovine osteocalcin was then prepared in triplicate by serial dilution to give 
standards of 100, 50, 33, 20,10, 5, 3.3, 2, and lng/ml. 50 pi primary antibody 
(diluted 1/10 in Bent T) was then added to all tubes except TC and NSB. Next, 50 pi 
2% NRS was added to all tubes except TC, to produce a larger more visible pellet, 
followed by 50 pi 1 2 5I-osteocalcin. The total volume was made up to
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300 pi using Bent T (except TC), the contents were mixed well and all tubes were 
incubated overnight at 4°C. After this time, 50 pi secondary antibody (diluted to 20 ml 
with Bent T), 50 pi polyethylene glycol (5% in H2O; mw 8000) and 500 pi Bent T was 
added to all tubes except TC. Tubes were mixed again and after a further overnight 
incubation at 4°C, precipitates were collected by centrifugation at 3000 rpm/ 25 min/ 
4°C. The supernatants were removed by aspiration (not TC) and the amount of 
radioactivity in all tubes was monitored using a gamma counter.
A graph of logio concentration (abscissa) vs B/Bq (ordinate) was then plotted where 
B/Bq is calculated from the following equation:
B/Bq = Counts per min. (standard/samplel-NSB 
MAX-NSB
A typical standard curve is shown in Figure 2.3. Osteocalcin released into supernatants 
by bone cell cultures and osteosarcoma cell lines was determined using this curve and 
values were expressed as ng/well of conditioned medium.
Figure 2,3 A typical standard curve for the osteocalcin assay
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2.4.5 Growth of human osteoblast-like cells on different matrix 
components
24-well plates or 9 cm diameter tissue culture grade petri-dishes were coated with 
different concentrations of purified matrix components. Solutions of fibronectin 
(0.1-50 pg/cm2), collagen I (0.1-50 pg/cm2) and laminin (0.1-100 pg/cm2) were 
prepared by diluting stock solutions (1 mg/ml) in sterile PBS; 1 ml was added to wells 
of 24-well plates and 5 ml was added to 9 cm diameter dishes. Collagen I gels were 
prepared was described above (Method 2.3.3); 0.25-1 ml volumes were added to wells 
of 24 well plates and 10 ml volumes were added to 9 cm dishes. All experiments were 
performed in the presence of a control where wells were coated with sterile PBS; 1 ml 
was added to wells of 24-well plates and 5 ml was added to 9 cm diameter dishes. All 
coated plates and dishes were incubated overnight at 4°C to allow maximum attachment 
of fibronectin, collagen I film and laminin, and to ensure optimal equilibration of 
collagen I gels.
Following an overnight incubation, excess coating was removed and all wells/dishes 
were washed three times with PBS (1 ml/well for 24-well plates and 5 ml/plate for 9 cm 
dishes). Confluent cultures of human osteoblast-like cells were then trypsinised 
(Method 2.2.4) and plated onto purified matrix components in MEM+10% CS-FCS. 
24-well plates were seeded at 40 000 cell/well (1 ml/well) and 9 cm dishes were seeded 
at 600 000 cells/plate (10 ml/plate). 50 % of the medium was replaced every 2 days for 
the next 10 days to ensure a good supply of nutrients. Cells cultured in 24 well plates 
were assayed for changes in differentiated osteoblast phentoype. Therefore medium 
was removed 72 hr prior to the end of the treatment period, cells were washed with 
serum free medium (1 ml/well) and MEM+5% CS-FCS containing vitamin K (10-gM) 
and vitamin C (50 pg/ml) was replaced (500 pl/well). Half the cells also received 
1,25D (10-8M), a standard differentiating agent used to promote alkaline phosphatase 
activity and osteocalcin production, and to decrease proliferation (Skjodt et al.1985; 
Beresford et al. 1984b; Beresford et al.1986); the remainder were treated with vehicle 
alone. Cells to be assayed for changes in integrin subunit expression by FACS analysis 
were not stimulated with 1,25D but maintained in MEM+10% CS-FCS throughout the 
treatment period.
After a total of 10 days on different matrix components, cells in 24-well plates and 9 cm 
diameter dishes were assayed for changes in osteoblast phenotype.
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2.4.6 Treatment of human osteoblast-like cells and osteosarcoma cell 
lines with 1,25D, IL-lp and TGFp
Confluent cultures of MG-63, HOS TE85 and human osteoblast-like cells were seeded 
into 9 cm diameter petri-dishes or 24 well plates in MEM+10 % CS-FCS (Method
2.2.4). 9 cm dishes were seeded at 600 000 cells/plate (10 ml/plate) and 24-well plates 
were seeded at 40 000 cells/well (1 ml/well). After an overnight incubation, the 
medium was removed, cells were washed in serum free medium and treatments were 
applied (5 ml/9 cm dish; 500 pl/24-well plate). In order to study the effects of 1,25D, 
experiments were performed in MEM+5% CS-FCS supplemented with vitamin K 
(10_8M) and vitamin C (50 pg/ml): 10 8M 1,25D was added to half of the cells and the 
remainder received vehicle alone. Experiments investigating the effects of IL-lp and 
TGF-p were undertaken in MEM+3% CS-FCS. IL-lp was used at a concentration of 
10 U/ml and TGF-p was used at 25 ng/ml; test agents were added to half the wells and 
the remainder received vehicle alone. All cells were incubated under test conditions for 
up to 72 hr and at the end ot the treatment period, control and treated cells were assayed 
for modulation of osteoblast phenotype.
2.5 IMMUNOCYTOCHEMISTRY
2.5.1 Preparation of cryostat sections and cultured cells
Cryostat sections were cut from osteophytic bone isolated from femoral heads following 
orthopaedic surgery or from osteoclastoma tissue. Both tissues were dipped briefly into 
polyvinyl alcohol and chilled at -70°C by precipitate immersion in n-hexane (Chayen et 
al.1973). 8  pm sections of the tissues were then cut on a Bright's cryostat, fixed with 
acetone (10 min) and stored at -70°C until required.
Cells used for immunocytochemical studies were detached from confluent plates by 
trypsinisation and seeded onto 1 0  well multi-spot slides at 2 0 0 0  cells/well in growth 
medium (50 pl/well) (Method 2.2.4). Cells were cultured for 72 hr in a humidified 
box to prevent evaporation. At the end of the incubation period, the medium was 
removed, slides were washed in PBS and cells were fixed in acetone (10 min). Slides 
were air dried, wrapped in foil and stored at -70°C for up to 3 months.
2.5.2 Histology
8  nm cryostat sections of acetone fixed undecalcified human osteophyte were stained 
using Diff-Quik. This reagent consists of two solutions, Eosin G (solution 1) and 
Thiazine (solution 2), which when added consecutively, stain newly formed non­
mineralised osteoid pink and cells blue; mineralised bone remains unchanged.
2.5.3 Immunolocalisation procedures
All steps were performed at room temperature in a moist chamber to minimize 
evaporation. At each stage, the area around the edge of the well was carefully dried 
with a tissue to prevent inter-well carry over: 25 pi of reagent was added to wells of 
10 well multi-spot slides and 80 pi was added to wells of 4 well multi-spot slides. All 
studies were performed in the presence of an appropriately diluted negative control and 
if no staining was detected, the functionality of the mAb was assessed using a cell type 
known to express the subunit in question.
2.5.4 Alkaline phosphatase anti-alkaline phosphatase (APAAP) 
technique
This procedure was essentially performed according to the manufacturer's protocol 
(Dakopatts). Acetone fixed cells and sections were overlayed with mouse mAb or 
mouse IgG (negative control) diluted appropriately in TRIS-buffered saline 
(TBS; 0.05 M TRIS-HC1 pH 7.6, diluted 1/10 in 0.15 M isotonic saline). After 
30 min, slides were washed for 1-2 min in TBS and anti mouse IgG (Dakopatts code 
no. Z 259 diluted 1/25 in TBS) was added. After a further 30 min, slides were washed 
again and APAAP complex (Dakopatts code no. D 651 diluted 1/50 in TBS) was 
replaced. After a further 30 min, slides were washed for a third time and flooded with 
alkaline phosphatase substrate. Different substrates were used for sections and cells 
(see below) but in both cases 4 mM levamisole was added to block endogenous alkaline 
phosphatase activity. This is four times higher than that recommended in the 
manufacturer's protocol but was found to be the optimum concentration by previous 
titration. After 15-20 min the reaction was terminated by immersing slides in TBS and 
then in tap water. Cells and sections were then lightly counterstained with Mayer's 
Haematoxylin for 30 sec. Excess stain was removed with tap water and the slides were 
mounted in 90% glycerol in PBS. After sealing slides with nail varnish, specimens 
were examined microscopically.
Alkaline phosphatase substrate 1 (for acetone fixed cells)
Naphthol AS-MX phosphate 
Dimethylformamide 
0.1 M TRIS buffer pH 8.2 
1M levamisole 
Fast-Red TR salt
2  mg 
0 . 2  ml 
9.8 ml 
40 jil 
1 0  mg
Naphthol AS-MX phosphate was dissolved in dimethylformamide, diluted to 10 ml 
with TRIS buffer (pH 8.2) and levamisole was added. Immediately before staining, 
the Fast-Red salt was added to the substrate solution and filtered directly onto glass 
slides.
Alkaline phosphatase substrate 2 (for acetone fixed sections)
Naphthol AS-BI phosphate 5 mg
Dimethylformamide 60 pi
0.05 M TRIS buffer pH 8.7 10 ml
1M levamisole 40 pi
4% sodium nitrite (freshly prepared) 50 pi
5% New Fuchsin in 2 M HC1 20 pi
5% New Fuschin solution was mixed with 4% sodium nitrite in a fume hood for 
30-60 sec and TRIS buffer and levamisole were then added. Naphthol AS-BI substrate 
was dissolved in dimethylformamide and added to the above solution. The reagents 
were mixed well and then filtered directly onto glass slides.
2.5.5 Immunofluorescence (IF)
A standard indirect immunofluorescence procedure (Johnson, 1981) was employed for 
immunolocalisation of a 6  because mAb GoH3 is raised in rats. Slides were washed 
for 30 min in PBS /  2% FCS (washing buffer) and overlayed with mAb or rat IgG 
(negative control) diluted appropriately in washing buffer. After 30 min, slides were 
washed again and FITC-conjugated rabbit anti-rat immunoglobulin (diluted 1/100 in 
washing buffer) was applied. The secondary antibody was preabsorbed with 1% 
human AB serum (diluted in washing buffer) for 2 hr and immunoprecipitate was 
collected by centrifugation (10 000 rpm/5 min in a microfuge); this prevents non 
specific binding to human proteins. After a further 30 min, slides were washed in PBS
alone and cells and sections were counterstained for 30 sec by immersion in 0.002% 
ethidium bromide in PBS. Residual dye was removed by rapidly rinsing the slides 
twice in PBS and then washing them for a further 30 min. Slides were mounted using 
90% glycerol in PBS containing 2.5% DABCO (diaza-bi-cyclo-octane); this prevents 
quenching of fluorescence. After sealing with nail varnish, slides were examined 
microscopically.
On some occasions, a high background fluorescence was observed which resulted from 
non specific binding. This could be reduced by incubating cells and sections with 
rabbit serum (diluted 1/5 in washing buffer) for 20 min at the beginning of the 
procedure.
2.6 PREPARATION OF CELLS FOR FLOW  CYTOMETRY (FACS 
AN ALYSIS)
MG-63, HOS and human osteoblast-like cells were seeded into 9 cm diameter petri- 
dishes in MEM+10 % FCS (Method 2.2.4) and incubated under test conditions for up 
to 10 days. At the end of the treatment period, the medium was removed (and retained 
for osteocalcin assay if required) and cells were detached by trypsinisation or treatment 
with collagenase (Method 2.2.5): neither of these enzymes interfered with integrin 
subunit expression (see Chapter 5). Cell pellets were then resuspended in 5 ml growth 
medium and 2  x 1 0  pi aliquots were counted in a haemocytometer. 1 x 1 0 5  cells were 
transferred into FACS tubes and resuspended in 60 pi of mAb or IgG (negative 
control), appropriately diluted in PBS containing FCS (1%) and human AB serum 
(1:5 dilution). After 90 min on ice with occasional agitation, cells were washed in 4 ml 
dilution buffer (PBS+1% FCS) and resuspended in 50 pi of the appropriate FITC- 
conjugated secondary antibody (diluted 1/20 in dilution buffer). After a further 30 min 
on ice, cells were washed again, fixed in 500 pi paraformaldehyde (1% in PBS) and 
stored at 4°C until required. Integrin subunit expression was assessed by passing 
samples through a Becton Dickinson Facstar plus and collecting and analysing 5000 
events using the program LYSIS II.
2.6.1 Analysis of FACS data
The program LYSIS II gave measurements of side scatter (SSC), forward scatter 
(FSC) and mean fluorescence intensity (MFI). When analysing FACS data, values 
obtained for the negative control (i.e cells incubated in the presence of IgG) were used 
to produce a dot plot of SSC against FSC. These parameters gave an assessment of
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granularity and size, and were used to determine the homogeneity of the sample 
population. Cell preparations were typically slightly heterogeneous and so a specific 
region enclosing the majority of the population was selected and used for subsequent 
analysis. For detection of integrin subunit expression, MFI values obtained from all 
samples (ordinate) were plotted against cell number (abscissa) and data from negative 
controls were overlayed with data obtained using anti-integrin mAbs. When 
quantifying receptor sites/cell, MFI values obtained from preparations of 6 standardised 
FITC-coated fluorescent beads were used to plot a standard curve of fluorescence 
against number FITC particles/bead (Fig. 2.4): values for sites/cell were then 
determined by regression.
Figure 2.4 A typical standard curve of FITC particles/bead against fluorescence 
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2.7 ATTA CH M EN T ASSAYS
96-well flat bottomed plates were coated with PBS (control), fibronectin 
(0.001-5 |ig/cm2), collagen I (0.001-5 pg/cm2) and laminin (0.01-20 pg/cm2). 
Different concentrations of ECM proteins were prepared by diluting stock solutions 
(1 mg/ml) in PBS and 100 pi was added to each well. After an overnight incubation at 
4°C to allow optimal attachment of matrix proteins, excess coating was removed and 
wells were washed 3 x 100 pl/well PBS. Non specific binding was then blocked by the 
addition of 100 pl/well BSA (2 mg/ml in PBS). After 1 hr at room temperature, wells 
were washed again (3 x 100 pl/well PBS) and cells were seeded into wells at 15 000 
cells/well in serum free MEM (100 pl/well). Therefore, confluent cell layers were 
detached by trypsin (Method 2.2.4), washed in serum free medium (2 x 10 ml) to
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remove any traces of serum, counted and seeded into 96 well plates coated with ECM 
proteins (or PBS). Plates were incubated at 37°C for 2 hr and % adhesion was 
assessed using a Bradford protien assay (Bradford, 1976). This colourimetric assay 
was performed using a kit from Biorad Laboratories and is based on a differential 
colour change in response to varying concentrations of protein. More specifically, the 
absorbance maximum for an acidic solution of Coomassie Brilliant Blue G-250 shifts 
from 465 nm to 595 nm as binding to protein occurs.
In order to measure attached cell protein, the medium was carefully removed, cells were 
washed with 1 x 100 pl/well PBS and then lysed by the addition of 200 pl/well 
de-ionised H2O. 50 pl/well protein dye reagent was then added, wells were mixed and 
after 5 min the absorbance was recorded at 630 nm. All samples were assayed at least 
in triplicate and OD readings were subtracted from values obtained from blank wells 
containing ECM protein alone. In order to assess non attached cell protein, medium 
from supernatants and PBS from cell washes were pooled and retained. Cells within 
these fractions were collected by centrifugation in a microfuge ( 6  500 rpm/5 min) and 
resuspended in de-ionised H2O (Typically the contents from three wells were pooled 
and resuspended in 600 pi H2 O). 2 0 0  pi aliquots were dispensed into wells of a 
96-well plate and 50 pl/well Biorad dye reagent was added. After mixing well, cell 
lysates were left to stand for 5 min and the absorbance was recorded at 630 nm.
% adhesion was determined using the following equation:
% adhesion = OD from attached cells____________ x 100
OD from attached + non attached cells
CHAPTER 3.
MODULATION OF OSTEOBLAST PHENOTYPE 
BY EXTRACELLULAR MATRIX 
COMPONENTS
3.1 Abstract
The aim of this study was to investigate the effects of three different ECM proteins on 
the phenotypic characteristics of human osteoblast-like cells over a period of 1 0  days. 
Four of the main parameters commonly used to assess osteoblast function were 
examined, namely morphology, proliferation, alkaline phosphatase activity and 
osteocalcin production. All studies were undertaken in the presence and absence of 
1,25D, a bone-derived cell differentiating agent, and results obtained were compared to 
those observed on tissue culture plastic.
Culture on different concentrations of fibronectin (0.1-50 pg/cm2) for 10 days did not 
significantly affect cell morphology or alkaline phosphatase activity, but it slightly 
stimulated proliferation and decreased 1,25D induced osteocalcin release. Growth on 
different concentrations of laminin (1-100 pg/cm2) or type I collagen (0.1-50 pg/cm2) 
for the same time period did not affect morphology. However, both of these ECM 
components decreased cellular alkaline phosphatase activity and 1,25D induced 
osteocalcin production. The effects of collagen I film were generally more pronounced 
than those of laminin and in addition, this matrix caused a reduction in proliferation 
which was not apparent following growth on laminin. Culture of human osteoblast­
like cells on collagen gels (1.25-5 mm depth) exerted the most dramatic effects. This 
matrix induced a change in cell morphology and decreased cell proliferation, alkaline 
phosphatase activity and 1,25D induced osteocalcin release.
The effects of culturing human osteoblast-like cells on different ECM components are 
compared with results obtained using other osteoblast models and non-bone cell types. 
In addition, the relevance and possible implications of these findings in vivo are 
discussed.
3.2 Introduction
The ECM may be considered as an insoluble local mediator which plays an important 
role in regulating many different aspects of cell function. The ECM of bone is 
composed of at least 200 different proteins (Delmas et al.1984) many of which have yet 
to be fully characterised. Some of these proteins are the secretory products of 
osteoblasts and others are derived from the vascular basement membrane. The aim of 
these studies was to determine whether three of these ECM components, namely 
collagen I, fibronectin and laminin, affect the phenotype of cultured human osteoblast­
like cells. Collagen I, the most abundant protein in the bone matrix, can influence cell 
polarity, morphological organisation and gene expression of mouse mammary epithelial 
cells. In addition, it can influence the transformation of mesenchymal lens epithelium 
and promote capillary duct formation of endothelial cells (reviewed by von der Mark et 
al. 1992). Fibronectin is one of the most prevalent and versatile of the non collagenous 
bone matrix proteins and can promote attachment and spreading of mesenchymal and 
epithelial cells. It can also influence the proliferation and migration of embryonic 
tumour cells and can control cell differentiation, cell shape and cytoskeletal organisation 
(reviewed by von der Mark et al.1992). Laminin is a major adhesive glycoprotein of 
cell basement membranes and can control a number of biological activities. For 
example, it induces polarisation and differentiation of melanoma cells, endothelial cells 
and mouse mammary epithelial cells. It also stimulates neurite growth and enhances 
proliferation and motility of tumour cells and skeletal myoblasts. Angiogenesis is an 
essential prerequisite for bone formation (Trueta, 1963; Froidart and Reddi, 1980). 
Since osteoblasts and osteoprogenitor cells are in contact with the basement membrane 
of the invading vascular system, it has been suggested that the endothelial cell matrix, 
which is rich in laminin, may play a role in regulating bone cell function (Vukicevic et 
al.1990).
Methods for investigating the long term effects of ECM components on human 
osteoblast phenotype were developed from a number of different reports. Fibronectin 
and collagen I film were applied over a concentration range of 0.1-50 pg/cm2  and 
laminin was used over a range of 1-100 pg/cm2  . This range encompasses those 
concentrations used by other workers studying the effects of ECM proteins on non 
bone cell types (Kleinman et al.1981; Ruoslahti et al.1982; Aggeler et al.1988; Adams 
and Watt, 1989; Fernandez and Ben-Ze'ev, 1989; Vukicevic et al.1990). In light of the 
results obtained using primary cultures of mammary epithelial cells (Emerman and 
Pitelka, 1977; Lee et al.1984; 1985; 1987), hydrated collagen I gels were also prepared
to a depth of approximately 1.25-5 mm (0.25-1.0 ml volume in 24-well plates). 
Previous studies investigating the differentiating effects of ECM components were 
performed over a period of 6 - 8  days (Emerman and Pitelka, 1977; Lee et al.1984;
1985; 1987). Therefore human osteoblast-like cells were cultured on purified matrix 
components for 7 days and then half the cells were treated with 1,25D to induce the 
expression of the differentiated osteoblast phenotype. After a total of 10 days in 
culture, four different parameters of osteoblast phenotype were assessed, namely cell 
morphology, proliferation, alkaline phosphatase activity and osteocalcin production. 
The second two markers are indicative of a more differentiated osteoblast phenotype 
and when cells are grown on tissue culture plastic, levels are typically increased by 
1,25D (Beresford et al. 1984b; Skjodt et al. 1985; Beresford et al.1986). Any 
modulation of osteoblast phenotype following growth on different ECM proteins was 
assessed in the presence and absence of 1,25D by comparing levels obtained with those 
observed on medical grade polystyrene tissue culture plastic.
3.3 Methods
3.3.1 Effect of trypsin on cellular alkaline phopshatase activity
Human osteoblast-like cells were cultured in two 24-well plates in the presence and 
absence of 1,25D (Method 2.4.6). After 72 hr, cells from one plate were assayed for 
alkaline phosphatase directly, and cells from the other plate were detached by 
trypsinisation and then alkaline phosphatase activity was assessed. Cell layers to be 
assayed directly were washed with PBS ( l x l  ml) and lysed with 0.1% Tween 20 
(200 pl/well). Cells from the other plate were detached by trypsinisation (Method
2.2.5), resuspended in 0.1% Tween 20 (200 pl/well) and transferred to 24-well plates. 
1.80 ml substrate buffer (prepared as described in Method 2.4.2) was then added to all 
wells and both plates were incubated at 37°C for 30-40 min. 250 pi aliquots were 
transferred to wells of a flat bottomed 96-well plate and the absorbance was recorded at 
410 nm. Enzyme activity was then determined from a standard curve (prepared as 
described in Method 2.4.2) and results were expressed as pmol p-nitrophenol/ml/hour 
(Table 3.1 A).
3.3.2 Effect of collagenase on cellular alkaline phosphatase activity
Human osteoblast-like cells were cultured in two 24-well plates in the presence and 
absence of 1,25D (Method 2.4.6). After 72 hr, cells from one plate were trypsinised 
and assayed for alkaline phosphatase; cells from the other plate were incubated with
collagenase I (0.3% in serum free medium) for 30 min and 60 min, then trypsinised 
and alkaline phosphatase activity was assessed (Method 2.4.2). Enzyme activities were 
determined from a standard curve and results were expressed as pmol 
p-nitrophenol/ml/hour (Table 3. IB).
3.3.3 Effect of trypsin and collagenase on the osteocalcin assay
In order to assess the effects of trypsin, a standard curve was constructed in PBS using 
purified bovine osteocalcin (1-100 ng/ml; 250 pl/well). 125 pl/well trypsin/EDTA 
solution was then added and after 5 min at 37°C, enzyme activity was neutralised by 
the addition of 125 pi MEM+20% FCS. 3 x 50 pi aliquots of this solution were 
assayed for osteocalcin (Method 2.4.4). In order to assess the effects of collagenase in 
this assay, a series of osteocalcin standards were prepared (10-1000 ng/ml). 25 pi of 
each standard was then dispensed into wells of a 24-well plate and a collagen I gel 
(225 ul) was prepared on top. Collagenase I was added (0.3% in serum free medium; 
250 pl/well) and after 30 min at 37°C, 3 x 50 pi aliquots were assayed for osteocalcin. 
These assays were performed in the presence of two other standard curves: one of 
these was prepared as described above and the other was prepared in Bent T as 
described in Method 2.4.4.
3.3.4 Effect of collagen fibres on the osteocalcin assay
An osteocalcin standard curve was constructed in PBS using purified osteocalcin 
standard (10-1000 ng/ml). 25 pi aliquots were then overlayed with 225 pi collagen I 
gels as described above. After the gels had formed, they were dispersed by drawing 
the contents through a syringe, and then 3 x 50 pi aliquots were assayed for osteocalcin 
(Method 2.4.4). A similar standard curve was prepared simultaneously in serum free 
medium (10-1000 ng/ml; 250 pl/well) and 3 x 50 pi were assayed for osteocalcin.
3.3.5 Effect of collagen I gels on total osteocalcin production
Human osteoblast-like cells were cultured on tissue culture plastic and collagen I gels 
for 10 days (Method 2.4.5). At the end of the treatment period, supernatants were 
removed and retained for osteocalcin assay. Collagen I gels were then overlayed with 
an equal volume of serum free medium and mechanically dispersed using a syringe. 
These samples still contained attached cells and therefore cells seeded onto plastic were 
scraped and resuspended in appropriate volumes of serum free medium. Another 
control containing dispersed collagen I gels in the absence of cells was incorporated
into the assay and 3 x 50 pi aliquots of all samples were assessed for osteocalcin 
(Method 2.4.4).
3.4 Results
3.4.1 Effect of matrix components on cell morphology
Cell morphology following growth on fibronectin, collagen I film and laminin was not 
significantly different from that observed on tissue culture plastic (Fig. 3.1 A). All cells 
exhibited a typical flattened, fibroblastic morphology which was not affected by 1,25D. 
In contrast, cells cultured on collagen I gels displayed long cellular processes which 
penetrated the gel and after 1 0  days in culture, cells appeared to have migrated down 
into the matrix (Fig. 3.IB ) . The change in morphology was particularly apparent 
following growth on 1.25 and 2.5 mm gels and these progressively contracted after 
2 days in culture. None of these features was affected by the presence of 1,25D.
3.4.2 Effect of matrix components on cell proliferation
Cell counts were slightly reduced following treatment with 1,25D (Fig. 3.2) but 
different matrices exerted a variety of effects on cell number. Proliferation on 0.05 and 
0.5 pg/cm2  fibronectin was not significantly different from that observed on tissue 
culture plastic, in the presence or absence of 1,25D. However, at concentrations of 
5 and 50 pg/cm2  in the absence of this inducing agent, proliferation was significantly 
increased (Fig. 3.2A). Laminin exerted no significant effect on cell proliferation in the 
presence or absence of 1,25D over a concentration range of 1-100 pg/cm2  (Fig. 3.2B). 
In contrast, growth on collagen I film (Fig. 3.2C) and collagen I gel (Fig. 3.2D) 
reduced cell number at most ECM concentrations tested. This effect was observed 
irrespective of the presence or absence of 1,25D, but in the absence of this steroid, the 
inhibition of cell proliferation was more pronounced.
3.4.3 Effect of trypsin and collagenase on alkaline phosphatase activity
Alkaline phosphatase is a membrane bound enzyme which could potentially be 
degraded by enzymes such as trypsin and collagenase. Therefore preliminary 
experiments were undertaken to assess the effects of these enzymes on alkaline 
phosphatase activity (Methods 3.3.1 and 3.3.2). Results from these studies showed 
that there was no significant loss of alkaline phosphatase following treatment of human 
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Table 3.1. Effect of trypsin (Table 3.1 A) and collagenase (Table 3. IB) on cellular alkaline phosphatase 
activity. Human bone-derived cells were cultured in the presence or absence of 1,25D. After 72 hr, 
cells were treated with trypsin or collagenase and cellular alkaline phosphatase activity was assessed. 
Values obtained for each treatment represent means and standard deviations from six wells each of 
which was assayed in triplicate.
3.4.4 Effect of matrix components on alkaline phosphatase activity 
when related to cell number.
Alkaline phosphatase activity was increased following addition of 1,25D irrespective of 
ECM applied (Fig. 3.3). Enzyme activities obtained following growth on 0.05 and 
0.5 pg/cm2  fibronectin were not significantly different from those observed on tissue 
culture plastic (Fig. 3.3A). However in the presence of 1,25D, at concentrations of 
5 and 50 pg/cm2, cellular alkaline phosphatase was significantly increased. Culture on 
collagen I film over a concentration range of 0.05-5 pg/cm2  did not affect enzyme 
activity in the presence or absence of 1,25D. However, at a concentration of
50 pg/cm2, in the presence of 1,25D, alkaline phosphatase activity was statistically 
reduced (Fig. 3.3B). Growth on collagen I gels caused a marked reduction in enzyme 
activity both in the presence and absence of 1,25D (Fig. 3.3C): on this matrix, cells 
expressed up to three fold less alkaline phosphatase than control cells cultured on tissue 
culture plastic.
3.4.5 Effect of m atrix  components on alkaline phosphatase activity 
when related to cellular DNA.
In all experiments, alkaline phosphatase activity was increased following treatment with 
1,25D but basal and stimulated levels varied between experiments even when cells were 
cultured on tissue culture plastic (Fig. 3.4). This was thought to result from the fact 
that osteoblast-like cells were derived from patients of different age, sex and state of 
health. Culture on different concentrations of fibronectin had no consistent effect on 
alkaline phosphatase in the presence or absence of 1,25D (Fig. 3.4A). Similarly, 
culture on laminin at concentrations of 1 and 1 0  pg/cm2  did not affect enzyme activity 
(Fig. 3.4B). However, at concentrations of 50 and 100 pg/cm2  laminin, enzyme 
activity was reduced, in the presence and absence of 1,25D. Growth on collagen I Film 
at a concentration of 0.05 pg/cm2  did not affect enzyme activity (Fig. 3.4C). However, 
at concentrations of 0.5,5 and 50 pg/cm2, enzyme activity was reduced both in the 
presence and absence of inducing agents. Growth on collagen I gel also caused a 
marked decrease in alkaline phosphatase activity (Fig. 3.4D): this effect was 
independent of the depth of gel and more pronounced in the presence of 1,25D.
3.4.6 Effect of m atrix  components on osteocalcin production
Osteocalcin was only detected following treatment of bone-derived cells with 1,25D 
and the amount secreted decreased with increasing concentration of matrix applied 
(Fig. 3.5). The only exception to this occurred following growth on 50 pg/cm2  
laminin which reproducibly increased osteocalcin towards levels observed on tissue 
culture plastic (Fig. 3.5B). The general dose dependent decrease in osteocalcin release 
was particularly pronounced following growth on collagen I gels (Fig. 3.5D) and 
suggested possible retention by the matrix. Preliminary experiments (Method 3.3.3) 
showed that trypsin and collagenase interfered with the osteocalcin RIA (Fig. 3.6A). 
However, dispersed collagen fibres did not affect the osteocalcin standard curve 
(Fig. 3.6B) and therefore osteocalcin released into collagen I gels was assessed 
following mechanical disruption. Although the levels obtained following growth on 
tissue culture plastic varied between experiments, total osteocalcin was progressively
reduced following growth on increasing depths of collagen I gel (Fig. 3.7). This 
showed that the decreased osteocalcin secretion into the culture medium (Fig. 3.5D) did 
not result from increased retention by the collagen matrix.
3.5 Discussion
This study compares the effects of culture on different matrix components on the 
expression of the osteoblastic phenotype in human bone-derived cells. The apparent 
similarity between morphology on tissue culture plastic and different concentrations of 
fibronectin, laminin and collagen I film can be explained by the fact that most cells 
adopt a characteristic flattened morphology when they adhere and proliferate on any 
solid substratum (Knox and Griffiths, 1980). However, laminin has been shown to 
elicit distinct morphological changes in other cell types. For example, Sertoli cells 
become more columnar, Schwann cells become more elongated and B 16 melanoma 
cells form cell aggregates when cultured on this matrix (reviewed by Kleinman et 
al.1985). The change in cell shape observed following growth on collagen I gel 
correlates with data reviewed by Grinnell (1982). The fact that contact with collagen I 
film did not affect morphology suggests that the organisation of the collagen matrix 
and/or the ability of cells to penetrate this matrix are important factors in promoting 
changes in morphology. Gel contraction was typically observed following growth on 
1.25 and 2.5 mm gels and interestingly, these wells produced the most dramatic 
changes in morphology.
Proliferation of human osteoblast-like cells varied with ECM applied. The increased 
cell number observed following growth on fibronectin in the absence of 1,25D 
correlates with other data obtained using embryonic and tumour cell lines (reviewed by 
von der Mark et al. 1992). However, the absence of any proliferative effects following 
growth on different concentrations of laminin does not agree with other studies 
performed in non bone cell types which demonstrate a growth promoting effect of this 
ECM protein (reviewed by Kleinman et al.1985). Conflicting results have been 
obtained for the effects of laminin on the clonal osteoblast-cell line MC3T3-E1: 
Vukicevic et al.(1990) showed a time dependent stimulation of proliferation over a 
period of 8  days whereas Schotland et al.(1992) demonstrated a 60% reduction in cell 
proliferation over 1-15 days. The anti-proliferative effects of collagen I film and 
collagen I gel appear to be more consistent and the results of these studies are in good 
agreement with those of Vukicevic et al.(1990) and Schotland et al.(1992).
Throughout these studies, 1,25D slightly reduced cell number, a phenomenon which
typically accompanies induction of a more differentiated osteoblast phenotype in this 
culture system (Beresford et al. 1984b; Skjodt et al.1985; Beresford et al.1986).
The induction of alkaline phosphatase activity observed following addition of 1,25D is 
a well documented response of human osteoblast-like cells and is used for their 
characterisation (Beresford et al.1986). Growth on fibronectin did not generally affect 
basal or stimulated levels of alkaline phosphatase: although enzyme activity was 
slightly induced in one experiment when results were related to cell number, no such 
response was observed in three subsequent experiments when results were expressed 
per |ig DNA. In contrast, growth on increasing concentrations of laminin reduced 
alkaline phosphatase activity particularly in the presence of 1,25D. These results do not 
correlate with findings observed by Schotland et al.(1992) who demonstrated an 
increase in alkaline phosphatase after culturing MC3T3-E1 cells on this matrix. 
Experiments performed in other cell types also suggest that laminin in some way 
promotes differentiation. For example, laminin has been shown to stimulate 
differentiation of embryonic F9 cells, teratocarcinoma cells and B16 melanoma cells in 
different culture systems (reviewed by Kleinman et al.1985). The decreased levels of 
alkaline phosphatase activity observed following growth of human osteoblast-like cells 
on collagen I film and collagen I gel correlates with studies performed by Schotland et 
al.(1992), who demonstrated a 50% reduction in alkaline phosphatase after culturing 
MC3T3-E1 cells on collagen I film. However, when bone cells isolated from rat 
calvariae were seeded onto collagen I gel, a 127% increase in alkaline phosphatase 
activity was observed when compared to levels obtained on tissue culture plastic 
(Guerra et al.1992).
The absence of any detectable osteocalcin under basal conditions and its induction by 
1,25D is another characteristic feature of human bone-derived cells (Beresford et 
al. 1984b). In these experiments, growth of human osteoblast-like cells on increasing 
concentrations of fibronectin, collagen I film and laminin and on different depths of 
collagen I gel typically decreased 1,25D induced osteocalcin release. This apparent 
reduction may have resulted from retention by the matrix through non-specific binding 
of matrix components or through induced cell polarisation and specific secretion at the 
basal surface. However, when total osteocalcin released by cells grown on collagen I 
gels was assessed, levels continued to decrease with increasing depth of collagen I gel. 
It is possible that the reduction observed following growth on collagen I gel resulted 
from altered availability of 1,25D. Collagen I gels contained large amounts of serum 
(-37 %) which could bind this low molecular weight compounds and lower its effective 
concentration. However, this reduction cannot be attributed purely to relative
availability since a decrease in osteocalcin release was also observed following growth 
on collagen I film. The progressive reduction in osteocalcin release with increasing 
depths of collagen I gel might also result from the availability of nutrients and oxygen. 
This would correlate with the marked reduction in proliferation following growth on 
5 mm gels. However, the majority of cells remained towards the top of the matrix and 
moreover, no such effect was observed on alkaline phosphatase activity.
From these experiments, it can be seen that different matrix components exerted a 
variety of effects on human bone cell phenotype. Growth on different concentrations 
of fibronectin did not significandy affect cell morphology or alkaline phosphatase 
activity but it slighdy increased proliferation and decreased 1,25D induced osteocalcin 
release. The similarities observed between growth on fibronectin and on tissue culture 
plastic can be partly explained by the fact that fibronectin within the serum contributes 
to cell attachment when cells are seeded onto tissue culture plastic (-7.5 jig/ml). 
Therefore conditions in control and fibronectin coated wells would be very similar. 
However, pre-coated wells would contain considerably more fibronectin than non­
coated wells suggesting a higher affinity binding between the cell and its ECM. This 
could potentially contribute to the cells 'well-being' and thus result in increased cell 
proliferation. The apparent reduction in osteocalcin detected in supernatants could be 
due to cell polarisation and specific secretion into the matrix. However, the fact that 
this phenomenon occurred following growth on all matrices, together with the general 
adhesiveness of this glycoprotein, suggests that the decrease resulted from non-specific 
binding to fibronectin.
Growth on different concentrations of laminin did not affect cell morphology or cell 
proliferation. However, results from alkaline phosphatase and osteocalcin assays 
suggest that laminin decreased expression of the differentiated osteoblast phenotype. 
Although laminin has been shown to promote differentiation in many other cell types, a 
’de-differentiating1 response could be more advantageous to osteoblasts in vivo. 
Angiogenesis is a prerequisite for bone formation and laminin is a major component of 
the endothelial cell basement membrane. During early phases of bone formation and 
fracture repair, osteoprogenitor cells and osteoblasts are in contact with the invading 
vascular system. During these early phases of bone formation, osteoblasts and 
osteoprogenitor cells must produce the necessary cell numbers for subsequent matrix 
synthesis. By promoting a less differentiated osteoblast phenotype, laminin could help 
to ensure that cells remain in a proliferative phase.
Growth of human osteoblast-like cells on different concentrations of collagen I film and 
on different depths of collagen I gel reduced proliferation, alkaline phosphatase activity 
and 1,25D induced osteocalcin release. The 'de-differentiating' effects of both these 
matrices were more pronounced than those obtained for laminin and cellular responses 
to collagen I gels were typically more dramatic than those of collagen I films. The main 
difference in phenotypic effects of collagen I film and collagen I gel concerned cell 
morphology. The fact that cells cultured on collagen I gel exhibited a change in shape 
which could be correlated with gel contraction suggests that these two responses are 
intimately associated events. Both of these matrices affected cell proliferation and both 
reduced cellular alkaline phosphatase activity and 1,25D induced osteocalcin release. 
This suggests that contact with collagen I is sufficient to elicit a cellular response and 
that organisation of collagen fibres is not important for these phenotypic effects. 
Therefore, in these experiments, cell morphology, cell proliferation and differentiation 
do not appear to be linked.
The apparent ’de-differentiating' effects of type I collagen do not agree with studies 
performed using other cell types such as mouse mammary epithelial cells (Emerman 
and Pitelka, 1977) (see above) and hepatocytes. When hepatocytes are seeded onto 
plastic they round up and die within three days. If, however, they are seeded onto a 
collagen I gel, they attach and remain morphologically identifiable as hepatocytes for 
periods of 6-7 days in culture. Furthermore, if these collagen I gels are released from 
the culture dish, expression of cytochrome P450 is maintained (Strom and 
Michalopoulos, 1982). There is also some evidence to suggest that culture on a 3D 
matrix of type I collagen promotes a differentiated phenotype in osteoblast-like cells. 
For example Casser-Bette et al.(1990) demonstrated that when MC3T3-E1 cells are 
cultured on a matrix of denatured type I collagen for 56 days, cells exhibited 
characteristics typical of a differentiated osteoblast phenotype. This includes synthesis 
of type I collagen, matrix mineralisation and strong expression of alkaline phosphatase 
and osteocalcin in the absence of 1,25D. However, these results were not compared 
with data obtained from cells cultured for a similar time period on tissue culture plastic 
or on other 3D matrices such as agarose or methyl cellulose. Therefore the ability of 
type I collagen to induce a differentiated osteoblast phenotype in this system remains to 
be established.
From the experiments performed in our laboratory, one could speculate that culture on 
collagen I is encouraging progression through the osteoblast lineage and that the down 
regulation of gene expression and decreased proliferation represents the formation of 
osteocytes and/or osteoblast lining cells. These two cell types are both end cells of the
osteoblast lineage; osteoblast lining cells are formed in metabolically quiescent areas at 
the bone surface and osteocytes are produced when osteoblasts become surrounded by 
collagen matrix. However, this seems rather unlikely in view of the results obtained 
using MC3T3-E1 cells after 56 days culture on a matrix of denatured type I collagen 
fibres (Casser-Bette et al.1990).
It would have been very exciting if growth on a collagen matrix had increased alkaline 
phosphatase activity and osteocalcin release because this would provide direct evidence 
to suggest that the ECM is responsible, at least in part, for promoting osteoblast 
maturation and differentiation. It is possible that a longer time course is required for 
any ECM to promote a more differentiated osteoblast phenotype. Alternatively, 
collagen alone may not be sufficient for induction of the differentiated osteoblast 
phenotype and different results would perhaps have been obtained if these experiments 
were repeated using a combination of different ECM proteins. In view of the 
importance of matrix proteins in the presentation of cytokines (see Introduction), it 
would also have been interesting to perform some experiments using a combination of 
ECM components and cytokines. However, it is possible that an added exogenous 
matrix cannot substitute for cellular matrix synthesis. Deposition of type I collagen by 
osteoblast-like cells could form an important scaffolding for the temporal and spatial 
localisation of noncollagenous bone matrix proteins which could in turn participate in 
the regulation of bone cell function. Evidence from in vitro studies suggests that 
culture of human osteoblast-like cells in the presence of sodium ascorbate, which is 
important for collagen synthesis, also increases cell proliferation and production of the 
bone matrix proteins BSP and osteocalcin (Jon Beresford, personal communication). 
This suggests that proliferation and synthesis of type I collagen and noncollagenous 




Figure 3.1 Morphology of human osteoblast-like cells following growth on tissue 
culture plastic (A) and collagen I gel (2.5 mm) (B).
After 10 days, cells grown on tissue culture plastic (Fig. 3.1 A) exhibited a flattened, 
fibroblastic morphology. Cells cultured on a collagen I gel (Fig. 3. IB) displayed long 
cellular processes which penetrated the gel and after 10 days, cells appeared to have 
migrated down into the matrix. These changes in morphology were accompanied by 
gel contraction which typically occurred after 2 days in culture. None of these features 
were affected by the presence of 1,25D.
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Figure 3.2 Effect of different matrix components on cell proliferation.
Human osteoblast-like cells were cultured on fibronectin (0-50 pg/cm 2) 
(A), laminin (0-100 pg/cm2)(B), collagen I film (0-50 pg/cm2) (C) and 
collagen I gel (0-5 mm depth) (D); after 10 days, proliferation was 
assessed. Data were expressed as a % of control values i.e the cell 
counts obtained following growth on plastic in the absence of 1,25D 
(10'8M). All histograms represent means and standard deviations from 
two or three different expts; in each expt two sets of counts were performed 
from 2 or 3 wells. All data were pooled and cell counts obtained 
following growth on different matrix components were compared with 
those observed on plastic +/- 1,25D. The significance of any change 
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Figure 3.3. Effect of different matrix components on cellular alkaline 
phosphatase activity when related to cell no.
Human osteoblast-like cells were cultured on fibronectin (0-50 pg/cm2) 
(A), collagen I film (0-50 pg/cm2)(B) and collagen I gel (0-5 mm depth) 
(C). After 10 days, cells were detached and divided in a ratio of 1:2. 
Cells ffom the larger aliquot were assayed for alkaline phosphatase; cells 
from the smaller aliquot were counted in a haemocytometer. All 
absorbance readings were subtracted from blank values obtained by 
measuring ECM components digested in the absence of cells. Values 
represent means and standard deviations from three different wells 
each of each was assayed in triplicate. Enzyme activities obtained 
following growth on different matrix components were compared 
with results observed on plastic in the presence and absence of 1,25D 
(10'8M). The significance of any change in enzyme activity was 
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Figure 3.4 Effect of different matrix components on alkaline phosphatase 
activity when related to cell DNA.
Human osteoblast-like cells were cultured on fibronectin (0-50 pg/cm2)(A), 
laminin (0-100 pg/cm 2)(B), collagen I film (0-50 pg/cm 2)(C), and collagen I gel 
(0.5 mm depth)(D). After 10 days, cells were detached and divided in a ratio of 
1:2. Cells from the larger aliquot were assayed for alkaline phosphatase; cells 
from the smaller aliquot were assayed for cellular DNA. All absorbance and 
fluorescence readings were subtracted from blank values obtained by measuring 
ECM components digested in the absence of cells. Values represent means and 
standard deviations from three different wells each of which was assayed in 
triplicate. Enzyme activities obtained following growth on different matrix 
components were compared with results observed on plastic in the presence and 
absence of 1,25D (1CT®M). The significance of any change in enzyme activity was 
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Figure 3.5. Effect of different matrix components on osteocalcin production.
Human osteoblast-like cells were cultured on fibronectin (0-50 pg/cm2) (A), 
laminin (0-100 pg/cm2) (B), collagen I film (0-50 pg/cm2) (C), and collagen 
I gel (0-5 mm depth) (D). After 10 days, supernatants were assayed for 
osteocalcin production. All data were subtracted from blank values obtained 
for medium from wells coated with ECM proteins in the absence of cells. 
Values represent means and standard deviations from three different wells 
each of which was assayed in triplicate. Osteocalcin released by cells grown 
on different matrix components was compared with results observed on 
plastic in the presence and absence of 1,25D (10"*M). The significance of 
any change in osteocalcin release was determined using an unpaired 
Student's T-test. Results are representative of three different experiments.
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Figure 3.6. Effect of trypsin, collagenase (Fig 3.6A) and collagen fibres 
(Fig 3.6B) on the osteocalcin assay.
Standard curves were prepared in PBS from bovine osteocalcin and if 
necessary, overlayed with a collagen gel. Osteocalcin standards were 
quantified by RIA after treatment with trypsin or collagenase (Fig 3.6A) 
or in the presence of dispersed collagen fibres (Fig 3.6B). Data represent 
mean values obtained from two wells each of which was assayed in 
triplicate.
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Figure 3.7. Total osteocalcin released by cells grown on plastic and 
collagen gels.
Human osteoblast-like cells were cultured on plastic or collagen gels 
(1.25-5 mm) for 10 days. At the end of the treatment period 
supernatants, dispersed collagen gels and scraped cells (from uncoated 
wells) were assayed for osteocalcin production. All data were 
subtracted from appropriate blank values and represent means and 
standard deviations from three different wells, each of which was 
assayed in triplicate.
CHAPTER 4.
INTEGRIN SUBUNIT EXPRESSION BY 
HUMAN OSTEOBLASTS AND OSTEOCLASTS 
IN  SITU AND IN CULTURE
4.1 Abstract
The aim of this study was to establish which integrin subunits are present on human 
bone cells in situ and in culture, using cryostat sections of undecalcified human bone, 
osteoclastoma tissue and cultured human osteoblast-like cells. Integrin expression was 
identified indirectly using alkaline phosphatase anti-alkaline phosphatase conjugates and 
FITC-labelled secondary antibodies.
Staining patterns observed in situ show that osteoblasts and osteoclasts possess 
different integrin subunits. Osteoblasts express primarily a l ,  a3 and pi and weakly 
express a l. Osteoclasts express a2, aV, pi and p3. Subunits a4, a5, a6, aL, aM 
and p2 were not expressed by either of these cell types. Expression of pi by all cells of 
the osteoblastic lineage was constitutive, but a l  and a3 subunits were expressed by 
osteoblasts actively synthesizing bone and some of the osteoblast lining cells. All 
integrin subunits identified on osteoblasts in situ were maintained on culture but there 
was an increased expression a2, and aV subunits were weakly positive. Expression 
of a2, a3, aV and pi subunits was independent of cell density but expression of a l  
was much greater in confluent cultures. Integrin expression of a2, aV, pi and p3 by 
osteoclasts did not vary according to osteoclast size, location or activation state. There 
was no evidence of subunit polarisation towards the bone surface exhibited by either 
osteoblasts or osteoclasts.
4.2 Introduction
The ECM plays an important role in regulating cell function. Cellular interactions with 
the ECM occur through specific families of receptors, one of which are the integrins. 
These transmembrane proteins are ap heterodimers which play a structural role in 
mediating adhesion, and in addition, transmit information between the outside and the 
inside of the cell. The cell surface expression of integrin subunits partly determines the 
local environment immediately surrounding the cell and cytoskeletal associations 
potentially affect the way in which a cell responds to signals ffom its environment.
In view of the importance of integrin molecules, a study was undertaken to establish the 
pattern of integrin subunits expressed by human bone cells in situ and in culture. 
Immunolocalisation experiments were performed using cryostat sections of 
undecalcified human osteophyte, osteoclastoma tissue and cultured human osteoblast­
like cells. The sections were cut from developing osteophytes obtained from 
osteoarthritic femoral heads, or from osteoclastoma neoplasms (giant cell tumours); 
cells were cultured from explants of trabecular bone. Human osteophyte is highly 
cellular and extremely metabolically active and therefore provides a very good model 
for studying bone cells in situ. Osteoclastoma tissue was used because it is rich in the 
relatively rare, multi-nucleated osteoclasts (Horton et al. 1985b). All 
immunolocalisation experiments were repeated using cultures of human osteoblast-like 
cells in order to determine whether integrin subunit expression was maintained during 
in vitro conditions. Integrin subunit expression was detected using mAbs and 
identified indirectly using alkaline phosphatase anti-alkaline phosphatase conjugates 
(APAAP) or FlTC-conjugated secondary antibodies (Method 2.5).
4.3 Results
4.3.1 Histology of the osteophyte
Typical histological staining patterns observed for sections of human osteophyte are 
shown in Figure 4.1. This tissue provides a rich source of osteoblasts and osteoclasts 
and different stages of bone remodelling can be easily identified within the same 
section. For example, in this figure, metabolically quiescent areas, characterised by a 
continuous layer of osteoblast lining cells are visualised on several bone surfaces. 
However, immediately opposite one of these quiescent areas, there is evidence of active 
bone formation. Here, the osteoblasts are cuboidal and actively synthesizing bone 
matrix (osteoid). In addition, within the same section, there is evidence of bone
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resorption where osteoclasts are attached to the bone surface. These histological 
findings are in sharp contrast with those observed in sections of 'normal' bone: this 
tissue is typically relatively acellular and osteoclasts are a very rare occurrence (not 
shown).
4.3.2 Titration of mAbs for antigenic detection
Titration experiments were performed with all the anti-integrin mAbs to obtain the 
optimum concentrations required for antigenic detection. MAb dilutions used in 
subsequent immunolocalisation studies are summarised in Table 4.1. Many of these 
mAbs were positive at much lower concentrations than those described, but it was 
decided to use all immunochemicals at saturating concentrations. Some mAbs were 
negative at all concentrations tested: in these situations, the functionality of the mAb 
was assessed using an appropriate positive control.






Optimum dilution in 
sections of 
osteophyte
Detection in other cell types
a l T52/7 1/50
a2 G19 1/50
a3 PB15 1/20
a4 HP2/1 negative lymphocytes, 1/50
a5 SAMI negative U937 cells, 1/20









Titration of anti-integrin mAbs in acetone fixed human osteoblast-like cells. MAbs derived from 
ascites were diluted between 1/25 and 1/3200 but mAbs from tissue culture supernatants were not 
diluted prior to use. All experiments were performed in the presence of appropriately diluted negative 
controls (IgG) and binding of mAbs was identified by APAAP or IF (Method 2.5).
4.3.3 Integrin subunit expression by bone cells in situ and in culture
Typical staining patterns observed from immunolocalisation studies are shown in 
Figs. 4.2-4.7 and summarised in Table 4.2. In studies employing the APAAP 
technique, positive areas stained red; any purple colouration resulted from the 
counterstain haematoxylin and represents mineralised bone and cell nuclei (Fig. 4.2).
The pi subunit was strongly expressed by all osteoblasts in areas of recent/active bone 
formation (Fig. 4.3A), by all osteoblast lining cells (Fig. 4.3B) and also by osteocytes 
(Fig. 4.3C). In addition, positive staining was also apparent around the large multi­
nucleated osteoclasts (Fig. 4.3C) and in the marrow (Fig. 4.3B). Expression of a l  
and a3 subunits was similar: these subunits were expressed by all ‘active’ osteoblasts 
(Fig. 4.4A) and some osteoblast lining cells (Fig. 4.4B), but neither subunit could be 
detected on osteoclasts (Fig. 4.4C). The differential staining patterns obtained for cells 
of the osteoblastic lineage suggest that expression of some subunits varies according to 
cell phenotype. aV, p3 and a2 subunits were expressed by all osteoclasts (Fig. 4.5 
and 4.6): expression of aV and p3 were similar (Fig. 4.5) but staining patterns 
observed for the a2 subunit were typically less intense than those observed for aV and 
P3 (Fig. 4.6A). Osteoblast lining cells were negative for all of these subunits but a2 
was also occasionally visualised on osteoblasts in areas of active/recent bone formation 
(Fig. 4.6B). Integrin expression of a2, pi, aV and p3 by osteoclasts agrees with 
previous findings (Horton et al. 1985a; 1985b; Horton and Davies, 1989) and did not 
vary according to size, location or activation state of the cells. Neither osteoblasts nor 
osteoclasts showed any evidence of polarisation towards the bone surface.
Subunits aL, aM, p2, a4, a5 and a6 could not be identified on either osteoblasts or 
osteoclasts. aL, aM and p2 subunits showed a similar pattern of expression which 
was restricted to the marrow (Fig. 4.7C): no staining was observed on bone surfaces 
(Fig. 4.7A) or on osteoclasts (Fig. 4.7B). a6 subunits could be visualised on 
endothelial cells lining the occasional blood vessel but all other cell types within 
osteophytic tissue were negative (data not shown). No staining was apparent with 
mAbs directed against a4 and a5 subunits (data not shown). This did not result from 
impaired functionality as a4 subunits could be identified on freshly prepared 
lymphocytes and a5 subunits were observed on U937 cells (a myeloid cell line) (see 
Table 4.1).
Table 4.2 Imrnunolocalisation of integrin subunits in crvostat sections of undecalcified
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a4 (CDw49d) HP2/1 - -
a5 (CDw49e) SAMI - -
a6 (CDw49f) GoH3 - -




aL (C D lla) 












p3 (CD61) C22 Osteoblasts - 
Osteoclasts +++ 
Marrow -
negative; +/-, 1% positive; +, positive; ++, more positive; +++, strongly positive
In situ staining patterns observed for cells of the osteoblastic lineage were maintained in 
culture (Figs. 4.3D, 4.4E, 4.4F) but there appeared to be increased expression of a2 
(Fig. 4.6C), and aV subunits were weakly positive (data not shown). Expression of 
a2, a3, aV and pi subunits was independent of cell density but expression of a l  was 
much greater in confluent cultures.
4.4 Discussion
In addition to its obvious structural role, the extracellular matrix of bone is concerned 
with the phenotypic regulation of associated cells. Therefore, the expression of 
selective receptors by these cells for specific ligands within the extracellular matrix is 
likely to be critical in controlling cell function.
Staining patterns obtained in situ showed that osteoblasts primarily express integrin 
subunits a l ,  a3 and pi. Both of these a  subunits can combine with pi forming a lp i 
(VLA-1), a receptor for collagen and laminin, and a3pl (VLA-3), a receptor for 
collagen, fibronectin and laminin. All staining patterns observed in situ were 
maintained in culture but there appeared to be increased expression of a2, and aV 
subunits became weakly positive.
Osteoclasts expressed a different selection of integrin subunits, namely a2, aV, pi and 
p3; findings which correlate with those reported previously (Horton et al. 1985a;
1985b; Horton and Davies, 1989). pi can combine with a2 forming a receptor for 
collagen and laminin, or with aV to form a receptor which binds a range of ligands 
such as collagen, fibronectin, vitronectin, fibrinogen and von Willebrand's factor 
(Humphries, 1990). aV can also associate with p3 to encode a receptor with a broad 
specificity: possible ligands include fibronectin, vitronectin, laminin, osteopontin, 
bone sialoprotein, thrombospondin, fibrinogen and von Willebrand's factor. 
Osteopontin has been localised in the bone matrix underlying resorbing rat osteoclasts 
which may indicate a possible involvement of this protein in osteoclast adhesion in vivo 
(Mark et al. 1987; Reinholt et al. 1990). In the more recent of these studies (Reinholt et 
al.1990), high levels of osteopontin were localised in the clear zone of the osteoclast 
plasma membrane whereas much less staining was observed in the ruffled border and 
deeper within the bone. Highest expression of the vitronectin receptor (aVp3) was also 
observed at the clear zone, suggesting that osteopontin may function as an anchor of 
osteoclasts to bone by binding to the vitronectin receptor and to hydroxyapatite. 
However, in another study, aVp3 was not shown to mediate tight sealing zone 
attachment of osteoclasts to the bone surface (Lakkakorpi et al.1991). Therefore the
receptor-ligand interactions required for attachment of osteoclasts to the bone matrix are 
yet to be established.
Niether osteoblasts or osteoclasts expressed ctL, aM and p2 subunits but positive 
staining was observed in the marrow. This staining pattern is to be expected as 
expression of these subunits is restricted to leukocytes (Humphries, 1990). The result 
obtained for osteoclasts is interesting because leukocytes and osteoclasts are thought to 
be derived from a common pluripotent stem cell (CFU-GM). Negative osteoclastic 
staining could suggest that expression of these antigens is lost during the fusion of 
mononucleated osteoclast precursor cells. Alternatively, this result could imply that 
osteoclastic and leukoctyic lineages diverge at an ealy stage in their pathways of 
differentiation.
Subunits a4, a5 and a6 could not be detected on bone cells in situ or in culture. a4 
can combine with pi to form a fibronectin receptor (VLA-4) which recognises the 
alternatively spliced region of fibronectin. The negative findings correlate with 
previous reports suggesting that this subunit is expressed by resting lymphocytes, 
monocytes, neural-crest derived-cells (Springer, 1990) and melanoma cells (Albelda 
and Buck, 1990). Staining patterns obtained using monoclonal antibodies against ot5 
and a6 subunits were also negative: a5pl (VLA-5) encodes a classical fibronectin 
receptor and a6 can associate with pi to form a laminin receptor (VLA-6). The result 
obtained for a5 correlates with reports suggesting that this subunit is poorly expressed 
in most tissues (Albelda and Buck, 1990), but the negative finding observed for a6 is 
surprising as the laminin receptor is considered to be present on most cell types 
(Albelda and Buck, 1990).
Apart from mediating cell adhesion, the integrin molecules play an important role in 
transmitting signals between the external environment and the interior of the cell. As 
mentioned previously, one mechanism by which this communication could occur is 
through alterations in the cell surface expression of integrin subunits. This may be 
relevant in the context of the osteoblast in that the expression of a l ,  a2 and a3 subunits 
is restricted to certain osteoblast populations. However it is not possible to determine 
whether this is a cause or a consequence of the altered phenotype. Individual cells can 
also vary their adhesive properties by regulating the specificity and affinity of a given 
integrin molecule (see Introduction). This may be important in the case of osteoclast 
aVp3 receptor, which is constitutively expressed on osteoclasts irrespective of their site 
in bone.
The fact that osteoblasts and osteoclasts expressed a different pattern of integrin 
subunits suggests that these two cell types adhere to different ligands within the ECM 
and respond to signals from the external environment in different ways. Further 
studies to determine whether there is a difference in the adhesive specificity of these 
two cell types now need to be undertaken. The ligand binding ability of rat osteoclasts 
has already been investigated in vitro (Helfrich et al.1992). In this study osteoclasts 
adhered well to proteins such as osteopontin, BSP, vitronectin and fibronectin but 
failed to adhere to laminin. Attachment assays undertaken in our laboratory 
demonstrated that human osteoblast-like cells adhered well to laminin (data not shown), 
which suggests that the integrin subunit expression of osteoblasts and osteoclasts is 
indeed important for adhesive recognition. This could have important implications for 
the local control of bone remodelling where the amount of osteoclastic bone resorption 
at a given site is balanced by osteoblastic bone formation. It is possible that alterations 
in the composition of the ECM may favour the activity of one or other of these cell 
types. In support of this, there is evidence in a rat model that the ability of bone matrix 
to recruit osteoclasts decreases with age (Groessner-Schriber et al.1991). This could 
lead to an imbalance and might eventually result in pathological conditions such as 
osteoporosis.
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Figure 4.1 Histology of the osteophyte
Metabolically quiescent areas are characterised by a continuous layer of flattened 
osteoblast lining cells (OBL). In areas of active bone formation, cuboidal osteoblasts 
(OB) actively synthesise osteoid (OD). In areas of bone resorption, osteoclasts (OC) 
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AFigure 4.2 Negative control (mouse IgG) of integrin subunit expression in cryostat 
sections of undecalcified osteophyte, in sections of osteoclastoma and cultured 
osteoblast-like cells.
In sections of osteophyte (A), haematoxylin stains mineralised bone (MB) and cell 
nuclei (N): the lighter areas surrounding the mineralised bone represent newly formed 
non-mineralised osteoid (OD). In sections of osteoclastoma (B), haematoxylin stains 
cell nuclei thus enabling the large multi-nucleated osteoclasts (OC) to be easily visualised. 
In cultured osteoblast-like cells (C), haematoxylin stains cell nuclei (N). Original 








Figure 4.3 Expression of pi subunits in cryostat sections of undecalcified osteophyte 
and cultured osteoblast-like cells.
Osteoblasts (A; OB), osteoblast lining cells (B; OBL), marrow cells (B; M), 
osteocytes (C; OS) and osteoclasts (C; OC) are strongly positive. Expression by 
osteoblast-like cells is maintained in culture (D).









Figure 4.4 Expression of c3  subunits in cryostat sections of undecalcified human 
osteophyte, in sections of osteoclastoma and in cultured osteoblast-like cells.
Note positive staining of osteoblasts in areas of active/recent bone formation (A; OB) 
but differential staining of osteoblast lining cells (B; OBL). No expression is 
observed on osteoclasts (C; OC) which stain strongly for aV (D; positive control). 
Expression is maintained in culture (E). Staining patterns observed for a l  subunits 
are very similar but expression in cultured osteoblast-like cells is only readily 
apparent in confluent cultures (F).
Original magnification: A, B, C, D, E, F x 200. Bar, 45
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Figure 4.5 Expression of aV (A) and |33 (B) in cryostat sections of undecalcified 
human osteophyte.
Osteoclasts are positive (OC) but osteoblast lining cells (OBL) which cover the bone 







Figure 4.6 Expression of a2 in cryostat sections of undecalcified human osteophyte and 
cultured osteoblast-like cells.
Osteoclasts are positive (A; OC) but osteoblast lining cells are negative (A; OBL). Some 
osteoblastic staining is observed in areas of active/recent bone formation (B; OB) and 
expression is also observed in culture (C).
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Figure 4.7 Expression of p2 in cryostat sections of undecalcified human osteophyte 
and sections of osteoclastoma.
Osteoblast lining cells which cover the bone surface are negative (A; OBL) and 
osteoclasts (B; OC) are negative, but there is positive staining in the marrow (C; M). 
Original magnification: A, B x 200; C x 400. Bar, 45 nm
CHAPTER 5.
REGULATION OF INTEGRIN SUBUNIT 




The aim of this study was to examine the expression of integrin subunits on human 
osteoblast-like cells by flow cytometry, and to determine whether expression of the 
major subunits was modulated by agents known to affect other aspects of human bone 
cell function. For these studies, experiments were performed to assess the effects of 
1,25D, IL-lp and TGFp, and growth on fibronectin, laminin, collagen I film and 
collagen I gels, on integrin subunit expression. Any modulation of integrin subunit 
expression was compared with other phenotypic effects elicited by these agents, and the 
significance of any correlations was assessed.
Under basal conditions, the major integrin subunits expressed by human osteoblast-like 
cells were a3 and pi although a l and a2 subunits were also present at relatively high 
concentrations. Treatment of human osteoblast-like cells with 1,25D (10 8M) for 
24-72 hr did not affect the expression of a l ,  a3, or pi subunits, but expression of a2 
was statistically increased after 72 hr. Administration of IL-lp (10 U/ml) for similar 
time periods, exerted pronounced effects on integrin subunit expression. Expression of 
a l  and a2 subunits was increased at all time points and levels of pi were elevated after 
48 and 72 hr. Expression of a3 subunits was increased after 24 hr but decreased after 
48 and 72 hr. Another cytokine, TGFp (25 ng/ml), also influenced integrin subunit 
expression. Like IL-lp, this cytokine increased expression of a2 at all time points and 
levels of pi were elevated after 48 and 72 hr. Unlike the actions of IL-lp however, 
expression of a3 subunits in TGFp treated cells was not significantly different from 
controls after 48 and 72 hr but decreased after 24 hr. In addition, a l  subunit 
expression was not affected following TGFp administration.
Culture of human osteoblast-like cells on ECM components for a period of 10 days also 
influenced integrin subunit expression. Growth on fibronectin (5 pg/cm2) and laminin 
(10 pg/cm2) did not dramatically affect expression of a l ,  a2, a3 or pi subunits. 
However, expression of a3 was statistically increased by fibronectin, and conversely, 
expression of a l ,  a3 and pi were significantly reduced by laminin. Culture on collagen 
I gels (2.5 mm depth) exerted profound effects on integrin subunit expression, the most 
pronounced of which was a 3.5 fold increase in the expression of a2. Other changes 
included an increase in expression of a l  and pi and a decrease in expression of a3.
The effects of collagen I film (10 pg/cm2) were different to those of collagen I gels: 
growth on this matrix decreased expression of all the major integrin subunits but 
particularly a l  which was reduced by over 50%.
The modulation of integrin subunit expression exhibited by cytokines and different 
matrix components could not be correlated with changes in proliferation, alkaline 
phosphatase activity or osteocalcin production. However, expression of cx2 subunits 
was direcdy associated with gel contraction and corresponding changes in cell 
morphology, which implies that different integrin subunits exert specific effects.
5.2 Introduction
Apart from mediating cell adhesion, the integrin molecules play an important role in 
transmitting signals between the external environment and the interior of the cell. One 
such mechanism by which this communication could occur is through changes in the 
level of integrin subunits expressed. Many soluble mediators have been shown to 
affect integrin subunit expression in non bone cell types and interestingly, some of 
these, namely IL-lp, TGFp, 1,25D, glucocorticoids, retinoic acid, TNFa and IFNy, 
also influence the actions of osteoblasts and osteoclasts (see Introduction). In view of 
their direct effects on the phenotypic characteristics of different cell types (Chapter 3), 
ECM components themselves are also likely to modulate integrin receptor function.
Very little information is available concerning the regulation of integrin subunit 
expression in normal adult human bone. A few experiments have been performed in 
vitro using osteosarcoma cell lines but at present there is no published data from bone 
cell cultures. The aim of this study was to examine the expression of integrin subunits 
on human osteoblast-like cells by flow cytometry (FACS analysis), and determine 
whether expression of the major integrin subunits was modulated by agents known to 
affect other aspects of bone cell function. For these experiments cells were cultured 
over a period of 1-3 days, in the presence and absence of three soluble mediators: 
1,25D, IL-lp and TGFp; each at a concentration known to produce a functional 
response. In light of the results obtained following growth on the different matrix 
components (Chapter 3), cells were also cultured on collagen I, fibronectin and laminin 
for a period of 10 days and integrin subunit expression was compared to levels 
obtained following growth on plastic. A modulation of integrin subunit expression was 
compared with other phenotypic effects elicited by these agents, and the significance of 
any correlations was assessed.
These studies required very large numbers of bone cells and in view of their slow 
growth rate (4-5 days) and the difficulty of obtaining sufficient bone for the 
establishment of cultures, all experiments were performed using just one reagent 
concentration over a very specific time period. 1,25D is a standard differentiating agent 
which decreases cell proliferation and induces alkaline phosphatase activity and 
osteocalcin production in human bone-derived cells over a period of 24-72 hr 
(Beresford et al. 1984b; Skjodt et al. 1985; Beresford et al. 1986); it was used at the 
optimum concentration of 10 8M in the presence of 5% CS-FCS. II-ip acts on human 
osteoblast-like cells over a similar time period, and increases proliferation (Gowen et
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al.1985; Gowen, 1988; Evans et al.1989), plasminogen activator activity (Evans et 
al.1989) and prostaglandin synthesis (Gowen, 1988; Evans et al.1989). In addition, it 
reduces basal and 1,25D stimulated alkaline phosphatase activity (Evans et al.1989) and 
decreases 1,25D induced osteocalcin production (Beresford et al. 1984b). This agent 
was used at the optimum concentration of 10 U/ml (10_12M) in the presence of 3% 
CS-FCS. The effects of TGFp on osteoblast-like cells are complex and dependent on 
the experimental model chosen for investigation. Centrella et al.(1987) showed that the 
TGFp (0.15-15 ng/ml) increased proliferation when added to confluent cultures of rat 
osteoblast-like cells in serum free medium for 23 hr. However, these effects were 
biphasic and dependent on cell density and concentration of TGFp applied. In contrast, 
Pfeilschifter et al.(1987) showed that similar concentrations of TGFp (0.1-10 ng/ml) 
inhibited proliferation when added to rat osteosarcoma cells (ROS 17/2.8) for 48 hr in 
the presence of 5% FCS or 1 mg/ml BSA. These authors also demonstrated enhanced 
alkaline phosphatase activity following treatment with TGFp and in both experimental 
models, collagen synthesis was increased. In order to assess the effects of TGFp on 
human bone-derived cells, it was decided to use a concentration of 25 ng/ml TGFp in 
the presence of 3% CS-FCS. The concentration of TGFp applied was higher than that 
used in other studies, but the actual concentration added is likely to be less than 
25 ng/ml: TGFp is a labile, sticky peptide and therefore small amounts will be lost 
through denaturation and attachment to the storage vessel. It would have been better to 
perform all these studies in serum free medium to prevent test agents acting in concert 
with other growth factors present within serum. However, cells were very unhealthy 
after 72 hr under these conditions and therefore all experiments were performed in the 
presence of small amounts of CS-FCS.
In order to assess the effects of ECM components on integrin subunit expression, 
human osteoblast-like cells were cultured on collagen I, fibronectin and laminin under 
conditions known to exert maximal effects on cell phenotype (Chapter 3). Cells were 
therefore cultured on 10 pg/cm2 laminin, 10 pg/cm2 collagen I film and 2.5 mm gels for 
a period of 10 days. Growth on fibronectin exerted little effect on cell phenotype but 
cells were cultured on 5.0 pg/cm2 fibronectin to determine whether this matrix affected 
the levels of integrin subunits expressed. Any modulation of integrin subunit 
expression following growth on the different ECM components was correlated with the 
phenotypic effects reported in Chapter 3.
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5.3 Methods
5.3.1 Effect of collagenase I on integrin subunit expression
Human osteoblast-like cells were cultured for 72 hr and then half the cells were 
detached by trypsinisation (Method 2.2.5) and prepared for FACS analysis (Method 
2.6). The remaining cells were pre-incubated with collagenase I (0.3% in serum free 
medium) for 30 min, then detached with trypsin and prepared for FACS analysis. MFI 
values obtained for individual integrin subunits were converted to receptor sites/cell and 
the effects of collagenase were determined.
5.4 Results
5.4.1 Detection of integrin subunits by FACS analysis
Accurate assessment of integrin subunit expression by flow cytometry requires single 
cell suspensions. Initially this was achieved by scraping bone-derived cells off the 
bottom of the tissue culture dish but this technique was very damaging and produced 
clumped cell preparations which were difficult to analyse. An alternative approach was 
to detach cells enzymically using trypsin and therefore experiments were undertaken to 
compare the intensity of APAAP staining between cytospin preparations of trypsinised 
cells and cells cultured on glass slides. Both of these cell preparations produced similar 
staining patterns but the APAAP technique is not strictly quantitative and it was difficult 
to compare the intensity of staining produced due to differences in morphology: cells 
seeded onto multi-spot slides were spread out whereas those spun onto glass slides 
were rounded (data not shown). In light of the similar staining patterns observed, it 
was concluded that enzymic digestion with trypsin did not grossly affect antigenic 
detection. Therefore this method was used in all subsequent experiments for the 
preparation of single cell suspensions for FACS analysis.
In order to assess the integrin subunit profile of bone-derived cells, cultures of human 
osteoblast-like cells were prepared for FACS analysis (Method 2.6) using all the anti- 
integrin mAbs to ensure that subunits detected by FACS analysis were similar to those 
identified in previous immunolocalisation studies. When analysing FACS results, a dot 
plot of side scatter (SSC) against forward scatter (FSC) was produced from negative 
control data and a region enclosing the majority of the population was selected for 
subsequent analysis (Fig. 5.1). Histograms for individual integrin subunits, of cell 
number against fluorescence, were then overlayed with data from appropriately diluted
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negative controls, and the integrin subunit profile of human osteoblast-like cells was 
determined (Fig. 5.2).
The illustrations in Figure 5.2 clearly demonstrate that a l ,  a2, a3 and pi were the 
major integrin subunits expressed by cultured human osteoblast-like cells: there was no 
staining with mAb raised against a4, a6, p2 and p3, and aV subunits were weakly 
expressed. All these observations correlate with results obtained in previous 
immunolocalisation studies (Chapter 4). The only discrepancy between results 
obtained by FACS and APAAP concerned expression of a5. This subunit was 
detected on bone derived cells by FACS at a 1/25 dilution of mAb but no staining was 
observed using APAAP. This may have resulted from the time of fixation and/or the 
type of fixative employed. When integrin subunits were identified by APAAP, cells 
and sections were fixed with acetone at the beginning of the procedure. However, 
when detected by FACS, cells were fixed with 1% para-formaldehyde at the end of the 
procedure. It is possible that fixation conditions required for the APAAP technique 
specifically mask antigenic expression of a5 in human osteoblast-like cells and 
therefore care should be taken when interpreting negative data obtained from 
immunolocalisation studies.
5.4.2 Titration of mAbs for antigenic detection
In order to accurately quantify the number of integrin receptor sites/cell, mAbs must be 
present at saturating concentrations. Therefore, cultures of osteoblast-like cells were 
prepared for FACS analysis (Method 2.6) using all the positive anti-integrin mAbs over 
a range of mAb concentrations. No such titration experiments were performed for 
mAbs directed against a5 and aV subunits: previous results demonstrated that anti- 
integrin a5 should be diluted 1/25, and anti-integrin aV should be added directly to 
cells without prior dilution. When analysing FACS data, MFI values were obtained for 
each sample and titration curves of fluorescence against mAb dilution were prepared 
(Fig. 5.3).
Based on results from titration experiments and relative availability, mAb dilutions used 
in subsequent FACS experiments are shown in Table 5.1.
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Table 5.1 mAb dilutions used for FACS experiments
Integrin subunit 
detected
mAb Optimum dilution of 
mAb





p i 4B4 1/50
Human osteoblast-like cells were cultured for 72 hr and prepared for FACS analysis using anti-integrin 
mAbs (or equivalent concentrations of IgG) (Method 2.6). mAbs derived from ascites were diluted 
between 1/25 and 1/3200 but mAbs from tissue culture supernatants were not diluted prior to use.
MFI values were used to plot a titration curve and optimum concentrations of anti-integrin mAbs were 
determined.
5.4.3 Quantitation of integrin subunit expression on human osteoblast­
like cells
Human osteoblast-like cells were cultured for 72 hr and then prepared for FACS 
analysis using saturating concentrations of mAb or IgG (Method 2.6). MFI values 
obtained for each sample were converted to receptor sites/cell using results obtained 
from 6 standardised preparations of FITC-coated beads. Under basal conditions, a3 
and pi were the major integrin subunits expressed although a l  and a2 subunits were 
also present at relatively high concentrations (Table 5.2). In subsequent experiments it 
was therefore decided to study the expression of these four integrin subunits: aV 
subunit expression was not further pursued due to the low values obtained for receptor 
sites/cell. Expression of a5 was not further investigated due to the high concentration 
of mAb required for its detection and the negative staining patterns obtained in previous 
immunolocalisation studies (Chapter 4).
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Table 5.2. A quantitative comparison of the integrin subunits expressed bv human
osteoblast-like cells


















Human osteoblast-like cells were cultured for 72 hr and prepared for FACS analysis using saturating 
concentrations of mAb (or IgG) (Method 2.6). MFI values were converted to receptor sites/cell and a 
minimum of 9 different values were pooled to quantify integrin subunit expression.
5.4.4. Modulation of integrin subunit expression by 1,25D, IL-lp and 
TGFp
Confluent cultures of primary human osteoblast-like cells were treated with test agents 
for 24-72 hr (Method 2.4.6) and prepared for FACS analysis using saturating 
concentrations of mAb (or equivalent concentrations of IgG) (Method 2.6). At each 
time point, cells were also assayed (in triplicate) for effects of the test agents on alkaline 
phosphatase activity (Method 2.4.2), osteocalcin production (Method 2.4.4) (1,25D
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treated groups only) and in the IL-lp and TGFp treated groups, cell proliferation 
(Method 2.4.1). The modulation of integrin subunit expression following treatment 
with 1,25D, IL-lp and TGFp is illustrated in Figs. 5.4,5.6 and 5.8, and the typical 
effects of these agents on other aspects of bone cell function, are summarised in 
Figs. 5.5, 5.7 and 5.9.
Values obtained for integrin subunit sites/cell in control groups remained constant 
throughout the treatment period. Addition of 1,25D consistently increased alkaline 
phosphatase activity and osteocalcin production (Fig. 5.5) but did not affect the 
expression of a l ,  a3 or pi subunits (Fig. 5.4). After 72 hr however, there was a small 
but statistically significant increase in expression of a2 (Fig. 5.4B). In contrast to 
1,25D, IL-lp exerted dramatic effects on the number of integrin subunits expressed 
(Fig. 5.6). The most noticable of these concerned expression of a l  and a2 subunits 
which were significantly increased at all time points (Fig. 5.6A and B). The expression 
of pi subunits was also increased, but not to the same extent as those for a l  and a2 
and only after 48 and 72 hr (Fig. 5.6D). a3 subunit expression was increased by 
treatment with IL-lp at 24 hr, but decreased at 48 and 72 hr (Fig. 5.6C). Addition of 
TGFp also modulated integrin subunit expression (Fig. 5.8). The most pronounced 
effect concerned expression of a2 subunits, which were significantly enhanced at 24 hr 
and further increased after 48 and 72 hr (Fig. 5.8B). Expression of pi subunits was 
also increased after 48 and 72 hr but the effect was less marked than that observed for 
a2 (Fig. 5.8D). Expression of a3 subunits was not significantly different from 
controls at 48 and 72 hr but statistically decreased after 24 hr (Fig. 5.8C). Expression 
of a l  subunits was not significantly altered following administration of this cytokine 
(Fig. 5.8A).
The modulation of integrin subunit expression in response to IL-lp and TGFp could not 
be correlated with effects on cell proliferation or alkaline phosphatase activity (Fig. 5.7 
and Fig. 5.9): neither of these agents significantly influenced cell number over 
24-72 hr and both exerted different effects on cellular alkaline phosphatase.
5.4.5 Modulation of integrin subunit expression by different ECM 
components
Human osteoblast-like cells were cultured on plastic, fibronectin (5 pg/cm2), laminin 
(10 pg/cm2), collagen I film (10 pg/cm2) and collagen I gels (2.5 mm depth; 10 ml) 
(Method 2.4.5). After 10 days, cells were detached by enzymic digestion with trypsin 
or collagenase (Method 2.2.5), prepared for flow cytometry and analysed as described
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(Method 2.6). Preliminary experiments showed that treatment of human osteoblast-like 
cells with collagenase did not affect integrin subunit detection (Table 5.3). The effects 
of culturing human osteoblast-like cells on different matrix components are illustrated in 
Fig. 5.10. Growth on 5 |ig/cm2 fibronectin and 10 ng/cm2 laminin did not dramatically 
alter expression of a l ,  a2, a3 or pi subunits (Fig. 5.10A and B). However, 
fibronectin statistically increased expression of a3 subunits and laminin significantly 
decreased expression of a l ,  a3 and pi. Culture of human osteoblast-like cells on 
collagen I film exerted more pronounced effects on integrin subunit expression 
(Fig. 5.10C): a l  subunits were decreased by more than 50% and expression of a2, a3 
and pi were also significandy reduced. Growth on collagen I gels typically altered cell 
morphology, promoted gel contraction (as described in Chapter 3) and profoundly 
influenced integrin subunit expression (Fig. 5.10D). The most striking effect was 
observed with a2, expression being increased by 3.5 fold: other effects included an 
increased expression of a l  and pi and a decreased expression of a3. The fact that 
collagen I film and collagen I gels exhibited different effects suggests that the 
organisation of collagen fibres within the ECM is important for the regulation of 
integrin subunit expression.
Table 5.3. Effect of collagenase digestion on integrin subunit detection
Mean number receptor sites/cell (standard deviation)
(n=3)
Integrin subunit detected Control 30 min collagenase 
digestion
a l 107094 (3720) 105650 (2804)
a2 101005 (3245) 102192 (2629)
a3 130383 (9787) 139664 (2021)
31 547060 (16875) 528445 (17104)
Human osteoblast-like cells were cultured for 72 hr and half the cells were pie-incubated with 
collagenase I (30 min/ 37°C) before detachment by trypsinisation. Cell suspensions were then 
prepared for FACS analysis using saturating concentrations of mAb (or IgG). MFI values were 




Under basal conditions, a3 and pi were the primary integrin subunits expressed which 
can combine to form a3pi, a receptor which is commonly found in cells from most 
tissues and binds collagen , fibronectin and laminin (Humphries, 1990). a l  and a2 
subunits were also expressed at relatively high concentrations. These subunits 
associate with pi to form receptors for collagen and laminin (Humphries, 1990).
The effects of IL-lp on integrin subunit expression generally correlated with previous 
findings obtained using MG-63 osteosarcoma cell lines. For example, Dedhar (1989) 
showed that IL-lp (5 pM; 20 hr) increased expression of the integrin a5pl by 6-10 fold 
and Milam et al.(1991) demonstrated that treatment with IL-lp (10 pM, 48 hr) 
modulated the expression of multiple integrin subunits: the greatest response occurred 
with a2 subunit expression which was elevated 3.3 fold. In addition, Santala and 
Heino, (1991) showed that IL-lp (10 U/ml, 22 hr), increased expression of a l and 
decreased expression of a3; however, in this report IL-lp exerted no effect on 
expression of pi. The effects of TGFp on integrin subunit expression of human 
osteoblast-like cells also correlated with studies performed using MG-63 cells. For 
instance, Heino and Massague (1989) showed that addition of TGFp (5 ng/ml; 12-24 hr 
in serum free medium) elevated levels of a2 and pi and decreased expression of a3 
subunit mRNA. Results obtained from osteosarcoma cell lines were often observed 
over a shorter time period and effects were more dramatic than those displayed by 
normal osteoblast-like cells. These differences could result from the altered growth 
properties exhibited by transformed cells. Alternatively, the low serum concentrations 
present in experiments utilising bone-derived cells could affect their responsiveness to 
TGFp.
Studies documenting the effects of 1,25D on cell-matrix interactions in bone cell types 
have mainly been concerned with effects on ECM synthesis. In these studies, 
expression of a2 was statistically increased but only after 72 hr, a finding which could 
imply that the actions of 1,25D occur indirectly via induction of a bone cell product. In 
support of this, studies performed by other members of our laboratory have 
demonstrated that addition of 1,25D increased TGFp mRNA (Merry and Gowen,
1992): in light of the effects of TGFp on integrin subunit expression it is possible that 
production of TGFp in response to 1,25D is promoting increased expression of a2.
Although there have been no published data on the effects of 1,25D on integrin subunit 
expression of osteoblast-like cells, one report has demonstrated a 50 fold increase in
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expression of aV(33 following addition of 1,25D to osteoclast precursor cells (Medhora 
et al. 1993). 1,25D is known to increase synthesis of ECM proteins such as 
osteopontin in bone-derived cells (Prince and Butler, 1987). Osteopontin is a potential 
ligand for the integrin molecule aVp3 and it is therefore possible that production of 
ECM proteins and modulation of integrin subunit expression act together to regulate the 
bone remodelling cycle.
Each of the FACS experiments was performed in conjunction with other assays in an 
attempt to correlate regulation of integrin subunit expression with modulation of 
osteoblast phenotype. 1,25D treated cells exhibited a time dependent increase in alkaline 
phosphatase activity and osteocalcin production, and in previous reports, this has been 
correlated with a decrease in cell proliferation (Beresford et al.1986). In these studies 
however, it was not possible to show that the decrease in proliferation and enhancement 
of differentiation were associated with changes in integrin subunit expression. 
Experiments monitoring changes in proliferation and alkaline phosphatase activity were 
performed using cells treated with IL-lp and TGFp. Neither of these agents increased 
cell number over 72 hr. This finding may have resulted from the slow doubling time 
(4-5 days) of osteoblast-like cells and longer incubation periods would probably be 
required for a proliferative response. Alternatively, the proliferative effects of IL-lp 
could be inhibited by prostaglandin production (Gowen, 1988; Evans et al.1989) and 
indomethacin (1 pM) should perhaps have been incorporated into the experimental 
assay. In contrast to the similar effects on cell proliferation, IL-lp and TGFp both 
elicited different effects on cellular alkaline phosphatase activity. From these studies, 
the functional significance of a modulation of integrin subunit expression is therefore 
difficult to ascertain.
It was shown earlier (Chapter 3) that growth on a variety of ECM components affected 
four different aspects of osteoblast function. Therefore cells were cultured under these 
conditions to determine whether there were any corresponding changes in integrin 
subunit expression. The minimal effects of fibronectin (5 pg/cm2) on integrin subunit 
expression correlate with the minor effects of this substrate on proliferation and 
expression of a differentiated osteoblast phenotype (Chapter 3). As mentioned 
previously, this can partly be explained by the high concentrations of fibronectin 
present within serum which would make conditions in control and fibronectin coated 
plates very similar. In previous experiments, growth on laminin (10 pg/cm2), collagen 
I film (10 pg/cm2) and collagen I gels (2.5 mm depth) reduced alkaline phosphatase 
activity and osteocalcin production. The fact that these three matrices exerted different 
effects on integrin subunit expression suggests that integrin subunit expression and
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induction of a differentiated osteoblast phenotype are not intimately associated events.
A major difference observed between growth of human osteoblast-like cells on collagen 
I film and collagen I gels was that of morphology. Cells cultured on collagen I film 
looked very similar to those grown on plastic. However, cells cultured on collagen I 
gels produced long cellular extensions which penetrated the gel, and this was associated 
with gel contraction. Cells cultured on collagen I gels exhibited a 3.5 fold increase in 
expression of a2 which was not observed following growth on collagen I film. This 
suggests that the ot2 subunit is concerned with mediating gel contraction and that the 
different cytoskeletal interactions which result, lead to the characteristic changes in cell 
morphology. This finding agrees well with studies performed by Schiro et al.(1991) 
who demonstrated that the integrin molecule a2pl mediated reorganisation and 
contraction of collagen matrices. The involvement of the a2 subunit was later 
confirmed by Chan et al.(1992) who used chimeric constructs to demonstrate that the 
cytoplasmic domain of the a2 subunit specifically promoted gel contraction. This data 
suggests that integrins not only transduce signals from the matrix to the cytoskeleton, 
but can also be used by the cell to modify the tertiary structure of the matrix. This 




Figure 5.1 A typical population of human osteoblast-like cells prepared for FACS 
analysis.
Dotplots of side scatter (SSC) against forward scatter (FSC) were produced from 
negative controls to assess the homogeneity of the cell population (A). Heterogeneous 
cells were excluded by selecting a region enclosing the majority of the population (B), 
and this was used for subsequent analysis.
I l l
Figure 5.2A
Figure 5.2 Detection of integrin subunit expression in human osteoblast-like cells by 
FACS analysis.
Human osteoblast-like cells were cultured for 72 hr and then prepared for FACS 
analysis using anti-integrin mAbs (or equivalent concentrations of IgG) (Method 2.6). 
mAbs derived from ascites were diluted 1/25, 1/50 and 1/100 but mAbs from tissue 
culture supernatants were not diluted prior to use. MFI values (abscissa) were plotted 
against cell no. (ordinate) and the integrin subunit profile was determined. The first 
peak represents negative control (IgG); the second peak represents the fluorescence 
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Figure 5.3 Titration of anti-integrin mAbs.
Human osteoblast-like cells were cultured for 72 hr and prepared for 
FACS analysis using anti-integrin a l (A), o 2  (B), a3 (C) and pi (D) 
or equivalent concentrations of IgG. Values obtained for mean 
fluorescence intensity at each mAb dilution were then used to plot a 
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Figure 5.4 Modulation of integrin subunit expression by 1,25D.
Human osteoblast-like cells were treated with 1,25D (10r*M) for 24, 48 
and 72 hr and then prepared for FACS analysis using saturating 
concentrations of mAb (or IgG). MFI values were converted to receptor 
sites/cell and integrin subunit expression was represented as a % of 
control values i.e. the no. integrin subunits expressed by cells from 
control plates at each time period. Assays were undertaken in duplicate 
or triplicate and experiments were performed 2 or 3 times. All data 
were pooled and the significance of any modulation in expression of 
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Figure 5.5 Effect of 1,25D on alkaline phospahatase activity and 
osteocalcin production.
Human osteoblast-like cells were treated with 1,25D (10”3M) for 
24-72 hr. At intervals of 24 hr, cells were assayed for alkaline 
phosphatase activity (A) and supernatants were assayed for 
osteocalcin production (B). Points are means and standard deviations 
from three samples and are representative of 3 experiments.
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Figure 5.6. Modulation of integrin subunit expression by IL-1 p.
Human osteoblast-like cells were treated with IL-1 p (10 U/ml) for 24, 48 
and 72 hr and then prepared for FACS analysis using saturating 
concentrations of mAb (or IgG). MFI values were converted to receptor 
sites/cell and integrin subunit expression was represented as a % of control 
values i.e. the no.integrin subunits expressed by control cells at each time 
period. Assays were undertaken in duplicate or triplicate and experiments 
were performed 2 or 3 times. All data were pooled and the significance 
of any modulation in expression of al(A), a2(B), a3 (C) and pl(D) 




















Figure 5.7 Effect of IL-1 p on alkaline phospahatase activity and 
proliferation.
Human osteoblast-like cells were treated with IL-1 p (10 U/ml) for 
24-72 hr. At intervals of 24 hr, cells were assayed for alkaline 
phosphatase activity (A) and proliferation (B). Points are means 
and standard deviations from three samples and are representative 
of 3 experiments.
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Figure 5.8. Modulation of integrin subunit expression by TGF p.
Human osteoblast-like cells were treated with TGF p (25 ng/ml) for 24, 48 
and 72 hr and then prepared for FACS analysis using saturating 
concentrations of mAb (or IgG). MFI values were converted to receptor 
sites/cell and integrin subunit expression was represented as a % of 
control values i.e. the no.integrin subunits expressed by control cells at 
each time period. Assays were undertaken in duplicate or triplicate and 
experiments were performed 2 or 3 times. All data were pooled and 
the significance of any modulation in expression of al(A), a2(B), a3 (C) 
























Figure 5.9 Effect of TGFp on alkaline phospahatase activity and 
proliferation.
Human osteoblast-like cells were treated with TGF p (25 ng/ml) for 
24-72 hr. At intervals of 24 hr, cells were assayed for alkaline 
phosphatase activity (A) and proliferation (B). Points are means and 
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Figure 5.10 Modulation of integrin subunit expression by ECM 
components.
Human osteoblast-like cells were cultured on plastic (control), fibronectin 
(5 pg/cm2) (A), laminin (10 pg/cm2) (B), collagen I film (10 pg/cm2) (C) 
and collagen I gel (2.5 m m ) (D) for 10 days and then prepared for FACS 
analysis using saturating concentratrions of mAb (or IgG). MFI values 
were converted to receptor sites/cells and integrin subunit expression was 
represented as a % of control values i.e. the no.integrin subunits in cells 
from control plates at each time period. Assays were undertaken in triplicate 
and experiments were performed 2 times. All data were pooled and the 
significance of any modulation in expression of a l, a2, a3 and pi subunits 
was assessed using an unpaired Student's T-test.
CHAPTER 6
INTEGRIN SUBUNIT EXPRESSION BY MG-63 




The aim of this study was to select an osteosarcoma cell line whose integrin subunit 
profile resembled that of osteoblast-like cells and whose expression was modulated by 
cytokines in a similar manner to that observed in bone-derived cells. Therefore, we 
have assessed the integrin subunit profiles of MG-63 and HOS TE85 cells by FACS 
analysis and compared results with those obtained for human osteoblast-like cells. The 
most suitable cell line has also been treated with cytokines to determine whether integrin 
subunit expression was modulated in a similar fashion to bone-derived cells.
MG-63 and HOS TE85 cells expressed all the integrin subunits detected on human 
osteoblast-like cells. However, neither cell line exhibited an integrin subunit profile 
identical to that of bone cell cultures due to expression of a4 and a6 subunits by 
osteosarcoma cells and because of differences in the relative concentrations of 
individual integrin subunits expressed. MG-63 cells were considered to be more 
representative of bone cell cultures than HOS cells and furthermore, MG-63 cells 
provided good single cell suspensions for FACS analysis. Addition of IL-lp and 
TGFp to cultures of MG-63 cells differentially regulated integrin subunit expression 
and some of these modulations in subunit expression resembled those observed in 
bone-derived cells. These results therefore support the use of MG-63 cells to explore 
the functional implications of a modulation of integrin subunit expression.
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6.2 Introduction
Previous experiments investigating the role of the ECM and its corresponding cell 
surface receptors in regulation of bone cell phenotype have been performed using 
human osteoblast-like cells derived from explants of trabecular bone. These cells 
exhibited a doubling time of 4-5 days, and a 4-6 week growth period was required 
before confluency was achieved. The slow growth rate and the difficulty in obtaining 
sufficient bone for establishment of cultures made assays difficult to develop and 
repetitive experiments difficult to perform. Osteosarcoma cell lines could provide an 
alternative source of osteoblast-like cells. These cells divide more rapidly than primary 
cultures and can be maintained by routine subculture. However, these cells possess 
abnormal growth characteristics and it is not always possible to extrapolate effects on 
homogeneous cell lines to those of bone-derived cells which contain heterogeneous cell 
populations comprised of cells at several stages of maturation. Therefore, if 
osteosarcoma cell lines are to produce data of physiological relevance, it is important 
that different cell lines are extensively characterised and the cell line whose particular 
function most closely resembles that exhibited by human osteoblast-like cells is chosen 
for investigation.
Two readily available human osteosarcoma cell lines are MG-63 and HOS TE85. 
MG-63 cells were originally derived from an osteogenic sarcoma from a 14 year old 
male (Heremans et al.1978) and HOS TE85 cells were from a sarcoma of a 13 year old 
female (McAllister et al.1971). MG-63 cells are considered to show a number of 
features typical of an undifferentiated osteoblast phenotype. These include the 
synthesis of collagen types I and III, and low basal expression of alkaline phosphatase 
and osteocalcin which can be induced by 1,25D (Franceschi and Young, 1990; 
Lajeunesse et al.1990). These cells have been used as an experimental model to study a 
variety of different osteoblast functions such as adhesion (Dedhar et al.1987;
Franceschi et al.1987; Heino and Massague, 1989), extracellular matrix synthesis 
(Bassols and Massague, 1988; Franceschi et al.1988), alkaline phosphatase activity 
(Franceschi et al. 1985; Boyan et al.1989; Franceschi and Young, 1990) and osteocalcin 
production (Lajeunesse et al.1990; Lajeunesse et al.1991). HOS cells have not been as 
widely used as MG-63 cells despite their higher basal expression of alkaline 
phosphatase. These cells have been previously employed for studying the effects of 
oestrogen (Komm et al.1988) and for the localisation of oestrogen and androgen 
receptors (Komm et al.1988; Benz et al. 1991b). Other experiments concerning the 
isolation and purification of insulin-like growth factor (IGF) binding proteins
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(Hassager et al.1991; Lempert et al.1991; Mohan and Baylink, 1991) have also been 
performed.
The aim of this study was to select an osteosarcoma cell line whose integrin subunit 
profile resembled that of bone cell cultures and whose expression was modulated by 
cytokines in a similar manner to that observed in osteoblast-like cells.
6.3 Results
6.3.1 Detection of integrin subunits on MG-63 and HOS cells by FACS 
analysis
Cultures of MG-63 and HOS cells were prepared for FACS analysis (Method 2.6) 
using all the anti-integrin mAbs to determine which integrin subunits were expressed by 
these cell types: mAbs derived from ascites were diluted 1/25,1/50 and 1/100 and 
mAbs derived from tissue culture supernatants were added directly onto cells without 
prior dilution; all experiments were performed in the presence of appropriately diluted 
negative controls (IgG). When analysing FACS results, a dot plot of SSC against FSC 
was produced from negative control data, and a region enclosing the majority of the 
population was selected and used for subsequent analysis (Fig. 6.1). Histograms for 
individual integrin subunits, of cell number against fluorescence, were overlayed with 
data obtained from negative controls and the integrin subunit expression of both 
osteosarcoma cell lines was determined (data not shown). MG-63 and HOS cells 
exhibited a very similar profile of integrin subunits, a l ,  a2, a3, a4, a5, a6, aV and 
pi could be detected on both cell types and there was no staining with mAbs directed 
against p2 and p3. Except for the expression of a4 and a6 subunits, this pattern of 
integrin subunit expression was qualitatively similar to that observed for human 
osteoblast-like cells (Table 6.2).
6.3.2 Titration of mAbs for antigenic detection
Accurate quantitation of the number of integrin receptor sites/cell, requires that mAbs 
are present at saturating concentrations. Therefore MG-63 and HOS cells were 
prepared for FACS analysis (Method 2.6) using all the positive anti-integrin mAbs (or 
IgG) over a range of mAb concentrations. No such titration experiments were therefore 
performed with mAbs raised against a5 and aV; the optimal dilutions for these mAbs 
were 1/25 and neat respectively. When analysing FACS data, MFI values were 
obtained for each sample and titration curves of fluorescence against mAb dilution were
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prepared. Optimal mAb dilutions obtained for both osteosarcoma cell lines were 
identical and are summarised in Table 6.1.
Table 6.1. mAb dilutions for FACS experiments using osteosarcoma cell lines
Integrin subunit 
detected
mAb Optimal dilution of 
mAb








MG-63 and HOS cells were cultured for 72 hr and prepared for FACS analysis using anti-integrin 
mAbs (or equivalent concentrations of IgG) (Method 2.6). mAbs derived from ascites were diluted 
between 1/25 and 1/3200 and mAbs from tissue cultures supernatants were added directly onto cells 
without prior dilution. MFI values were used to plot a titration curve and optimum concentrations of 
anti-integrin mAbs were determined.
6.3.3 Quantitation of integrin subunit expression on MG-63 and HOS 
cells
MG-63 and HOS cells were cultured for 72 hr and then prepared for flow cytometry 
using saturating concentrations of mAb or IgG (Method 2.6). MFI values obtained for 
each of the integrin subunits were converted to receptor sites/cell and compared with 
previous data obtained from bone cell cultures. MG-63 and HOS cells expressed all the 
integrin subunits detected on human osteoblast-like cells and in each cell type, a3 and 
pi were the subunits most highly expressed (Table 6.2). However, compared to 
MG-63 and HOS cells, normal bone-derived cells expressed greater numbers of o l, a2 
and cx5 subunits and lesser numbers of a3 subunits.
The aim of this study was to select an osteosarcoma cell line whose integrin subunit 
profile resembled that of human osteoblast-like cells. The major subunits detected on 
bone cell cultures were a l ,  oc2, a3 and pi. Both osteosarcoma cell lines strongly
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Table 6.2 A comparison of integrin subunit expression bv MG-63. HOS and human
osteoblast-like cells
Integrin subunit sites/cell
Integrin subunit MG-63 cells HOS cells Human osteoblast
detected -like cells
a l 18407 50859 101023
(767) (6067) (6077)
a2 65730 6675 101866
(2434) (775) (6707)
a3 276055 255905 127184
(6900) (20306) (5134)
a4 35652 20048 negative
(574) (821)
a5 19428 27147 47544
(771) (4196) (3735)
a6 21091 31097 negative
(1272) (2537)
aV 13822 25793 15561
(240) (2045) (1701)
PI 573787 386258 556947
(21878) (29561) (26167)
P2 negative negative negative
P3 negative negative negative
MG-63, HOS and human osteoblast-like cells were cultured for 72 hr and prepared for FACS analysis 
using saturating concentrations of mAb (or IgG) (Method 2.6). MFI values were converted to receptor 
sites/cell and data obtained from a minimum of 9 different samples were pooled to produce means and 
standard errors for each of the integrin subunits.
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expressed a3 and pi but the expression of a l  and a2 was dependent on cell type. 
Compared to HOS cells, MG-63 cells expressed greater numbers of a2 subunits but 
lesser numbers of a l  subunits. Overall however, it was judged that the integrin 
subunit profile of MG-63 cells more closely approximated to that of normal bone- 
derived cells. The differentiated response of MG-63 cells observed following addition 
of 1,25D also closely resembled that of normal osteoblast-like cells (Franceschi and 
Young, 1990; Lajeunesse et al.1990) and therefore this osteosarcoma cell line was 
selected for further investigation.
6.3.4 Modulation of integrin subunit expression on MG-63 cells by 
IL-lp and TGFp
Confluent cultures of MG-63 cells were treated with test agents for 24-72 hr (Method 
2.4.6) and prepared for FACS analysis using saturating concentrations of mAb 
(or IgG) (Method 2.6). The effects of IL-lp (10 U/ml) and TGFp (25 ng/ml) on 
expression of a l ,  a2, a3 and pi subunits are illustrated in Figures 6.2 and 6.3 
respectively. In control cultures, over the course of these experiments, there was no 
significant variation in the numbers of a l ,  a2, a3 and pi subunits expressed. The 
addition of IL-lp significantly increased the expression of a l  (Fig. 6.2A) and a2 
subunits (Fig. 6.2B) at all time points. In contrast, there was a decreased expression of 
a3 (Fig. 6.2C) over a similar time period and a reduction in levels of pi (Fig. 6.2D) 
after 72 hr. In the presence of TGFp there was a time dependent increase in the 
expression of a2 (Fig. 6.3B) subunits over a period of 24-72 hr. a l  (Fig. 6.3B) and 
pi (Fig. 6.3D) subunits were also significantly increased but the effects were not as 
pronounced as those observed for a2. In contrast, there was a significant decrease in 
a3 (Fig. 6.3C) subunit expression which was first detectable after 48 hr.
6.4 Discussion
Integrin subunit profiles of MG-63, HOS and human osteoblast-like cells were similar 
in that a l ,  a2, a3, a5, aV and pi subunits were identified on all cell types. In each 
case, a3 and pi were the most highly expressed subunits which can combine to form 
a3pl, a receptor commonly found in cells from most tissues which binds collagen, 
fibronectin and laminin (Humphries, 1990). The most striking difference in subunit 
expression was observed with a4 and a6 subunits which were detected on MG-63 and 
HOS cells but not on bone-derived cells. Expression of these subunits by 
osteosarcoma cell lines could result from an adaptation to long term culture conditions 
and may not have originally been detected on these cells. However, invasion of tumour
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cells requires attachment to components of the basement membrane, degradation of the 
basement membrane and finally, migration to the underlying stroma. The laminin 
receptor a6pi has previously been shown to be over-expressed in highly invasive cells 
(Dedhar and Saulnier, 1990) and a4pl is clearly associated with migration (Chan et 
al.1992). Therefore expression of a4 and a6 by MG-63 and HOS cells could reflect 
the transformed nature of these cell lines. Another difference between osteosarcoma 
cell lines and osteoblast-like cells concerned the relative concentrations of individual 
a  subunits. For example, a l ,  a2 and a5 subunits were detected at higher levels in 
bone-cell cultures and a3 subunits were more strongly expressed by both osteosarcoma 
cell lines. A similar modulation of integrin subunit expression following oncogenic 
transformation has been reported elsewhere. For example, Plantefaber and Hynes, 
(1989) demonstrated a reduction in expression of three different a  subunits with 
oncogenic transformation, whilst expression of a3 subunits was slightly increased or 
unchanged.
These comparative studies showed that MG-63 and HOS cells expressed all the integrin 
subunits detected on bone-derived cells. However neither cell line exhibited an integrin 
subunit profile identical to that observed in bone cell cultures, due to expression of a4 
and a6 subunits by osteosarcoma cell lines, and because of differences in relative 
concentrations of individual integrin subunits expressed. MG-63 cells provided better 
single cell suspensions than HOS cells for FACS analysis and furthermore, overall 
values obtained for integrin subunit sites/cell in MG-63 cells were more representative 
of osteoblast-like cells. Therefore experiments were performed using MG-63 cells to 
assess the modulation of integrin subunit expression by cytokines. Addition of IL-lp 
exerted significant effects on the expression of a l ,  a2, a3 and pi subunits. The 
increased expression of a l  and a2 and the reduction in levels of a3 which was 
observed at 48 and 72 hr correlate well with findings observed using bone cell cultures 
(see Chapter 5). In addition, the elevated expression of a2 agrees with previous 
studies performed by Milam et al.(1991). The main difference in the modulation of 
integrin subunit expression between IL-lp treated MG-63 cells and osteoblast-like cells 
concerned expression of pi. This subunit was elevated in IL-lp treated bone cells and 
has previously shown to be increased in MG-63 cells (Dedhar, 1989), but in these 
experiments, expression of pi was significantly reduced.
Treatment of MG-63 cells with TGFp also modulated the expression of a l ,  a2, a3 and 
pi subunits. The increased expression of a2 and pi and the decreased expression of 
a3 correlates well with previous findings (Heino and Massague, 1989). The time 
dependent increase in expression of a2 and pi subunits also agrees with results
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obtained from osteoblast-like cells (see Chapter 5). However, the reduced expression 
of a3 and elevated expression of a l observed in these experiments do not correspond 
with data from bone-derived cells.
These experiments show that integrin subunit expression of MG-63 cells is 
differentially regulated by cytokines and that some of the changes in subunit expression 
resemble those observed in human osteoblast-like cells. Having investigated the effects 
of IL-lp and TGFp on the expression of a l ,  a2, a3 and pi subunits, it would be 
interesting to examine the effects of these agents on expression of some of the other a 
(and p ?) subunits. It is very possible that addition of IL-lp and TGFp would regulate 
the expression of other integrin subunits and evidence for this is already emerging. For 
example, Milam et al.(1991) showed that addition of IL-lp (10 pM; 48 hr) to cultures 
of MG-63 cells increased a5 and aV but decreased a4 subunit mRNA, in addition to 
increasing expression of a2. Heino and Massague (1989) demonstrated that addition 
of TGFp (200 pM (approx.5 ng/ml); 12-24 hr in serum free medium) to MG-63 cells 
increased expression of a5 in addition to regulating expression of a2, a3 and pi. 
Finally, Ignotz et al.(1989) reported increased synthesis of p3 subunits following TGFp 
administration to MG-63 cells (250 pM (approx. 6 ng/ml); 12 hr in MEM + 0.1%
FCS). This latter report was rather surprising as p3 could not be detected in this cell 
type under our experimental conditions. Possible implications of a modulation in the 





Figure 6.1 Typical populations of MG-63 (A) and HOS TE85 cells (B) prepared for 
FACS analysis.
Dotplots of side scatter (SSC) against forward scatter (FSC) were produced from 
negative controls to assess the homogeneity of the cell population. Heterogeneous cells 
were excluded by selecting a region enclosing the majority of the population, and this 
was used for subsequent analysis.
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Figure 6.2. Modulation of integrin subunit expression by IL-1 p.
MG-63 cells were treated with IL-1 p (10 U/ml) for 48 and72 hr and prepared for 
FACS analysis using saturating concentrations of mAb (or IgG). MFI values were 
converted to receptor sites/cell and expression of a l (A), a2 (B), a3 (C) and pi 
(D) subunits was expressed as a % of control values i.e the no. of a l, a2, a3 and 
pi subunits expressed by cells in control plates at each time period. Assays were 
undertaken in triplicate and experiments were performed twice. Values represent 
means and standard deviations from pooled data: the significance of any 
modulation of expression was assessed using an unpaired Student's T-test
Figure &3.








B. a l  subunit expression (n=6) 
300 * * *
** p < 0.01 
*** p < 0.001
139










** p < 0.01
100 -
m
Figure 6.3. Modulation of integrin subunit expression by TGF p.
MG-63 cells were treated with TGF p (25 ng/ml) for 24-72 hr and prepared for 
FACS analysis using saturating concentrations of mAb (or IgG). MFI values were 
converted to receptor sites/cell and expression of a l (A), a2 (B), a3 (C) and pi 
(D) subunits was expressed as a % of control values i.e the no. of a l ,  a2, a3 and 
pi subunits expressed by cells in control plates at each time period. Assays were 
undertaken in triplicate and experiments were performed twice. Values represent 
means and standard deviations from pooled data: the significance of any 
modulation of expression was assessed using an unpaired Student's T-test
CHAPTER 7.
THE EFFECT OF CYTOKINES ON ADHESION 




Previous studies demonstrated that the integrin subunit expression of human osteoblast­
like cells and MG-63 cells was modulated by IL-lp and TGFp. To assess the 
functional significance of these findings, an assay was developed using MG-63 cells to 
determine the effects of IL-lp and TGFp on cellular adhesion. Studies were performed 
using dishes coated with collagen I, fibronectin and laminin since it could be inferred 
from the integrin subunit profiles of MG-63 cells (and osteoblast-like cells) that these 
proteins were likely adhesion substrates. Cell adherence was assessed by protein assay 
which was found to be more sensitive than MTT and more convenient than measuring 
3H-thymidine incorporation. Background ECM proteins and blocking reagents did not 
interfere with the absorbance readings obtained in this assay.
Under basal conditions, maximal adhesion to collagen I and fibronectin occurred at 
0.1 pg/cm2  whereas maximal adhesion to laminin occurred at 5-20 pg/cm2  At these 
concentrations, 90-100 % of cells attached to all matrices, compared with 20-40 % in 
uncoated wells. Time course experiments demonstrated that cells attached to these 
ECM proteins at similar rates, maximal adhesion occurring after 2 hr. Pre-treatment of 
MG-63 cells with IL-lp for 72 hr did not affect adhesion to uncoated plastic, collagen I 
or fibronectin over a concentration range of 0.001-5 pg/cm2. However, adhesion to 
some concentrations of laminin was significantly reduced (total concentration range 
0.01-20 pg/cm2). Addition of TGFp for a similar time period did not affect adhesion to 
plastic or any of the other ECM proteins tested.
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7.2 Introduction
The process of bone remodelling consists of a complex sequence of cellular events 
occurring at discrete sites in the skeleton. It must be temporally and spatially controlled 
to ensure that the amount of bone resorption balances the amount of bone formation. 
Cytokines are among the local mediators considered to play an important regulatory role 
because they are extremely potent and labile and can affect many different aspects of 
cell function (Gowen, 1991; Gowen, 1992b; MacDonald and Gowen, 1992). As over 
90% of bone is composed of matrix, it seems likely that integrin-mediated adhesive 
interactions will also exert some kind of regulatory control. Previous experiments 
demonstrated that integrin subunit expression of human osteoblast-like cells was 
modulated by cytokines and ECM components, but the significance of this finding in 
terms of differentiated cell phenotype was unknown (Chapter 5). To further assess the 
functional relevance of this finding, an assay was developed to determine the effects of 
these cytokines on cell adhesion.
These experiments required very large numbers of cells and so it was decided to use an 
osteosarcoma cell line. MG-63 cells expressed all the integrin subunits detected on 
osteoblast-like cells and furthermore, integrin subunit expression was differentially 
regulated by IL-lp and TGFp in a similar manner to that of bone-derived cells (Chapter 
6 ). Integrin subunit profiles exhibited by this osteosarcoma cell line (and human 
osteoblast-like cells) suggested that potential ligands used for attachment include 
collagen I, fibronectin and laminin. Therefore, an adhesion assay was developed and 
the effects of IL-lp and TGFp on % adhesion of MG-63 cells to these three ECM 
components were assessed.
7.3 Methods
7.3.1 A comparison of three different methods for assessment of cell 
number
Three commonly used techniques for the assessment of cell number are MTT reduction, 
3 H-thymidine incorporation and protein content, using a dye binding assay. MTT 
(3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyl tetrazolium bromide) is a tetrazolium salt 
which labels metabolically active cells and can be measured colourimetrically 
(Mosmann, 1983). Cell protein content can be assessed colourimetrically using a 
Bradford protein assay which employs the stain Coomassie brilliant blue (Bradford, 
1976).
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To determine the effects of cytokines on cell adhesion, a sensitive assay system was 
required for accurately monitoring small changes in cell number. Therefore, confluent 
cultures of MG-63 cells were seeded into flat bottomed 96 well plates in MEM+10% 
FCS at a cell density of 100-20 000 cells/well (100 pl/well) and the sensitivity of these 
three different assay systems was compared.
7.3.1.1 MTT reduction
MG-63 cells were cultured for 24 hr at 37°C and then 20 pl/well MTT solution 
(5 mg/ml in PBS) was added. After 4 hr at 37°C, the medium was removed and cells 
were solubilised by the addition of 100 jil/well acidified isopropanol (1 ml 4 M HC1 + 
99 ml isopropanol). After 30 min at 37°C, the absorbance was measured on an ELISA 
plate reader at 630 nm and 570 nm reference and test wavelengths, respectively.
7.3.1.2 3H-thymidine incorporation
MG-63 cells were cultrued for 8  hr and then luCi/well 3H-thymidine was added 
(10 pi/well). After 20 hr at 37°C, the medium was removed and cells were lysed by the 
addition of 20 pl/well 0.1% Tween 20. After 20 min at room temperature, 200 pl/well 
H2O was added and cell lysates were transferred onto filters using a cell harvester. 
Wells were washed 3 times in H2O and all insoluble contents were collected onto the 
filters. Filters were then transferred into scintillation vials, scintillant was added 
(500 pl/tube) and cell number was assessed by counting 3H using a p counter.
7.3.1.3 Bradford protein assay
MG-63 cells cultured for 28 hr and then the medium was removed, cells were washed 
in PBS (3 x 100 pi) and lysed by the addition of 200 pl/well H2 O. After 20 min at room 
temperature, 50 pl/well protein dye binding reagent was added (Biorad), well contents 
were mixed thoroughly and after a further 5 min, the absorbance was recorded at 
630 nm.
7.3.2 Effect of background protein on Bradford assay
The attachment assay to be developed for these experiments was based on protocols 
described by Adams and Watt (1990; 1991) where cells were seeded onto pre-coated 
wells and attachment to ECM proteins was assessed after blocking non specific binding
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using BSA. If a protein assay was to be used as a measurement of cell number, it was 
important to assess the effects of background protein on absorbance readings. In order 
to determine the effects of BSA, 100 pi BSA (2 mg/ml in PBS) was added to wells of a 
96 well plate. After 1 hr at room temperature, BSA was removed and wells were 
washed with PBS (3 x 100 pi PBS). A standard curve (0-25 pg/ml BSA in H2 O) was 
then prepared using a stock solution of BSA (100 pg/ml) and 200 pi aliquots were 
transferred into control wells and wells pre-coated with BSA. To assess the effects of 
ECM proteins, flat bottomed 96 well plates were coated with collagen I, fibronectin or 
laminin (0-100 pg/cm2  in PBS) and then BSA (Method 2.7). Wells were washed 
extensively to remove unbound protein (3 x 100 pi PBS) and 200 pl/well H2 O was 
replaced. 50 pi protein dye binding reagent was then added to all wells, the contents 
were mixed thoroughly and after 5 min, the absorbance was recorded at 630 nm.
7.4 Results
7.4.1 A comparison of three different methods for assessment of cell 
number
MG-63 cells were cultured for a total of 28 hr and then cell number was assessed by 
MTT reduction, 3 H-thymidine incorporation or by protein assay. The Bradford protein 
assay (Fig. 7.1 A) produced a larger change in absorbance readings over a concentration 
of 100-20 000 cells/well than the MTT assay (Fig. 7.IB). 3 H-thymidine incorporation 
(Fig. 7.1C) also gave a good range of counts over these cell concentrations but this 
assay was very time consuming and in light of the number of experiments that could be 
performed, it was decided to use the protein assay in subsequent experiments to assess 
cell attachment.
7.4.2 Effect of background protein on Bradford assay
Preliminary experiments were performed to assess the effects of ECM protein and BSA 
on the Bradford protein assay. It can be seen from Figure 7.2 and Table 7.1 that a 
BSA coating did not interfere with the protein standard curve and that absorbance 
readings obtained from wells coated with ECM proteins were not substantially different 
from those of wells coated with PBS.
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Table 7.1 Effect of ECM proteins on Bradford assay
Concentration ECM 
protein (pg/cm2)
Fibronectin Collagen I Laminin
0.00 .000 .000 .000
o.io .004 .005 -.006
0.50 .002 .009 .005
1.00 .000 .002 .000
5.00 .005 .001 .001
20.0 .000 .01 .005
50.0 .003 .018 .006
100.0 .006 .010 .005
A Bradford protein assay was performed in flat bottomed 96 well plates pre-coated with collagen I, 
fibronectin or laminin (0-100 pg/cm2) and then with BSA (2 mg/ml).
7.4.3 Adhesive properties of MG-63 cells
7.4.3.1 Concentration dependent binding to selected ECM proteins
MG-63 cells were seeded into flat bottomed 96 well plates pre-coated with 
0.001-100 pg/cm2  collagen I, fibronectin or laminin and after 4 hr at 37°C, attached 
cell protein was assessed (Method 2.7). MG-63 cells bound in a saturable manner to 
all three ECM proteins (Fig. 7.3A). Adhesion to collagen I and fibronectin was very 
similar and maximum attachment occurred at 0.1 pg/cm2. In contrast, cells bound to 
laminin less readily, with optimum attachment occurring at 5 pg/cm2.
7.4.3.2 Time dependent binding to selected ECM proteins
MG-63 cells were seeded into flat bottomed 96 well plates pre-coated with collagen I, 
fibronectin (5 pg/cm2) or laminin (20 pg/cm2), and attached cell protein was assessed at 
intervals over the next 5 hr (Method 2.7). Cells attached to collagen I, fibronectin and 
laminin at similar rates; maximal attachment occurring after 2 hr (Fig. 7.3B).
In light of these findings, subsequent adhesion assays were performed after 2 hr using
0.001-0.5 pg/cm2  fibronectin and collagen I, and 0.01-20 pg/cm2  laminin.
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7.4.4 % Adhesion of MG-63 cells to ECM proteins
Having optimised the assay conditions, it was decided to correct for any differences in 
seeding densities by expressing adhesion to ECM proteins as a percentage of the total 
protein/well. Therefore cells were seeded into pre-coated wells (or uncoated wells) in 
serum free medium as described and after 2 hr, total protein was assessed (Method 
2.7). Dose response curves for ECM proteins were similar to those described 
previously (Fig. 7.4). Cells attached to collagen I and fibronectin very readily and 
100% adhesion occurred at 0.1 pg/cm2. A higher concentration was required for 
attachment to laminin and 5-20 pg/cm2  was required for 100% adhesion. Attachment to 
uncoated plastic was low by comparison, and values of approximately 2 0 % were 
typically obtained in these experiments.
7.4.5 Effect of cytokines on cell adhesion
Confluent cultures of MG-63 cells were cultured in the presence and absence of IL-lp 
and TGFp for 72 hr (Method 2.4.6) and % adhesion to plastic and different ECM 
proteins was assessed (Method 2.7). Typical results from experiments investigating 
the effects of IL-lp and TGFp are illustrated in Figures 7.5 and 7.6 respectively. 
Neither of these agents significantly affected background adhesion to plastic which 
accounted for 20-40% of the total adhesion. Addition of IL-lp did not affect adhesion 
to collagen I (Fig. 7.5A) or fibronectin (Fig. 7.5B) but adhesion to some 
concentrations of laminin were slightly but statistically reduced (Fig. 7.5C). In the 
experiment shown, adhesion to 0 .1 , 1 . 0  and 1 0  pg/cm2  laminin was decreased but the 
concentrations at which this reduction occurred were not consistent between 
experiments. Treatment with TGFp did not affect adhesion to collagen I (Fig. 7.6A) 
but attachment to fibronectin (Fig. 7.6B) and laminin (Fig. 7.6C) appeared to be 
slightly increased. However, none of these findings was statistically significant.
7.5 Discussion
The adhesive properties of MG-63 cells observed under basal conditions were similar 
to those described by other investigators (Heino and Massague, 1989; Santala and 
Heino, 1991; Brighton and Albeda, 1992). However, in previous studies, fewer cells 
adhered to laminin than to collagen I and fibronectin (Heino and Massague, 1989; 
Brighton and Albeda, 1992) and attachment to laminin occurred at a slower rate than 
that observed for other ECM proteins (Heino and Massague, 1989). The comparatively 
low values obtained for % adhesion to laminin may have resulted from differences in
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experimental protocol. In all these reports, adhesion was assessed after washing 
attached cells three times in PBS and therefore values obtained for % cell adhesion 
would also depend on the strength of attachment to different matrix components. In 
our laboratory, attachment was assessed after one PBS wash which was undertaken 
carefully to prevent detachment of loosely adherent cells.
Treatment of MG-63 cells with IL-lp and TGFp (72 hr) did not markedly affect cell 
adhesion. The lack of effects on attachment to collagen I and fibronectin correlate with 
previous studies performed using this cell type (Heino and Massague, 1989; Santala 
and Heino, 1991). However in these reports, IL-lp increased adhesion to laminin by 
1.22-1.3 fold (Santala and Heino, 1991) and TGFp reduced adhesion to laminin by 
39-59% (Heino and Massague, 1989). These experiments were performed in serum 
free medium after a 1 2  hr treatment period and it is possible that these variations 
accounted for the different effects. However, the changes in integrin subunit 
expression reported by these authors following treatment with IL-lp and TGFp were 
similar to those observed in our laboratory. If a modulation of integrin subunit 
expression is important for cell adhesion one would predict that the effects of cytokines 
on attachment would be very similar.
The minimal effects of IL-lp and TGFp on adhesion of MG-63 cells to collagen I and 
fibronectin could result from ligand redundancy. MG-63 cells expressed three collagen 
receptors (a lp l, a2pl, a3pl) and four fibronectin receptors (a3pl, a4pi, a5pl and 
aVpi) and therefore a modulation in expression of one of these receptors could easily 
be masked by another integrin molecule binding to the same ligand. IL-lp and TGFp 
increased expression of a l  and a2 subunits but decreased expression of a3 (Chapter 
6 ): the fact that neither of these cytokines affected adhesion to collagen I suggests that 
the decrease in expression of a3 subunits was masked by the increased expression of 
a l  and a2. The situation is made more complex by the modulation of other a  integrin 
subunits and differences in receptor affinity. For example, IL-lp has previously been 
shown to increase expression of a5 and aV, and to decrease expression of a4 subunit 
mRNA (Milam et al. 1991). The a5pi heterodimer is considered to be of a higher 
affinity nature than a3pl (Plantefaber and Hynes, 1989) and therefore increased 
expression of a5 could compensate for the decreased expression of a3. This in turn 
could minimise the effects of H-lp on adhesion of MG-63 cells to fibronectin.
From previous studies (Heino and Massague, 1989; Santala and Heino, 1991) it would 
appear that major effects of IL-lp and TGFp on the adhesive properties of MG-63 cells 
occur following attachment to laminin. This suggests that even though MG-63 cells
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express four potential laminin receptors (a lp l, a2pl, a3bl and a 6 pi), integrin- 
mediated adhesion to this ECM protein is fairly specific. In our laboratory, the 
decreased adhesion to laminin observed following addition of IL-lp could be correlated 
with a decreased expression of a3 and pi subunits. This suggests that a3pl is the 
major integrin molecule responsible for mediating adhesion to laminin. The lack of 
significant effects of TGFp on adhesion to laminin despite the reduction in a3 subunit 
expression observed following treatment with this cytokine (Chapter 6 ) could result 
from the increased expression of pi subunits. Alternatively, these findings could result 
for the sensitivity of the experimental assay: addition of IL-lp for 72 hr decreased a3 
subunit expression by approximately 38% whereas treatment with TGFp for a similar 
time period only decreased of a3 subunit expression by approximately 21%. The 
smaller changes in integrin subunit expression observed following addition of TGFp 
may not be sufficient to detect a change in cell adhesion using this assay.
Apart from the effects of ligand redundancy and receptor affinity, there are many 
technical problems which, with hindsight, could be associated with the minimal 
responses observed in this assay. The effects of cytokines on adhesion of MG-63 cells 
were assessed after trypsinisation. It is possible that even though integrin subunits 
were immunologically 'intact' i.e. recognised by mAbs, they were not functional and 
therefore not contributing to cell adhesion. It would have been better to detach cells 
using EDTA or collagenase and then perform adhesion assays in the presence of 
cycloheximide to ensure that attachment resulted from existing integrin subunits. 
Another possibility would be to assess the functional relevance of a modulation of 
integrin subunit expression in situ. For example, the effects of cytokines could be 
determined by measuring the strength of attachment: one such experiment was 
performed (data not shown) but unfortunately there was not sufficient time to optimise 
the assay conditions.
Another problem associated with this adhesion assay was that non specific basal 
adhesion to uncoated wells accounted for 20-40% of the total adhesion and cells 
attached very readily to all ECM proteins over the appropriate concentration range. In 
order to see a difference in cell attachment properties, the difference between control 
and treated cells would therefore need to be very great. All these experiments were 
performed using 96 well plates treated for tissue culture. It would have been better to 
use bacteriological plastic to reduce non specific binding and to maximise absorption of 
ECM proteins. Another improvement could be made when determining % adhesion. It 
would have been better to measure non attached cell protein in each well since pooling 
supernatants does not correct for inter-well variations at each ECM protein
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concentration. Results would perhaps also have been more meaningful if a larger 
number of samples had been statistically analysed (n=3): it was not possible to pool 
data from multiple studies due to inter-experiment variation and therefore each 
experiment should have contained a larger number of replicates. Finally, MG-63 cells 
were probably not an ideal experimental model of human osteoblast-like cells. This 
osteosarcoma cell line expressed a3 subunits at levels 5 fold higher than oc2 and 15 fold 
higher than a l. In view of the low affinity nature of these cell surface receptors, a 
modulation in expression of a l  or a 2  subunits is likely to be less relevant than a 
modulation in expression of a3. Human bone-derived cells expressed lower levels of 
a3 and relative concentrations of a l  and a2 subunits were much greater. It would 
therefore be interesting to repeat these experiments using this cell type to determine 


































Figure 7.1 A comparison of three different assays for assessment of 
cell number.
MG-63 cells were seeded into flat bottomed 96 well plates in 
MEM+10% FCS at a cell density of 100-20 000 cells/well.
After a total of 28 hr, cell number was assessed by MTT 
reduction (A), Bradford protein assay (B) and 3H-thymidine 
incorporation (C). Points represent means and standard deviations 











60 1 2 3 4 5
BSA (Mg/200 Ml)
m  + BSA
o — -BSA
Figure 7.2 Effect of BSA on protein assay standard curve.
A protein standard curve was prepared using BSA over a concentration of 
0-25 Mg/ml- 4 x 200 pi aliquots were transferred to wells of a 96-well plate, 
half of which had been pre-coated with BSA (2 mg/ml, 1 hr). 50 pl/well 
dye reagent was added to all wells, the contents were mixed thoroughly and 
after 5 mins, the absorbance was recorded at 630 nm. Duplicates varied 
by < 10 %.
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Figure 7.3 Adhesion of MG-63 cells to ECM proteins.
MG-63 cells (15 000) were seeded into microtitre wells pre-coated with 
collagen I, fibronectin and laminin in serum free MEM. Attachment after 
4 hr at 37 °C to different concentrations of ECM proteins (A). Time course for 
attachment to collagen I, fibronectin (5 pg/cm2) and laminin (20 pg/cm2) (B). 
Points shown are means and standard deviations from 6 wells and are 
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Figure 7.3 Adhesion of MG-63 cells to ECM proteins.
MG-63 cells (15 000) were seeded into microtitre wells pre-coated with 
collagen I, fibronectin and laminin in serum free MEM. Attachment after 
4 hr at 37 °C to different concentrations of ECM proteins (A). Time course for 
attachment to collagen I, fibronectin (5 pg/cm2) and laminin (20 pg/cm2) (B). 
Points shown are means and standard deviations from 6 wells and are 
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Figure 7.5 Effect of IL-1 p on adhesion to ECM proteins.
MG-63 cells were cultured in MEM+3% CS-FCS +/- IL-1 p (10 U/ml).
After 72 hr, cells were resuspended in serum free medium and added to 
microtitre wells coated with collagen I (A), fibronectin (B) and laminin (C). 
After 2 hr, % adhesion was assessed and values obtained at each ECM 
concentration from control and treated wells were compared using an unpaired 
Student's T-test. Points are means and standard deviations from three wells 
and are representative of three different experiments.
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Figure 7.6 Effect of TGFp on adhesion to ECM proteins.
MG-63 cells were cultured in MEM+3% CS-FCS +/- TGF p (25 ng/ml).
After 72 hr, cells were resuspended in serum free medium and added to 
microtitre wells coated with collagen I (A), fibronectin (B) and laminin (C). 
After 2 hr, % adhesion was assessed and values obtained at each ECM 
concentration from control and treated wells were compared using an unpaired 
Student's T-test. Points are means and standard deviations from three wells 
and are representative of three different experiments.




The aim of this project was to investigate the role of cell-matrix interactions in the 
regulation of human bone cell function. Growth of human osteoblast-like cells on 
fibronectin, laminin, collagen I film and collagen I gel exerted a variety of effects on 
proliferation, alkaline phosphatase activity and 1,25D induced osteocalcin release 
(Chapter 3). However, none of these effects could be correlated with quantitative 
changes in integrin subunit expression (Chapter 5). It is possible that growth on 
different matrix components promoted a re-distribution of integrin subunits. In support 
of this, it has been demonstrated that the organisation of integrin receptors in fibroblasts 
and human endothelial cells is specifically determined by ECM molecules (Dejana et 
al.1988; Singer et al.1988). Alternatively, different matrix molecules could affect the 
internal tension of the cytoskeleton through their specific shear strengths (Bill Whish; 
personal communication). These phenomena would not necessarily affect the number 
of integrin subunits expressed but they would alter their cytoskeletal associations. 
Bissell and Barcellos-Hoff (1987) have suggested that the organisation of the 
cytoskeleton, which is determined by the ECM, is critical for expression of a particular 
cell phenotype. These workers found that primary cultures of mouse mammary 
epithelial cells expressed a more differentiated phenotype (as indicated by increased 
expression of p-casein and transferrin mRNA) when cultured on 'released' collagen I 
gel or matrix from Engelbreth-Holmes-Swarm tumour (EHS). They postulated that 
this relationship results from an increase in mRNA half life occurring both in the 
nucleus, as a result of cytoskeleton-nuclear matrix interactions, and in the cytoplasm as 
the result of polysome-cytoskeleton interactions.
The only matrix-mediated cellular response that could be correlated directly with a 
change in the cell surface expression of integrin subunits occurred following growth on 
collagen I gel. This matrix increased expression of a2 integrin subunits by 3.5 fold 
and was directly associated with a change in cell morphology and gel contraction. The 
mechanism of gel contraction is thought to involve changes in the cytoskeleton as it 
does not involve the breakdown of collagen and is prevented following the addition of 
colchicine (Strom and Michalopoulos, 1982). Gel contraction probably results from a 
difference in internal and external forces and supports the hypothesis that interactions 
between the ECM and the cytoskeleton play an important role in regulating cell 
function. This finding also demonstrates that different integrin molecules can translate 
specific signals into events which physically modify the structure of the matrix. The 
ability of a cell to organise its collagen matrix is essential for the formation of lamellar 
bone where collagen fibres are arranged in a distinct orientation and mineralisation 
occurs at specific foci. These characteristics contribute to the compressive strength and
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rigidity of lamellar bone and are in sharp contrast with those of the mechanically 
inefficient woven bone where collagen fibres appear as disorganised bundles.
Integrin a  subunits were differentially expressed by cells of the osteoblastic lineage in 
situ (Chapter 4) and were the major integrin subunits to be regulated by cytokines and 
ECM components in vitro (Chapters 5 and 6 ). In situ hybridisation studies performed 
by other members of our laboratory have localised expression of IL-lp and TGFp to 
specific areas of active bone formation. Taken together, these findings could suggest 
that modulation of integrin subunit expression in response to transient expression of 
IL-ip and TGFp is important during the formation phase of the bone remodelling cycle. 
We were unable to correlate a modulation of integrin subunit expression with changes 
in the differentiated osteoblast phenotype (Chapter 5) or with cell adhesion (Chapter 7). 
However, integrin molecules regulate many diverse aspects of cell phenotype, 
including gene induction (Werb et al.1989; Dhawan and Farmer, 1990; Dhawan et 
al.1991; Seftor et al.1992), phagocytosis (Graham et al.1989; Savill et al.1990) and 
migration (Chan et al.1992). It is therefore possible that regulation of integrin subunit 
expression by cytokines is associated with other phenotypic effects which have yet to 
be established.
In addition to IL-ip and TGFp, there are many other soluble mediators which affect the 
actions of osteoblasts and osteoclasts and regulate integrin subunit expression (see 
Introduction). Furthermore, many of the factors considered to play a role in the 
process of bone remodelling including IL-lp, TGFp, IGF-I and II and 1,25D also 
stimulate ECM synthesis (see Introduction). ECM molecules influence the presentation 
of cytokines and growth factors (see Introduction) and in addition modulate integrin 
subunit expression (Chapter 5). ECM components have also been demonstrated to 
increase cytokine release (Nathan and Spom, 1991). For example, IL-1 release from 
human peripheral blood monocytes is stimulated by collagen fragments, hydroxyapatite 
and to a lesser extent by TGFp (Pacifici et al.1991). These interactions between soluble 
mediators, ECM components and integrin subunit expression could provide some of 
the links required to increase our understanding of the regulatory mechanisms 
controlling the bone remodelling cycle.
The modulation of integrin subunit expression which occurred in response to cytokines 
and ECM components provides further evidence to suggest that integrin molecules are 
performing some kind of signalling role. Changes in cytoskeletal associations and 
other biochemical signals could occur through changes in tyrosine phosphorylation. In 
support of this, it has been shown that clustering of pi integrins, a process which is
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observed during the formation of adhesive contacts between cells and their ECM, is 
specifically associated with enhanced tyrosine phosphorylation of a complex of proteins 
of 115-130 KD (Komberg et al.1991). It has also been demonstrated that adhesion of 
mouse fibroblasts to substrata coated with fibronectin causes increased tyrosine 
phosphorylation of proteins of about 120 KD, whereas adhesion of cells to substrata 
coated with non-specific ligands such as polylysine failed to produce this effect (Guan 
et al.1991). One of the components of this 115-130 KD tyrosine-phosphorylated 
complex, a 125 KD protein, encodes a novel tyrosine kinase from the src family and is 
termed ppl25 Focal Adhesion Kinase (ppl25fak) (Hanks et al.1992; Schaller et 
al.1992). Observations in platelets also suggest a role for integrins in tyrosine kinase- 
mediated signal transduction. When platelets are activated by agonists, the allbp3 
receptor complex undergoes a conformational change which exposes a binding site for 
fibrinogen (Shattil et al.1985). This results in receptor clustering, a subsequent 
association of receptor complexes with cytoskeletal proteins (Phillips et al.1980) and a 
stimulation of tyrosine kinase activity which occurs in three temporal waves (Tusznski, 
1987; Ferrell and Martin, 1989; Golden et al.1990). Recently a strong correlation has 
been demonstrated between ligation of platelet integrins and activation of ppl25fak 
(Lipfert et al.1992). These examples provide compelling evidence to suggest that 
ligation of integrins, followed by receptor clustering and cytoskeletal reorganisation, 
can affect ppl25fak, leading to activation and increased tyrosine phosphorylation of this 
protein. Therefore it seems likely that integrin-mediated activation of ppl25fak is an 
early step in the signal transduction cascade which permits the flow of information 
between the external environment and the interior of the cell.
Signal transduction via the integrins does not necessarily require a change in the level of 
cell surface expression. This could be important in the case of the osteoclast in which 
there is constitutive expression of integrin subunits in situ, irrespective of their location 
in bone (Chapter 4). Evidence is emerging that signal transduction in osteoclasts 
involves the src gene which encodes a pp60c src tyrosine kinase, c-src is critical for 
osteoclast activity since targeted disruption of the c-src proto-oncogene leads to 
osteopetrosis in mice (Soriano et al.1991): three other src-like kinases c-fyn, c-yes 
and c-lyn are expressed at normal levels in osteoclasts from src deficient mice but 
these proteins do not compensate for the absence of pptiO0 -5510 (Home et al.1992). 
pptiO0 ’ 810 is highly expressed on the ruffled border of osteoclasts (Tanaka et al.1992) 
and is required for the formation of these membranes (Boyce et al.1992). Furthermore, 
binding of a cyclic RGD peptide to isolated osteoclasts induces a wave of tyrosine 
phosphorylation and the translocation of a src substrate p85 (Neff et al. 1992). In 
another study, occupancy of the osteoclast aVp3 by osteopontin stimulates a src
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associated phosphatidylinositol 3 kinase (PI3 kinase) resulting in phosphatidylinositol 
trisphosphate (PIP3 ) formation (Hruska et al.1992). The src substrate p85 is one of the 
two subunits comprising PI3 kinase so taken together, these findings provide 
compelling evidence to suggest that integrin-mediated tyrosine phosphorylation may be 
an important mechanism of signal transduction in osteoclasts.
In addition to changes in phosphorylation, a number of other integrin-mediated 
signalling events have been described. For example, in platelets there is evidence that 
integrin ligation can affect calcium activated proteases, the Na+/H+ antiporter and the 
subcellular distribution of PI3 kinase as well as influencing patterns of tyrosine 
phosphorylation. Osteopontin can influence calcium transients in osteoclasts via the 
aVp3 integrin (Miyauchi et al.1991), while both cAMP and calcium are affected by p2 
integrin-mediated events in neutrophils. In addition, signalling events involving 
arachidonic acid metabolites have been associated with integrin-dependent cell 
adhesion. The relationship of these additional processes to integrin-mediated tyrosine 
phosphorylation is at present unknown (reviewed by Juliano and Haskill, 1993).
The ability of integrins to function as true signalling receptors suggests that the 
activities of integrin molecules can be regulated by both extracellular and intracellular 
signals to elicit a specific cellular response. This could have important implications in 
the context of bone remodelling and it helps to explain why binding of integrin 
molecules to ECM components modulates cell activities in ways which extend far 
beyond adhesion. For example, it could account for gel contraction and the changes in 
differentiated osteoblast phenotype observed in vitro during experimental studies. One 
could also speculate that integrin-mediated signals elicited by the ECM could affect the 
development and differentiation state of osteoblasts in vivo thus influencing matrix 
deposition and the formation of osteoblast lining cells and osteocytes. An important 
area which warrants further investigation concerns the role of integrin-mediated signals 
elicited in response to mechanical strain. Profound changes in bone modelling and 
remodelling occur after only very short periods of loading (Rubin and Lanyon, 1985). 
Evidence suggests that this involves increased biosynthetic activity of osteocytes 
(Skerry et al.1989) and changes in the orientation of proteoglycans within the bone 
matrix (Skerry et al.1990). Although osteocytes themselves are not thought capable of 
bone formation, they could translate signals to osteoblasts through gap junctions or 
through local cytokine production. Since integrins form a direct link between the ECM 
and the cytoskeleton, these cell surface receptors could potentially initiate the osteocytic 
response. Induction of bone resorption would not necessarily require signals from 
osteocytes. Osteoblast lining cells are also appropriately positioned to detect changes in
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mechanical strain (Paed et al.1988). One could speculate that changes in mechanical 
loading could be transmitted to the interior of the osteoblast lining cell via the integrins. 
This could induce cytokine release which in turn could initiate bone resorption and 
subsequent bone formation. This process would continue until the increased strain was 
no longer detected by cells of the osteoblastic lineage and the new structure was 
optimally suited to the prevailing mechanical load.
Integrin-mediated signalling could also be of vital importance to the osteoclast. For 
example one could postulate that initiation of bone resorption, which requires 
attachment of mononuclear precursor cells to the bone matrix involves integrin- 
mediated activation. Similarly, the formation of multinucleated osteoclasts, which 
requires fusion of mononuclear cells, and the process of bone resorption, which 
requires an intimate association between the sealing zone of the osteoclast and its ECM, 
could also be associated with integrin-mediated activation. Of equal importance with 
activation of integrins is their inactivation: this could be important during the reversal 
stage of the bone remodelling cycle when osteoclasts detach from the bone matrix and 
perhaps undergo fission to form TRAP positive mononuclear cells.
Most of these examples rely on integrin molecules responding to external stimuli 
elicited by the ECM. However, it is equally possible that signals transmitted from 
within the cell affect integrin activation. This phenomenon is perhaps best illustrated in 
non-adherent cells such as lymphocytes. Stimulation of the T-cell antigen receptor/CD3 
complex augments the affinity of certain integrins for ligand, promoting transient cell 
adhesion (Springer, 1990). This could be of importance in the case of the osteoclast 
during the reversal phase of the bone remodelling cycle with detachment from the bone 
surface (and osteoclast fission?) possibly resulting from an intracellular inactivation of 
integrin receptors.
The biochemical signals activated by integrin receptor clustering are similar to those 
elicited by several growth factor receptors following ligand binding. This suggests that 
signalling pathways triggered by soluble growth factors and ECM molecules could 
converge and/or synergise with each other to regulate cell growth and differentiation.
In fact integrins could be required in conjunction with growth factor receptors to 
regulate cell phenotype. This type of relationship can be observed using mouse 
mammary epithelial cells. Terminal differentiation of alveolar structures and production 
of milk proteins require both lactogenic hormones and contact with the basement 
membrane. The signal from the basement membrane is integrin mediated, as antibodies 
against the pi integrin family block p-casein production (Streuli et al.1991). A 161
base pair enhancer in the 5' regulatory region of the p-casein gene conveys 
responsiveness to ECM and lactogenic hormones. This enhancer does not exhibit any 
sequence homology with other nuclear protein-binding sites, suggesting that specific 
matrix-response elements are required for expression of the correct cell phenotype 
(Schmidhauser et al.1992). Therefore, in addition to providing temporal and spatial 
localisation of cytokines and growth factors, ECM components may be required or 
could at least amplify a cellular response. This means that soluble and insoluble factors 
cannot be considered in isolation and that cell-matrix interactions play a vital role in the 
control of a given cell type. The potential interplay between ECM, integrins and 
cytokines in the local control of bone remodelling is summarised in Figure 8.1.
There are many unanswered questions concerning bone remodelling and the scheme 
depicted in Figure 8.1 only represents a fraction of the overall potential regulatory 
network. Hopefully as research progresses it will be possible to unravel more of these 












A schematic representation of the potential interplay between ECM, integrins and 
cytokines during bone remodelling.
1. ECM molecules determine the distribution of integrin receptors and modulate 
their cell surface expression.
2. By binding to different ligands, the integrin subunit expression determines the 
microenvironment immediately surrounding the cell.
3. Two way signalling between the ECM and interior of the cell is mediated via 
the integrins through activation of biochemical secondary messengers and/or 
changes in cytoskeletal associations.
4. Matrix molecules present cytokines and growth factors to neighbouring cells.
5. Cytokines affect matrix production.
6. Cytokines elicit a cellular response.
Signals elicited by 3 and 6  could converge and synergise with each other to 
amplify a cellular response.
7. Matrix molecules affect cytokine release.
8 . Cytokines modulate integrin receptor function.
BIBLIOGRAPHY
168
Adams, J.C. and Watt, F.M. (1989). Fibronectin inhibits the terminal differentiation of 
human keratinocytes. Nature 340, 307-309.
Adams, J.C. and Watt, F.M. (1990). Changes in keratinocyte adhesion during terminal 
differentiation: Reduction in fibronectin binding precedes a5pi integrin loss from the cell 
surface. Cell 63, 425-435.
Adams, J.C. and Watt, F.M. (1991). Expression of pi, p3, p4 and p5 integrins by human 
epidermal keratinocytes and non-differentiating keratinocytes. J. Cell Biol. 115, 829-841.
Aggeler, J., Park, C.S., and Bissell, M.J. (1988). Symposium: Role of the extracellular 
matrix in mammary development. Regulation of milk protein and basement membrane 
gene expression: the influence of the extracellular matrix. J. Dairy Sci. 71,2830-2842.
Akatsu, T., Takahashi, N., Udagawa, N., Imamura, K., Yamaguchi, A., Sato, K., 
Nagata, N., and Sato, T. (1991). Role of prostaglandins in interleukin 1 induced bone 
resorption in mice in vitro. J. Bone Miner. Res. 6,183-190.
Albelda, S.M. and Buck, C.A. (1990). Integrins and other cell adhesion molecules. 
FASEB J. 4, 2868-2880.
Amano, S., Hanazawa, S., Hirose, K., Ohmori, Y., and Kitano, S. (1988). Stimulatory 
effect on bone resorption of interleukin- 1 like cytokine produced by an osteoblast rich 
population of mouse calvarial cells. Calcif. Tissue Int. 43, 88-91.
Amento, E.P., Bhalla, A.K., Kumick, J.T., Kradin, R.L., Clemens, T.L., Holick, S.A., 
Holick, M.F., and Krane, S.M. (1984). la  dihydroxyvitamin D3  induces maturation of the 
human monocyte line U937 and in association with a factor from human T-lymphocytes 
augments production of the monokine mononuclear cell factor. J. Clin. Invest. 73,731- 
739.
Anderson, R.E., Schraer, H., and Gay, C.V. (1982). Ultrastructural immunocytochemical 
localisation of carbonic anhydrase in normal and calcitonin treated chick osteoclasts. Anat. 
Rec. 204, 9-20.
Armstrong, K.F. and Jackson, S.M. (1972). Anatomy and physiology for nurses. 8 th 
Edition. Bailliere, Tindall, London: pp. 57-64.
Austin, L.A. and Heath, H. (1981). Part HI. Calcitonin: physiology and paraphysiology. 
N. Eng. J. Med. 304, 269-278.
Bankson, D.D., Rifai, N., Williams, M.E., Silverman, L.M., and Gray, T.K. (1989). 
Biochemical effects of 17p-oestradiol on UMR 106 cells. Bone Miner. 6 , 55-63.
Bar-Shavit, Z., Teitelbaum, S.L., Reitsma, P., Hall, A., Pegg, L.E., Trail, J., and Kahn, 
A.J. (1983). Induction of monocytic differentiation and bone resorption by 1,25 
dihydroxyvitamin D3 . Proc. Natl. Acad. Sci. USA 80, 5907-5911.
Barcellos-Hoff, M.H., Neville, P.N., Aggeler, J., and Bissell, M.J. (1987). Polarised 
secretion by mammary epithelial cells on EHS-matrix. J. Cell Biol. 105,220A.(Abstract)
Baron, R. and Vignery, A. (1982). Behaviour of osteoclasts during a rapid change in their 
number induced by high doses of parathyroid hormone of calcitonin in intact rats. Metab. 
Bone Dis. Rel. Res. 2, 339-346.
169
Baron, R. (1990). Anatomy and ultrastructure of bone. In Primer on the metabolic bone 
diseases and disorders of mineral metabolism, M J . Favus, ed. (Kelseyville: American 
Society for Bone and Mineral Research), pp. 3-7.
Basara, M.L., McCarthy, J.B., Barnes, D.W., and Furcht, L.T. (1985). Stimulation of 
haptotaxis and migration of tumour cells by serum spreading factor. Cancer Res. 45,2487- 
2494.
Bassols, A. and Massague, J. (1988). Transforming growth factor p regulates the 
expression and structure of extracellular matrix chondroitin/dermatan sulphate 
proteoglycans. J. Biol. Chem. 263, 3039-3045.
Bentz, H., Nathan, R.M., Rosen, D.M., Armstrong, R.M., Thompson, A.Y., Segarini, 
P.R., Mathews, M.C., Dasch, J.R., Piez, K.A., and Seyedin, S.M. (1989). Purification 
and characterisation of a unique osteoinductive factor from bovine bone. J. Biol. Chem. 
264, 20805-20810.
Benz, D.J., Haussler, M.R., and Komm, B.S. (1991a). Estrogen binding and estrogenic 
responses in human osteoblast-like cells. J. Bone Miner. Res. 6 , 531-541.
Benz, D.J., Haussler, M.R., Thomas, M.A., Speelman, B., and Komm, B.S. (1991b). 
High affinity binding and androgenic regulation of a l  (I)-procollagen and transforming 
growth factor p steady state messenger ribonucleic acid levels in human osteoblast-like 
osteosarcoma cells. Endocrinology 128, 2723-2730.
Beresford, J.N., Gallagher, J.A., Gowen, M., Couch, M., Poser, J., Wood, D.D., and 
Russell, R.G.G. (1984a). The effects of monocyte conditioned medium and interleukin 1 
on the synthesis of collagenous and non-collagenous proteins by mouse bone and human 
bone cells in vitro. Biochim. Biophys. Acta 801, 58-65.
Beresford, J.N., Gallagher, J.A., Poser, J.W., and Russell, R.G.G. (1984b). Production 
of osteocalcin by human bone cells in vitro: effects of l,25(OH)2D3, 24,25(OH)2D3, 
parathyroid hormone and glucocorticoids. Metab. Bone Dis. Rel. Res. 5, 229-234.
Beresford, J.N., Gallagher, J.A., and Russell, R.G.G. (1986). 1,25 dihydroxyvitamin D3 
and human bone derived cells in vitro: effects on alkaline phosphatase, type I collagen and 
proliferation. Endocrinology 119,1776-1785.
Beresford, J.N., Fedarko, N.S., Fisher, L.W., Midura, M.J., Yanagishita, M., Termine, 
J.D., and Gehron Robey, P. (1987). Analysis of the proteoglycans synthesised by human 
bone cells in vitro. J. Biol. Chem. 262, 17164-17172.
Beresford, J.N. (1989). Osteogenic stem cells and the stromal system of bone and 
marrow. Clin. Orthop. 240, 270-280.
Bertolini, D.R., Nedwin, G.E., Bringman, T.S., Smith, D.D., and Mundy, G.R. (1985). 
Stimulation of bone resorption and inhibition of bone formation in vitro by human tumour 
necrosis factors. Nature 319, 516-518.
Bianco, P., Silvestrini, G., Termine, J.D., and Bonucci, E. (1988). Immunohistochemical 
localisation of osteonectin in developing human and calf bone using monoclonal antibodies. 
Calcif. Tissue Int. 43, 155-161.
170
Bianco, R., Fisher, L.W., Young, M.F., Termine, J.D., and Gehron Robey, P. (1991). 
Expression of bone sialoprotein (BSP) in developing human tissues. Calcif. Tissue Int. 49, 
421-426.
Bissell, M J. and Barcellos-Hoff, H. (1987). The influence of extracellular matrix on gene 
expression: is structure the message ? J. Cell Sci. Suppl 8 , 327-343.
Bodary, S.C., Lipari, T., Muir, C., Napier, M., Pitti, R., and MacLean, J.S. (1991). 
Deletion of the cytoplasmic and transmembrane domains of GPIIbllla results in a 
functional receptor. J. Cell Biol. 115, 289A.(Abstract)
Bonner-Fraser, M. (1985). Alterations in neural crest migration by a monoclonal antibody 
that affects cell adhesion. J. Cell Biol. 101, 610-617.
Bonner-Fraser, M. (1986). An antibody to a receptor for fibronectin and laminin perturbs 
cranial neural crest development in vivo. Dev. Biol. 117, 528-536.
Boyan, B.D., Schwartz, Z., Bonewald, L.F., and Swain, L.D. (1989). Localisation of 
1,25-dihydroxyvitamin D3 responsive alkaline phosphatase in osteoblast cell lines (ROS 
17/2.8, MG-63 and MC3T3) and growth cartilage cells in culture. J. Biol. Chem. 264, 
11879-11886.
Boyce, B.F., Aufdemorte, T.B., Garrett, I.R., Yates, A.J.P., and Mundy, G.R. (1989). 
Effects of interleukin I on bone turnover in normal mice. Endocrinology 125, 1142-1150.
Boyce, B.F., Yoneda, T., Lowe, C., Soriano, P., and Mundy, G.R. (1992). Requirement 
of
pp60°'src expression for osteoclasts to form ruffled borders and resorb bone in mice. J. 
Clin. Invest. 90, 1622-1627.
Bradford, M.M. (1976). A rapid and sensitive method for the quantitation of microgram 
quantities of protein utilising the principle of protein-dye binding. Anal. Biochem. 72,248- 
254.
Brandt, J., Srour, E.F., van Besien, K., Bridell, R.A., and Hoffman, R. (1990).
Cytokine dependent long term culture of highly enriched precursors of haemopoietic 
progenitor cells form human bone marrow. J. Clin. Invest. 86,932-941.
Brighton, C.T. and Albelda, S.M. (1992). Identification of integrin cell substratum 
adhesion receptors on cultured rat bone cells. J. Orthop. Res. 10,776-773.
Bronckers, A.L., Gay, S., Dimuzio, M.T., and Butler, W.T. (1985). Immunolocalisation 
of gamma-carboxyglutamic acid containing proteins in developing molar tooth germs of the 
rat. Collagen Rel. Res. 5, 17-22.
Bronckers, A.L., Gay, S., Finkelman, R.D., and Butler, W.T. (1987). 
Immunolocalisation of gla proteins (osteocalcin) in rat tooth germs: comparison between 
indirect immunofluorescence, avidin-biotin-peroxidase complex and avidin-biotin-gold 
complex with silver enhancement. J. Histochem. Cytochem. 35, 825-830.
Canalis, E. (1986). Interleukin-1 has independent effects on deoxyribonucleic acid and 
collagen synthesis in cultures of rat calvariae. Endocrinology 118,74-81.
171
Canalis, E. (1987). Effects of tumour necrosis factors on bone formation in vitro. 
Endocrinology 121, 1596-1604.
Canalis, E.M. (1980). Effect of insulin like growth factor I on DNA and collagen synthesis 
in cultures of rat calvariae. J. Clin. Invest. 66,709-719.
Carrington, J.L., Roberts, A.B., Flanders, K.C., Roche, N.S., and Reddi, A.H. (1988). 
Accumulation, localisation and compartmentalisation of transforming growth factor p 
during endochondral bone development. J. Cell Biol. 107,1969-1975.
Casser-Bette, M., Murray, A.B., Closs, E.I., Erfle, V., and Schmidt, J. (1990). Bone 
formation by osteoblast-like cells in a three dimensional cell culture. Calcif. Tissue Int. 46, 
46-56.
Centrella, M., Massague, J., and Canalis, E. (1986). Human platelet derived transforming 
growth factor p stimulates parameters of bone growth in fetal rat calvariae. Endocrinology 
119, 2306-2312.
Centrella, M., McCarthy, T.L., and Canalis, E. (1987). Transforming growth factor beta 
is a bifunctional regulator of replication and collagen synthesis in osteoblast-enriched 
cultures of fetal rat bone. J. Biol. Chem. 262, 2869-2874.
Centrella, M., McCarthy, T.L., and Canalis, E. (1988). Tumour necrosis factor a  inhibits 
collagen synthesis and alkaline phosphatase activity independently of its effect on 
deoxyribonucleic acid synthesis in osteoblast-enriched organ culture. Endocrinology 123, 
1442-1448.
Chambers, T.J. and Dunn, C.J. (1982). The effect of parathyroid hormone, 1,25 
dihydroxycholecalciferol and prostaglandins on the cytoplasmic activity of isolated 
osteoclasts. J. Pathol. 137, 193-203.
Chambers, T J. and Magnus, C.J. (1982). Calcitonin alters behaviour of isolated 
osteoclasts. J. Pathol. 136, 27-39.
Chambers, T.J. and Ali, N.N. (1983). Inhibition of osteoclastic motility by prostaglandins 
I2, E2  and 6 -oxo-El. J. Pathol. 139, 383-397.
Chambers, T.J. and Moore, A. (1983). The sensitivity of isolated osteoclasts to 
morphological transformation by calcitonin. J. Clin. Endocrinol. Metab. 57, 819-824.
Chambers, T.J., Athanasou, N.A., and Fuller, K. (1984). Effect of parathyroid hormone 
and calcitonin on the cytoplasmic spreading of isolated osteoclasts. J. Endocrinol. 102, 
281-286.
Chan, B.M.C., Kassner, P.D., Schiro, J.A., Byers, R.H., Kupper, T.S., and Hemler, 
M.E. (1992). Distinct cellular functions mediated by different VLA integrin a  subunit 
cytoplasmic domains. Cell 68,1051-1060.
Chase, L.R. and Aurbach, G.D. (1970). The effect of parathyroid hormone on the 
concentration of adenosine 3'5' monophosphate in skeletal tissue in vitro. J. Biol. Chem. 
245, 1520-1526.
172
Chayen, J., Bitensky, L., and Butcher, R.G. (1973). Practical Histochemistry. (London: 
Wiley).
Cheifetz, S., Weatherbee, J.A., Tsang, M.L-S., Anderson, J.K., Mole, J.E., Lucas, R., 
and Massague, J. (1987). The transforming growth factor p system, a complex pattern of 
cross reactive ligands and receptors. Cell 48,409-415.
Chenu, C., Pfeilschifler, J., Mundy, G.R., and Roodman, G.D. (1988). Transforming 
growth factor beta inhibits formation of osteoclast-like cells in long term human marrow 
cultures. Proc. Natl. Acad. Sci. USA 85, 5683-5687.
Chyun, Y.S. and Raisz, L.G. (1984). Stimulation of bone formation by prostaglandin E2 . 
Prostaglandins 27, 97-103.
Clark, R.A.F. (1990). Fibronectin matrix deposition and fibronectin receptor expression in 
healing and normal skin. J. Invest. Dermatol. 6 , 1285-1345.
Clezardin, P., Malaval, L., Ehrensperger, A.S., Delmas, P., Dechavanne, M., and 
McGregor, J.L. (1988). Complex formation of human thrombospondin with osteonectin. 
Eur. J. Biochem. 175, 275-284.
Clezardin, P., Jouishomme, H., Chavassieux, P., and Marie, P.J. (1989). 
Thrombospondin is synthesised and secreted by human osteoblasts and osteosarcoma cells: 
a model to study the different effects of thrombospondin in cell adhesion. Eur. J. Biochem. 
181, 721-726.
Clezardin, P., Malaval, L., Morel, M-C., Guichard, J., LeCompte, T., Trzeciak, M-C., 
Dechavanne, M., Breton-Gorius, J., Delmas, P.D., and Kaplan, C. (1991). Osteonectin is 
an a-granule component involved with thrombospondin in platelet aggregation. J. Bone 
Miner. Res. 6 , 1059-1070.
Dana, N., Fathallah, D.M., and Amaout, A.M. (1991). Expression of a soluble and 
functional form of the human p2 integrin CDllb/CD18. Proc. Natl. Acad. Sci. USA 8 8 , 
3106-3110.
Darribere, T., Yamada, K., Johnson, K., and Boucaut, J. (1988). The 140K Da 
fibronectin receptor complex is required for mesodermal cell adhesion during gastrulation 
in the amphibian Pleurodeles waltii. Dev. Biol. 126, 182-194.
Davies, J., Warwick, J., Totty, N., Philp, R., Helfrich, M., Horton, M. (1989). The 
osteoclast functional antigen, implicated in the regulation of bone resorption is 
biochemically related to die vitronectin receptor. J. Cell Biol. 109,1817-1826.
Dedhar, S., Argraves, W.S., Suzuki, S., Ruoslahti, E., and Pierschbacher, M.D. (1987). 
Human osteosarcoma cells resistant to detachment by arg-gly-asp containing peptide 
overproduce the fibronectin receptor. J. Cell Biol. 105,1175-1182.
Dedhar, S. (1989). Regulation of the expression of cell adhesion receptors, integrins by 
recombinant human interleukin lp in human osteosarcoma cells: inhibition of cell 
proliferation and stimulation of alkaline phosphatase activity. J. Cell Physiol. 138,291- 
299.
173
Dedhar, S. and Saulnier, R. (1990). Alterations in integrin subunit expression on 
chemically transformed human cells: specific enhancement of laminin and collagen receptor 
complexes. J. Cell Biol. 110, 481-489.
Defilippi, P., Truffa, G., Stefanuto, G., Altruda, F., Silengo, L., and Tarone, G.
(1991a). Tumour necrosis factor a  and interferon y modulate the expression of the 
vitronectin receptor (integrin (33) in human endothelial cells. J. Biol. Chem. 266,7638- 
7645.
Defilippi, P., Van Hinsbergh, V., Bertolotto, A., Rossino, P., Silengo, L., and Tarone,
G. (1991b). Differential distribution and modulation of expression of alpha 1/beta 1 
integrin on human endothelial cells. J. Cell Biol. 114, 855-863.
Dejana, E., Colella, S., Conforti, G., Abbadini, M., Gaboli, M., and Marchisio, P.C. 
(1988). Fibronectin and vitronectin regulate the organisation of their respective arg-gly-asp 
adhesion receptors in cultured endothelial cells. J. Cell Biol. 107, 1215-1223.
Delmas, P.D., Russell, T.P., Riggs, L.B., and Mann, K.G. (1984). Identification of the 
noncollagenous proteins of bovine bone by two dimensional gel electrophoresis. Calcif. 
Tissue Int. 36, 308-316.
Dewhirst, F.E., Stashenko, P.P., Mole, J.E., and Tsurumachi, T. (1985). Purification 
and partial sequence of human osteoclast activating factor: identity with interleukin- 1 beta. 
J. Immunol. 135, 2562-2568.
Dewhirst, F.E., Argo, J.M., Peros, W.J., and Stashenko, P. (1987). Synergism between 
parathyroid hormone and interleukin 1 in stimulating bone resorption in organ culture. J. 
Bone Miner. Res. 2, 127-134.
Dhawan, J. and Farmer, S.R. (1990). Regulation of a l  (I) - collagen gene expression in 
response to cell adhesion in Swiss 3T3 fibroblasts. J. Biol. Chem 265, 9015-9021.
Dhawan, J., Lichtler, A.C., Rowe, D.W., and Farmer, S.R. (1991). Cell adhesion 
regulates pro-al (I) collagen mRNA stability and transcription in mouse fibroblasts. J. 
Biol. Chem. 266, 8470-8475.
Dietrich, J.W., Canalis, E.M., Maina, D.M., and Raisz, L.G. (1976). Hormonal control 
of bone collagen synthesis in vitro: effects of parathyroid hormone and calcitonin. 
Endocrinology 98, 943-949.
Dodds, R.A., Merry, K.H., Littlewood, A.J., and Gowen, M. (1992). Detection of 
osteoblastic IL- lp, TGFp and IL- 6  mRNA at distinct stages of human bone remodelling by 
in situ hybridisation. Calcif. Tissue Int. 59, A5.(Abstract)
Doty, S.B. (1981). Morphological evidence of gap junctions between bone cells. Calcif. 
Tissue Int. 33, 509-512.
Dunlay, R., Ross, F.P., Sago, K., Price, P., Brown, E., and Teitelbaum, S.L. (1992). 
Differential regulation by retinoic acid of integrin expression and matrix attachment of 
transformed human osteoblasts and normal bone cells. J. Bone Miner. Res. 7 suppl 1, 
S259. (Abstract)
Dziak, R. and Stem, P.H. (1975). Calcium transport in isolated bone cells III. Effects of 
parathyroid hormone and 3'5'-AMP. Endocrinology 97, 1281-1287.
1 7 4
Elices, M J . and Hemler, M.E. (1989). The human integrin VLA-2 is a collagen receptor 
on some cells and a collagen/laminin receptor on others. Proc. Natl. Acad. Sci. USA 8 6 , 
9906-9910.
Elices, M.J., Urry, L.A., and Hemler, M.E. (1991). Receptor functions for the integrin 
VLA-3: fibronectin, collagen and laminin binding are differentially influenced by arg-gly- 
asp peptides and by divalent cations. J. Cell Biol. 112,169-181.
Emerman, J.T. and Pitelka, D.R. (1977). Maintenance and induction of morphological 
differentiation in dissociated mammary epithelium on floating collagen membranes. In vitro 
13, 316-328.
Eriksen, E.F., Colvard, D.S., Berg, N.J., Graham, M.L., Mann, K.G., Spelsberg, T.C., 
and Riggs, B.L. (1988). Evidence of oestrogen receptors in normal human osteoblast-like 
cells. Science 241, 84-86.
Ernst, M., Schmid, C., and Froesh, E.R. (1988). Enhanced osteoblast proliferation and 
collagen gene expression by oestradiol. Proc. Natl. Acad. Sci. USA 85,2307-2310.
Ernst, M., Heath, J.K., and Rodan, G.A. (1989). Estradiol effects on proliferation 
messenger ribonucleic acid for collagen and insulin-like growth factor I and PTH- 
stimulated adenylate cyclase activity in osteoblastic cells from calvariae and long bones. 
Endocrinology 125, 825-833.
Ernst, M., Schmid, C., Rodan, G.A., Zapf, , and Froesch, E.R. (1990). Systemic 
hormones may regulate the action of IGF-1 on osteoblasts via IGF-binding protein 3 
production by the same cells. Calcif. Tissue Int. 46, 33A.(Abstract)
Evans, B.D., Bunning, R.A.D., Van Damme, J., and Russell, R.G.G. (1989). Natural 
human IL-lp exhibits regulatory actions on human bone derived cells. Biochem. Biophys. 
Res. Commun. 159, 1242-1248.
Farley, J.R., Tarbaux, N.M., Hall, S.L., Linkhart, T.A., and Baylink, D.J. (1988). The 
anti bone resorptive agent calcitonin also acts in vitro to directly increase bone formation 
and bone cell proliferation. Endocrinology 123,159-167.
Farley, J.R., Wergedal, J.E., Hall, S.L., Herring, S., and Tarbaux, N.M. (1991). 
Calcitonin has direct effects on 3H thymidine incorporation and alkaline phosphatase 
activity in human osteoblast-like cells. Calcif. Tissue Int. 48, 297-301.
Feldman, R.S., Krieger, N.S., and Tashjian, A.H. (1980). Effects of PTH and calcitonin 
on osteoclast formation in vitro. Endocrinology 107,1137-1143.
Felix, R., Elford, P.R., Stoerckle, C., Cecchini, M., Wetterwald, A., Trechsel, U., 
Fleisch, H., and Stadler, B.M. (1988). Production of haematopoietic growth factors by 
bone tissue and bone cells in culture. J. Bone Miner. Res. 3, 27-32.
Fernandez, J.L.R. and Ben-Ze'ev, A. (1989). Regulation of fibronectin, integrin and 
cytoskeletal expression in differentiating adipocytes: inhibition by extracellular matrix and 
polylysine. Differentiation 42,65-74.
175
Ferrell, J.E. and Martin, G.S. (1989). Tyrosine specific protein phosphorylation is 
regulated by glycoprotein nbllla in platelets. Proc. Natl. Acad. Sci. USA 86,2234-2238.
Fisher, L.W., McBride, O.W., Termine, J.D., and Young, M.F. (1990). Human bone 
sialoprotein: deduced protein sequence and chromosomal localisation. J. Biol. Chem. 265, 
2347-2351.
Franceschi, R.T., James, W.M., and Zerlauth, G. (1985). la,25-dihydroxy vitamin D3 
specific regulation of growth, morphology and fibronectin in a human osteosarcoma cell 
line. J. Cell Physiol. 123, 401-409.
Franceschi, R.T., Linson, C.J., Peter, T.C., and Romano, P.R. (1987). Regulation of 
cellular adhesion and fibronectin synthesis by la,25-dihydroxyvitamin D3 . J. Biol. Chem. 
262,4165-4171.
Franceschi, R.T., Romano, P.R., and Park, K.Y. (1988). Regulation of type I collagen 
synthesis by 1,25-dihydroxyvitamin D3 in human osteosarcoma cells. J. Biol. Chem. 263, 
18938-18945.
Franceschi, R.T. and Young, J. (1990). Regulation of alkaline phosphatase by 1,25- 
dihydroxyvitamin D3 and ascorbic acid in bone derived cells. J. Bone Miner. Res. 5,1157- 
1167.
Fritsch, J., Grosse, B., Lieberherr, M., and Balsan, S. (1985). 1,25 Dihydroxyvitamin D3  
is required for growth independent expression of alkaline phosphatase in cultured rat 
osteoblasts. Calcif. Tissue Int. 37, 639-645.
Froidart, J.M. and Reddi, A.H. (1980). Immunofluorescent localisation of type IV 
collagen and laminin during endochondral bone differentiation and regulation by pituitary 
growth hormone. Dev. Biol. 75, 130-136.
Gailit, J. and Ruoslahti, E. (1988). Regulation of the fibronectin receptor affinity by 
divalent cations. J. Biol. Chem. 263, 12927-12933.
Gallagher, J.C., Riggs, B.L., and DeLuca, H.F. (1980). Effect of oestrogen on calcium 
absorption and serum vitamin D metabolites in post menopausal osteoporosis. J. Clin. 
Endocrinol. Metab. 51, 1359-1364.
Gehron Robey, P. and Fisher, L.W. (1987). Kinetics of non collagenous bone matrix 
protein production by bone cells in vitro. In Calcium regulation and bone metabolism: 
basic and clinical aspects, D.V. Cohn, T.J. Martin, and P.J. Meunier, eds. (Amsterdam: 
Elsevier Scientific Publishing Company Inc.), pp. 438-443.
Gehron Robey, P., Young, M.F., Flanders, K.C., Roche, K.C., Kondaiah, P., Reddi, 
A.H., Termine, J.D., Spom, M.B., and Roberts, A.B. (1987). Osteoblasts synthesize and 
respond to transforming growth factor p (TGFp) in vitro. J. Cell Biol. 105,457-463.
Gehron Robey, P. (1989). The biochemistry of bone. Endocrinol. Metab. Clinics N. 
America 18, 859-902.
Gehron Robey, P., Young, M.F., Fisher, L.W., and McClain, T.D. (1989). 
Thrombospondin is an osteoblast derived component of mineralised extracellular matrix. J. 
Cell Biol. 108, 719-727.
176
Girasole, G., Jilka, R.L., Passeri, G., Boswell, S., and Boder, G. (1992). 17p-estradiol 
inhibits Interleukin- 6  production by bone marrow derived stromal cells and osteoblasts in 
vitro: a potential mechanism for the antiosteoporotic effects of oestrogens. J. Clin. Invest. 
89, 883-891.
Glibert, F., Chenu, C., Malaval, L., and Delmas, P.D. (1989). Effects of 1,25- 
dihydroxyvitamin D3 , dexamethasone and 17p oestradiol on the synthesis of bone gla 
protein and osteonectin by human osteosarcoma cells. J. Bone Miner. Res. 4 suppl 1, 
333A.(Abstract)
Golden, A., Brugge, J.S., and Shattil, S.J. (1990). Role of platelet membrane 
glycoprotein Ilbllla in agonist induced tyrosine phosphorylation of platelet proteins. J. Cell 
Biol. I l l ,  3117-3127.
Gowen, M., Wood, D.D., Ihrie, E.J., McGiure, M.K.B., and Russell, R.G.G. (1983). 
An interleukin I like factor stimulates bone resorption in vitro. Nature 306, 378-380.
Gowen, M., Wood, D.D., and Russell, R.G.G. (1985). Stimulation of the proliferation of 
human bone cells in vitro by human monocyte products with interleukin 1 activity . J. Clin. 
Invest. 75, 1223-1229.
Gowen, M. and Mundy, G.R. (1986). Actions of recombinant interleukin 1, interleukin 2 
and interferon-yon bone resorption in vitro. J. Immunol. 136, 2478-2482.
Gowen, M. (1988). Actions of IL-1 and TNF on human osteoblast-like cells: similarities 
and synergism. In Monokines and other non-lymphocytic cytokines, Alan, R. Liss, Inc),
pp. 261-266.
Gowen, M., MacDonald, B.R., and Russell, R.G.G. (1988). Actions of recombinant 
human y interferon and tumour necrosis factor a on the proliferation and osteoblastic 
characteristics of human trabecular bone cells in vitro. Arthritis Rheum 31,1500-1507.
Gowen, M. (1991). Cytokines regulate bone cell function. Rheumatol. Rev. 1, 43-50.
Gowen, M. (1992a). Cytokines and skeletal disorders. In Cytokine interactions and their 
control, A. Baxter and R. Ross, eds. (John Wiley and sons ltd), pp. 125-137.
Gowen, M. (1992b). Interleukin I and tumour necrosis factor. In Cytokines and bone 
metabolism, M. Gowen, ed. (Boca Baton Ann Arbor, London: CRC press),
Graham, I.L., Gresham, H.D., and Brown, E J. (1989). An immobile subset of plasma 
membrane CD1 lb/CD 18 (Mac-1) is involved in phagocytosis of targets recognised by 
multiple receptors. J. Immunol. 142, 2352-2358.
Gray, T.K., Flynn, T.C., Gray, K.M., and Nabell, L.M. (1987). 17p-oestradiol acts 
directly on the clonal osteoblastic cell line UMR 106. Proc. Natl. Acad. Sci. USA 84, 
6267-6271.
Grinnell, F. (1982). Cell-collagen interactions: overview. In Methods in Enzymology. 
Volume 82. Strucural and contractile proteins. Part A, L.W. Cunningham and D.W. 
Frederiksen, eds. (New York: Academic Press), pp. 499-503.
Groessner-Schriber, B., Krukowski, M., Hertweck, D., and Osbody, P. (1991). 
Osteoclast formation is related to bone matrix age. Calcif. Tissue Int. 48, 335-340.
177
Grossman, CJ. (1984). Regulation of the immune system by sex steroids. Endocr. Rev.
5, 435-455.
Guan, J-L., Trevithick, J.E„ and Hynes, R.O. (1991). Fibronectin-integrin interactions 
induces tyrosine phosphorylation of a 120 KD protein. Cell Regul. 2,951-964.
Guerra, J.J., Rosenthal, A., and Clark, C.C. (1992). The role of ascorbic acid in the 
induction of alkaline phosphatase in rat calvaria bone cell cultures. J. Bone Miner. Res. 7 
Suppl 1, S265.(Abstract)
Hamilton, J.A., Lingelbach, S., Partridge, N.C., and Martin, T.J. (1985). Regulation of 
plasminogen activator production by bone-resorbing hormones in normal and malignant 
osteoblasts. Endocrinology 116, 2186-2191.
Hanazawa, S., Ohmori, Y., Amano, S., Hirose, K., Miyoshi, T., Kumegawa, M., and 
Kitano, S. (1986). Human purified interleukin 1 inhibits DNA synthesis and cell growth of 
the osteoblast-like cell line (MC3T3-E1) but enhances alkaline phosphatase in these cells. 
FEBS Lett. 203, 279-284.
Hanazawa, S., Amano, S., Nakada, K., Ohmori, Y., Miyoshi, T., Hirose, K., and 
Kitano, S. (1987). Biological characterisation of interleukin 1 like cytokine produced by 
cultured bone cells from newborn mouse calvaria. Calcif. Tissue Int. 41, 31-37.
Hanks, S.K., Calalb, M.B., Harper, M.C., and Patel, S.K. (1992). Focal adhesion 
protein-tyrosine kinase phosphorylated in response to cell attachment to fibronectin. Proc. 
Natl. Acad. Sci. USA 89, 8487-8491.
Hassager, C., Spencer, E.M., Fitzpatrick, L.A., Riggs, B.L., and Conover, C.A. (1991). 
Insulin-like growth factor binding protein secretion in osteoblast-like cells is cell line 
specific. J. Bone Miner. Res. 6  suppl 1, S146.(Abstract)
Hauschka, P.V., Lian, J.B., and Gallop, P.M. (1975). Direct identification of the calcium 
binding amino acid, gamma-carboxyglutamate, in mineralised tissue. Proc. Natl. Acad.
Sci. USA 72, 3925-3929.
Hayashi, Y., Haimovich, B., Reszka, A., Boettiger, D., and Horwitz, A. (1990). 
Expression and function of chicken integrin pi subunit and its cytoplasmic doamain 
mutants in mouse NIH 3T3 cells. J. Cell Biol. 110, 175-184.
Heath, J.K., Saklatvala, J., Meikle, M.C., Atkinson, S.J., and Reynolds, J.J. (1985). Pig 
interleukin 1 (catabolin) is a potent inhibitor of bone resorption in vitro. Calcif. Tissue Int. 
37, 95-97.
Heinegard, D., Bjome-Personn, A., Coster, L. Franzen, S., Malmstrom, A., Paulsson, 
M., Sandfalk, R., and Vogel, K. (1985). The core proteins of large and small interstitial 
proteoglycans from various connective tissues from distinct subgroups. Biochem. J. 230, 
181-194.
Heino, J., Ignotz, R.A., Hemler, M.E., Crouse, C., and Massague, J. (1989). Regulation 
of cell adhesion receptors by transforming growth factor p. J. Biol. Chem. 264, 380-388.
178
Heino, J. and Massague, J. (1989). Transforming growth factor p switches the pattern of 
integrins expressed in MG-63 human osteosarcoma cells and causes a selective loss of 
adhesion to laminin. J. Biol. Chem. 264, 21806-21811.
Helfrich, M.H., Nesbitt, S.A., Dorey, E.L., and Horton, M.A. (1992). Rat osteoclasts 
adhere to a wide range of RGD (Arg-Gly-Asp) peptide-containing proteins, including the 
bone sialoproteins and fibronectin, via aVp3 integrin. J. Bone Miner. Res. 7, 335-343.
Heremans, H., Billiau, A., Cassiman, J.J., Mulier, J.C., and Desomer, P. (1978). In 
vitro cultivation of human tissues II. Morphology and virological characteristics of three 
cell lines. Oncology 35,246-252.
Herrmann-Erlee, M.P.M. and Gaillard, P.J. (1978). The effects of 1,25 
dihydroxycholecalciferol on embryonic bone in vitro. A biochemical and histological study. 
Calcif. Tissue Res. 25, 111-118.
Hinman, J.W. (1972). Prostaglandins. Ann. Rev. Biochem. 41, 161-178.
Hogg, N. (1991). An integrin overview. Integrins and ICAM-1 in Immune responses. 
Chem. Immunol., N.Hogg, eds. (Basel, Karger), Vol 50, pp. 1-12
Holtrop, M.E. and Raisz, L.G. (1979). Comparison of the effects of 1,25 
dihydroxycholecalciferol, prostaglandin E2  and osteoclast activating factor with PTH on the 
ultrastructure of osteoclasts in cultured long bones of fetal rats. Calcif. Tiss. Int. 29,201- 
205.
Holtrop, M.E., Cox, K.A., Clark, M.B., Holick, M.F., and Anast, C.S. (1981). 1,25 
dihydroxycholecalciferol stimulates osteoclasts in rat bones in the absence of parathyroid 
hormone. Endocrinology 108, 2293-2301.
Home, W.C., Neff, L., Chatterjee, D., Lomri, A., Levy, J.B., and Baron, R. (1992). 
Osteoclasts express high levels of pp60c_src in association with intracellular membranes. J. 
Biol. Chem. 119, 1003-1013.
Horowitz, N., Colman, D.L., Flood, P.M., Kupper, T.S., and Jilka, R.A. (1989). 
Parathyroid hormone and LPS induce murine osteoblast-like cells to secrete a cytokine 
indistinguishable from granulocyte-macrophage colony stimulating factor. J. Clin. Invest. 
83, 149-157.
Horton, J.E., Raisz, L.G., Simmons, H.A., Oppenheim, J.J., and Mergenhagen, S.E. 
(1972). Bone resorbing activity in supernatant fluid from cultured human peripheral blood 
leukocytes. Science 177,793-795.
Horton, M.A., Lewis, D., McNulty, K., Pringle, J.A.S., and Chambers, T.J. (1985a). 
Human foetal osteoclasts fail to express macrophage antigens. J. Exp. Pathol. 66,103- 
108.
Horton, M.A., Lewis, D., McNulty, K., Pringle, J.A.S., and Chambers, T.J. (1985b). 
Monoclonal antibodies to osteoclastomas (giant cell tumours): definition of osteoclast 
specific cellular antigens. Cancer Res. 45, 5663-5669.
Horton, M.D. and Davies, J. (1989). Perspectives: Adhesion receptors in bone. J. Bone 
Miner. Res. 4, 803-807.
179
Hotchin, N.A. and Watt, F.M. (1992). Transriptional and post-translational regulation of 
pi integrin expression during keratinoctye terminal differentiation. J. Biol. Chem. 267, 
14852-14858.
Hruska, K.A., Rolnick, F., and Huskey, M. (1992). Occupancy of the osteoclast aVp3 
integrin by osteopontin stimulates a novel src associated phosphatidylinositol 3 kinase (PI3 
kinase) resulting in phosphatidylinositol triphosphate (PIP3 ) formation. J. Bone Miner.
Res. 7 suppl 1, S I06.(Abstract)
Humphries, M.J., Komoriya, A., Akiyama, S.K., Olden, K., and Yamada, K.M. (1987). 
Identification of two distinct regions of the type III connecting segment of human plasma 
fibronectin that promote cell type-specific adhesion. J. Biol. Chem. 262, 6886-6892.
Humphries, M.J. (1990). The molecular basis and specificity of receptor-ligand 
interactions. J. Cell Sci. 97, 585-592.
Hynes, R.O. (1987). Integrins: A family of cell surface receptors. Cell 48, 549-554.
Hynes, R.O. (1992). Integrins: Versatility, modulation and signalling in cell adhesion.
Cell 69, 11-25.
Ibbotson, K.J., Roodman, G.D., McManus, L.M., and Mundy, G.R. (1984). 
Identification and characterisation of osteoclast-like cells and their progenitors in cultures of 
feline marrow mononuclear cells. J. Cell Biol. 99,471-480.
Ignotz, R.A., Endo, T., and Massague, J. (1987). Regulation of fibronectin and type I 
collagen mRNA levels by tansforming growth factor p. J. Biol. Chem. 262, 6443-6446.
Ignotz, R.A. and Massague, J. (1987). Cell adhesion protein receptors as targets for 
transforming growth factor p action. Cell 51, 189-197.
Ignotz, R.A., Heino, J., and Massague, J. (1989). Regulation of cell adhesion receptors 
by transforming growth factor p. J. Biol. Chem. 264, 389-392.
Ingber, D. (1991). Integrins as mechanical transducers. Curr. Opin. Cell Biol. 3, 841-848.
Ishikawa, O., Yamakage, A., LeRoy, E.C., and Trojanowska, M. (1990). Persistant 
effect of TGFp on extracellular matrix gene expression in human dermal fibroblasts. 
Biochem. Biophys. Res. Comm. 169, 232-238.
Jeansonne, B.G., Feagin, F.F., McMinn, R.W., Shoemaker, R.L., and Rehm, W.S. 
(1979). Cell-to-cell communications of osteoblasts. J. Dent. Res. 58, 1415-1423.
Jeffredo, T., Horwitz, A., Buck, C., Rong, P., and Dieterlen-Lievre, (1988). Myoblast 
migration specifically inhibited in the chick embryo by grafted CS AT hybridoma cells 
secreting an anti-integrin antibody. Dev. 103,431-446.
Jilka, R.L., Hangoc, G., Girasole, G., Passeri, G., Williams, D.C., Abrams, J.S., 
Boyce, B., Broxmeyer, H., and Manalagas, S.C. (1992). Increased osteoclast 
development after oestrogen loss: mediation by interleukin-6 . Science 257, 88-91.
Johnson, G.D. (1981). Immunofluorescence and peroxidase techniques. In Techniques in 
Clinical Immunology, R.A. Thompson, ed. (London: Blackwell Scientific Publications).
180
Jones, S J . and Boyde, A. (1976). Experimental study of changes in osteoblastic shape 
induced by calcitonin and parathyroid hormone in an organ culture system. Cell Tissue 
Res. 169, 449-465.
Juliano, R.L. and Haskill, S. (1993). Signal transduction from the extracellular matrix. J. 
Cell Biol. 120, 577-585.
Jundt, G., Berghauser, K.H., Termine, J.D., and Schulz, A. (1987). Osteonectin-a 
differentiation marker of bone cells. Cell Tissue Res. 248,409-415.
Kahari, V-M., Larjava, H., and Uitto, J. (1991). Differential regulation of extracellular 
matrix proteoglycan (PG) gene expression. J. Biol. Chem. 266, 10608-10615.
Keeting, P.E., Scott, R.E., Colvard, D.S., Han, I.K., Spelsberg, T.C., and Riggs, B.L.
(1991). Lack of a direct effect of oestrogen on proliferation and differentiation of normal 
human osteoblast-like cells. J. Bone Miner. Res. 6,297-304.
Kirchhofer, D., Gailit, J., Ruoslahti, E., Grzesiak, J., and Pierschbacher, M.D. (1990a). 
Cation dependent changes in the binding specificity of platelet receptor GPIIblHa. J. Biol. 
Chem. 265, 18525-18530.
Kirchhofer, D., Languino, L.R., Ruoslahti, E., and Pierschbacher, M.D. (1990b). a2pi 
integrins from different cell types show different binding specificities. J. Biol. Chem. 265, 
615-618.
Kirchhofer, D., Grzesiak, J., and Pierschbacher, M.D. (1991). Calcium as a potential 
physiological regulator of integrin-mediated cell adhesion. J. Biol. Chem. 266,4471-4477.
Klein, D.C. and Raisz, L.G. (1970). Prostaglandins: stimulation of bone resorption in 
tissue culture. Endocrinology 86,1436-1440.
Kleinman, H.K., Klebe, R.J., and Martin, G.R. (1981). Role of collagenous matrices in 
the adhesion and growth of cells. J. Cell Biol. 88,473-485.
Kleinman, H.K., Cannon, F.B., Laurie, G.W., Hassell, J.R., Aumailley, M., Terranova, 
V.P., Martin, G.R., and DuBois-Dalcq, M. (1985). Biological activities of laminin. J.
Cell. Biochem. 27, 317-325.
Knox, P. and Griffiths, S. (1980). The distribution of cell-spreading activities in sera: a 
quantitative approach. J. Cell Sci. 46, 97-112.
Koli, K., Lohi, J., Hautanen, A., and Keski-Oja, J. (1991). Enhancement of vitronectin 
expression in human HepG2 hepatoma cells by transforming growth factor p. Eur. J. 
Biochem. 199, 337-345.
Komm, B.S., Terpening, C.M., Benz, D.J., Graeme, K.A., Gallegos, A., Korc, M., 
Greene, G.L., O'Malley, B.W., and Haussler, M.R. (1988). Oestrogen binding, receptor 
mRNA, and biological response in osteoblast-like osteosarcoma cells. Science 241, 81-83.
Konig, A., Muhlbauer, R.C., and Fleisch, H. (1989). Tumour necrosis factor a  and 
interleukin I stimulate bone resorption in vivo as measured by urinary [3H] tetracyclin 
excretion from pre-labelled mice. J. Bone Miner. Res. 3, 621-627.
i n
Komberg, L.J., Earp, S.H., Turner, C.E., Prokop, C., and Juliano, R.L. (1991). Signal 
transduction by integrins: increased protein tyrosine phosphotyiation caused by clustering 
of pi integrins. Proc. Natl. Acad. Sci. USA 8 8 , 8392-8396.
Kream, B.E., Rowe, D.W., Gworek, S.C., and Raisz, L.G. (1^980). Parathyroid 
hormone alters collagen synthesis and procollagen mRNA levels* in fetal rat calvaria. Proc. 
Natl. Acad. Sci. USA 77, 5654-5658.
Kream, B.E., Rowe, D., Smith, M.D., Maher, V., and Maje$k#t R- (1986). Hormonal 
regulation of collagen synthesis in a clonal rat osteosarcoma cell line. Endocrinology 119, 
1922-1928.
Krieger, N.S., Feldman, A.J., and Tashjian, A.H. (1982). Parathyroid hormone and 
calcitonin interactions in bone: irradiation induced inhibition of escape in vitro. Calcif. 
Tissue Int. 34, 197-203.
Kurpakus, M.A., Quaranta, V., and Jones, J.C.R. (1991). Surface relocation of alpha 6  
beta 4 integrins and assembly of hemidesmosomes in an in vitro* model of wound healing. 
J. Cell Biol. 115, 1737-1750.
Lajeunesse, D., Frondoza, C., Schoffield, B., and Sacktor, B. ('1990). Osteocalcin 
secretion by human osteosarcoma cell lines MG-63. J. Bone Miiner. Res. 5,915-922.
Lajeunesse, D., Kiebzak, G.M., Frondoza, C., and Sacktcr, 6 . (1991). Regulation of 
osteocalcin secretion by human primary bone cells and the hurnatn osteosarcoma cell line 
MG-63. Bone Miner. 14, 237-250.
Lakkakorpi, P.T., Horton, M.A., Helfrich, M.H., Karhulorpi, ;E-K., and Vaananen, 
H.K. (1991). Vitronectin receptor has a role in bone resorpdon b^ut does not mediate tight 
sealing zone attachment of osteoclasts to the bone surface. J. Ce*U Biol. 115,1179-1186.
Lawler, J.W. and Hynes, R.O. (1986). The structure of himrn tthrombospondin, an 
adhesive glycoprotein with multiple calcium binding homobges* with several different 
proteins. J. Cell Biol. 103, 1635-1648.
Lee, E.Y-H., Parry, G., and Bissell, M J. (1984). Modulator oi>f secreted proteins of 
mouse mammary epithelial cells by the collagenous substnta. J . . Cell Biol. 98,146-155.
Lee, E.Y-H., Lee, W-H., Kaetzel, C.S., Parry, G., and Bissell,, M.J. (1985). Interaction 
of mouse mammary epithelial cells and collagen substrata: le^uklation of casein gene 
expression and secretion. Proc. Natl. Acad. Sci. USA 82,1419^-1423.
Lee, E.Y-H., Barcellos-Hoff, M.H., Chen, L-H., Parry, G.,an<id Bissell, M J. (1987). 
Transferrin is a major milk protien and is synthesised by mimnaary epithelial cells. In vitro 
Cell Dev. Biol. 23, 221-226.
Lempert, U.G., Bautista, C., Strong, D.D., Baylink, D., mdMdohan, S. (1991). 
Purification of a novel human bone derived insulin-like grcwti fac to r binding protein 
(huBP-IGFBP): a potential candidate for fixing IGF II nnote. • J- Bone Miner. Res. 6  
suppl 1, S250.(Abstract)
Li, M.L., Aggeler, J., Farson, D.A., Hatier, C., Hassell, T., indd Bissell, M J. (1987). 
Influence of a reconstituted basement membrane and its conp*neents on casein gene
182
expression and secretion in mouse mammry epithelial cells. Proc. Natl. Acad. Sci. USA 
84, 136-140.
Lipfert, L., Haimovich, B., Schaller, M.D., Cobb, B.S., Parsons, J.T., and Brugge, J.S.
(1992). Integrin dependent phosphorylation and activation of the protein kinase ppl25fak in 
platelets. J. Cell Biol. 119,905-912.
Loef, E.B., Proper, J.A., Goustin, A.S., Shipley, G.D., Di Corleto, P.E., and Moses,
H.L. (1986). Induction of c-sis mRNA and activity similar to platelet-derived growth factor 
by transforming growth factor p: a proposed model for indirect mitogenesis involving 
autocrine activity. Proc. Natl. Acad. Sci. USA 83,2453-2457.
Lorenzo, J.A., Raisz, L.G., and Hock, J.M. (1983). DNA synthesis is not necessary for 
osteoclast responses to parathyroid hormone in cultured fetal long bones. J. Clin. Invest. 
72, 1924-1929.
Lucas, P.A., Price, P.A., and Caplan, A.I. (1988). Chemotactic response of mesenchymal 
cells, fibroblasts and osteoblast-like cells to bone gla protein. Bone 9, 319-323.
Lucht, U. (1973). Effects of calcitonin on osteoclasts in vivo: an ultrastructural and 
histochemical study. Z. Zellforsh 145, 75-87.
MacDonald, B.R., Gallagher, J.A., Ahnfelt-Ronne, I., Beresford, J.N., Gowen, M., and 
Russell, R.G.G. (1984). Effects of bovine parathyroid hormone and 1,25- 
dihydroxyvitamin D3 on production of prostaglandins by cells derived from human bone. 
FEBS. Lett. 169, 49-52.
MacDonald, B.R., Takahashi, N., McManus, L.M., Holahan, J., Mundy, G.R., and 
Roodman, G.D. (1987). Formation of multinucleated cells which respond to osteotropic 
hormones in long term human marrow cultures. Endocrinology 120, 2326-2333.
MacDonald, B.R. and Gowen, M. (1992). Cytokines in bone. Br. J. Rheumatol. 31, 149- 
155.
Malaval, L., Darbouret, B., Preaudat, C., Jolu, J-P., and Delmas, P.D. (1991). 
Intertissular variations in osteonectin: -a monoclonal antibody directed to bone osteonectin 
shows reduced affinity for platelet osteonectin. J. Bone Miner. Res. 6 , 315-323.
Manolagas, S.C., Burton, D.W., and Deftos, L J. (1981). 1,25-dihydroxyvitamin D3  
stimulates the alkaline phosphatase activity of osteoblast-like cells. J. Biol. Chem. 256, 
7115-7117.
Marcantonia, E.E., Guan, J.L., Trevithick, J.E., and Hynes, R.O. (1990). Mapping of the 
functional determinants of the integrin pi cytoplasmic domain by site directed mutagenesis. 
J. Cell Reg. 1, 597-604.
Marie, P J. and Travers, R. (1983). Continuous infusion of 1,25 dihydroxyvitamin D3 
stimulates bone turnover in the normal young mouse. Calcif. Tissue Int. 35, 418-425.
Marie, P.J., Hott, M., and Garba, M-T. (1985). Contrasting effects of 1,25 
dihydroxyvitamin D3 on bone matrix and mineral appositional rates in the mouse. 
Metabolism 34,777-783.
183
Mark, M.P., Prince, C.W., Oosawa, T., Bronckers, A.L., and Butler, W.T. (1987). 
Immunohistochemical demonstration of a 44 Kd phosphoprotein in developing rat bones.
J. Histochem. Cytochem. 35, 707-715.
Mark, M.P., Butler, W.T., Prince, C.W., Finkelman, R.D., and Ruch, J.V. (1988). 
Developmental expression of a 44 Kd phosphoprotein (osteopontin) and bone gamma 
carboxyglutamic acid (gla) containing protein (osteocalcin) in calcifying tissues of the rat. 
Differentiation 37,123-136.
Marks, S.C. and Popoff, S.N. (1988). Bone cell biology: The regulation of development, 
structure and function in the skeleton. Am. J. Anat. 183,1-44.
Martin, M. and Resch, K. (1988). Interleukin 1: more than just a mediator between 
leukocytes. TIPS 9, 171-177.
Massague, J. (1987). The TGF-p family of growth and differentiation factors. Cell 49, 
437-438.
Mates, G., Daniel, M., and Walker, C. (1986). Factors affecting the reproducibility of a 
spectrofluorimetric assay for the enumeration of human venous endothelium in culture. Cell 
Biol. Int. Rep. 10, 641-648.
Mauviel, A., Heino, J., Kahari, V-M., Hartmann, D-J., Loyau, G., Pujol, J-P., and 
Vuorio, E. (1991). Comparative effects of interleukin I and tumour necrosis factor-a on 
collagen production and corresponding procollagen mRNA levels in human dermal 
fibroblasts. J. Invest. Dermatol. 96, 243-249.
McAllister, R.M., Gardner, M.B., Greene, A.E., Bradt, C., Nichols, W.W., and 
Landing, B.H. (1971). Cultivation in vitro of cells from a human osteosarcoma. Cancer 
27, 397-402.
McCarthy, M.B., Doherty, W.J., and Gronowicz, G. (1992). Glucocorticoids inhibit 
integrin expression in osteoblasts. J. Bone Miner. Res. 7 suppl 1, S97.(Abstract)
McCarthy, T.L., Centrella, M., and Canalis, E. (1989). Regulatory effects of insulin like 
growth factor I and II on bone collagen synthesis in rat calvarial cultures. Endocrinology 
124, 301-309.
Medhora, M.M., Teitelbaum, S., Chappel, J., Alvarez, J., Mimura, H., Ross, F.P., and 
Hruska, K. (1993). la,25-Dihydroxy vitamin D3 up-regulates expression of the osteoclast 
integrin aVp3. J. Biol. Chem. 268, 1456-1461.
Menko, A.S. and Boettiger, D. (1987). Occupation of the extracellular matrix receptor 
integrin is a control point in myogenic differentiation. Cell 51, 51-57.
Merry, K.H., Dodds, R.A., Littlewood, A.J., and Gowen, M. (1992). Osteoclasts 
express osteopontin mRNA in sections of human bone as detected by in situ hybridisation. 
Calcif. Tissue Int. 50 suppl 1, A40. (Abstract)
Merry, K.H. and Gowen, M. (1992). The transcriptional control of TGFp in human 
osteoblast-like cells is distinct from that of IL-lp. Cytokine 4,171-179.
184
Metcalf, D. and Gearing, D.P. (1989). Fatal syndrome in mice engrafted with cells 
producing high levels of the leukaemia inhibitory factor. Proc. Natl. Acad. Sci. USA 8 6 , 
5948-5952.
Milam, S.B., Magnuson, V.L., Steffensen, B., Chen, D., and Klebe, R.J. (1991). IL-lp 
and prostaglandins regulate integrin mRNA expression. J. Cell Physiol. 149,173-183.
Miyauchi, A., Alvarez, J., Greenfield, E.M., Teti, A., Grano, M., Colucci, S., 
Zambonin-Zallone, A., Ross, F.P., Teitelbaum, S.L., Cheresh, D., and Hruska, K.A. 
(1991). Recognition of osteopontin and related peptides by an alpha v beta 3 integrin 
stimulates immediate cell signals in osteoclasts . J. Biol. Chem. 266,20369-20374.
Mohan, S. and Baylink, D. (1991). Isolation and characterisation of insulin like growth 
factor binding proteins (IGF-BP's) produced by human bone cells (HBC) in vitro. J. Bone 
Miner. Res. 6  suppl 1, S141.(Abstract)
Mosmann, T. (1983). Rapid colorimetric assay for cellular growth and survival: 
application to proliferation and cytotoxicity assays. J. Immunol. Methods 65, 55-63.
Mundy, G.R. (1990). Bone resorbing cells. In Primer on the metabolic bone diseases and 
disorders of mineral metabolism, M J. Favus, ed. (Kelseyville: American Society for Bone 
and Mineral Research), pp. 18-22.
Narbaitz, R., Stumpf, W.E., Sar, M., Huang, S., and DeLuca, H.F. (1983). 
Autoradiographic localisation of target cells for la-25 dihydroxyvitamin D3 in bones from 
foetal rats. Calcif. Tissue Int. 35, 177-182.
Nathan, C. and Spom, M.B. (1991). Cytokines in context. J. Cell Biol. 113, 981-986.
Neff, L., Horne, W.C., Male, P., Stadel, J.M., Samanen, J., Ali, F., Levy, J.B., and 
Baron, R. (1992). A cycic RGD peptide induces a wave of tyrosine phosphorylation and 
the translocation of a c-src substrate (p85) in isolated rat osteoclasts. J. Bone Miner. Res. 7 
suppl 1, SI06.(Abstract)
Nejweide, P.J., Van der Plas, A., and Scherft, J.P. (1981). Biochemical and histological 
studies on various bone cell preparations. Calcif. Tissue Int. 33, 529-540.
Nijweide, P.J., Gaillard, P.J., Hekkelman, J.W., Herrmann-Erlee, M.P.M., Van der 
Plas, A., and Vegt, G.B. (1978). The effects of irradiation on embryonic bone and 
cartilage in vitro. Radiat. Res. 73, 234-250.
Nijweide, P.J., Burger, E.H., and Feyen, J.M. (1986). Cells of bone: proliferation, 
differentiation and hormonal regulation. Physiol. Rev. 6 6 , 855-886.
Noda, M., Yoon, K., Prince, C.W., Butler, W.T., and Rodan, G.A. (1988). 
Transcriptional regulation of osteopontin production in rat osteosarcoma cells by type p 
transforming growth factor. J. Biol. Chem. 263, 13916-13921.
Noda, M. and Rodan, G.A. (1989). Transcriptional regulation of osteopontin production 
in rat osteoblast-like cells by parathyroid hormone. J. Cell Biol. 108,713-718.
Nomura, S., Willis, A.J., Edwards, D.R., Heath, J.K., and Hogan, B.L.M. (1992). 
Developmental expression of 2ar osteopontin and SPARC (osteonectin) RNA as revealed 
by in situ hybridisation. J. Cell Biol. 106, 441-450.
185
O'Shea, K.S. and Dixit, V.M. (1988). Unique distribution of the extracellular matrix 
component thrombospondin in the developing mouse embryo. J. Cell Biol. 107, 2737- 
2748.
Obara, M., Kang, M.S., and Yamada, K.M. (1988). Site directed mutagenesis of the cell 
binding domain of human fibronectin: separable synergistic sites mediate adhesive 
function. Cell 53, 649-657.
Ohmori, Y., Hanazawa, S., Amano, S., Hirose, K., Kumegawa, M., and Kitano, S. 
(1988). Effects of human recombinant interleukin la  and interleukin 1(3 on cell growth and 
alkaline phosphatase of the osteoblastic cell line MC3T3-E1. Biochim. Biophys. Acta 970, 
22-30.
Oldberg, A., Franzen, A., and Heinegard, D. (1986). Cloning and sequence analysis of rat 
bone sialoprotein (osteopontin) cDNA reveals as arg-gly-asp cell binding sequence. Proc. 
Natl. Acad. Sci. USA 83, 8819-8823.
Oldberg, A., Franzen, A., and Heinegard, D. (1988). The primary structure of a cell 
binding bone sialoprotein. J. Biol. Chem. 263, 19430-19432.
Oursler, M.J., Osdoby, P., Pyfferoen, J., and Riggs, B.L. (1991). Avian osteoclasts as 
estrogen target cells. Proc. Natl. Acad. Sci. USA 8 8 , 6613-6617.
Oursler, M.J., Pederson, L., Fitzpatrick, L., Riggs, B.L., and Spelsberg, T.C. (1992). 
Human giant cell tumours of bone (osteoclastomas) are oestrogen target cells. J. Bone 
Miner. Res. 7 suppl 1, SI 11.(Abstract)
Owen, M. (1988). Marrow stromal stem cells. J. Cell Sci. Suppl 10, 63-76.
Pacifici, R., Carano, A., Santoro, S.A., Rifas, L., Jeffrey, J.J., Malone, J.D., 
McCracken, R., and Avioli, L.V. (1991). Bone matrix constituents stimulate Interleukin-1 
release from human blood mononuclear cells. J. Clin. Invest. 87, 221-228.
Paed, M.J., Skerry, T.M., and Lanyon, L.E. (1988). Direct transformation from 
quiescence to bone formation in the adult periosteum following a single brief period of 
bone loading. J. Bone Miner. Res. 3, 647-656.
Parfitt, A.M. (1988). Bone remodelling: Relationship between the structure of bone and 
the pathogenesis of osteoporosis and prevention of fractures. In Osteoporosis: Etiology, 
Diagnosis and Management, L. Riggs and J. Melton, eds. (New York: Raven Press), pp. 
45-93.
Peck, W.A. and Woods, W.L. (1988). The cells of bone. In Osteoporosis: Etiology, 
Diagnosis and Management, L. Riggs and J. Melton, eds. (New York: Raven Press), pp. 
1-44.
Pfeilschbacher, J., Chenu, C., Bird, A., Mundy, G.R., and Roodman, G.D. (1989). 
Interleukin 1 and tumour necrosis factor stimulate the formation of human osteoclast-like 
cells in vitro. J. Bone Miner. Res. 4, 113-118.
Pfeilschifter, J., D'Souza, S.M., and Mundy, G.R. (1987). Effects of transforming 
growth factor p on osteoblastic osteosarcoma cells. Endocrinology 121, 212-218.
186
Pfeilschifter, J. and Mundy, G.R. (1987). Modulation of type p transforming growth 
factor activity in bone cultures by osteotropic hormones. Proc. Natl. Acad. Sci. USA 84, 
2024-2028.
Pfeilschifter, J., Seyedin, S.M., and Mundy, G.R. (1988). Transforming growth factor 
beta inhibits bone resorption in fetal rat long bone cultures. J. Clin. Invest. 82,680-685.
Phillips, D.R., Agin, P.P. (1977). Platelet membrane defects in Glanzmann's 
thrombasthenia. Evidence for decreased amounts of two major glycoproteins. J.Clin. 
Invest. 60, 535-545.
Phillips, D.R., Jennings, L.K., and Edwards, H.H. (1980). Identification of membrane 
proteins mediating the interaction of human platelets. J. Cell Biol. 8 6 ,77-86.
Plantefaber, L.C. and Hynes, R.O. (1989). Changes in integrin receptors on oncogenically 
transformed cells. Cell 56, 281-290.
Price, P.A., Otsuka, A.S., Poser, J.W., Kristaponis, J., and Raman, N. (1976). 
Characterisation of a gamma carboxyglutamic acid containing protein from bone. Proc. 
Natl. Acad. Sci. USA 73, 1447-1451.
Price, P.A. and Baukol, S.A. (1980)..l,25-dihydroxyvitamin D3 increases synthesis of the 
vitamin K-dependent bone protein by osteosarcoma cells. J. Biol. Chem. 255, 11660- 
11663.
Price, P.A., Williamson, M.K., Haba, T., Dell, R.B., and Jee, W.S.S. (1982). Excessive 
mineralisation with growth plate closure in rats with chronic warfarin treatrment. Proc.
Natl. Acad. Sci. USA 79, 7734-7738.
Prince, C.W. and Butler, W.T. (1987). 1,25 dihydroxyvitamin D3 regulates the 
biosynthesis of osteopontin, a bone derived cell attachment protein, in clonal osteoblast-like 
osteosarcoma cells. Collagen Rel. Res. 7, 305-313.
Raisz, L.G., Trummel, C.L., Holick, M.F., and DeLuca, H.F. (1972). 1,25 
dihydroxycholecalciferol: a potent stimulator of bone resorption in tissue culture. Science 
175, 768-769.
Raisz, L.G. and Lorenzo, J.A. (1980). Interactions of hormones, ions and drugs in the 
regulation of osteoclastic bone resorption. Adv. Exp. Med. Biol. 128, 579-596.
Reddi, A.H. and Anderson, W.A. (1976). Collagenous bone matrix-induced endochondral 
ossification and haemopoiesis. J. Cell Biol. 69, 557-572.
Reichardt, L., Bixby, J., Hall, D., Ignatius, M., Neugebauer, K., and Tomaselli, K. 
(1988). Integrins and cell adhesion molecules: neuronal receptors that regulate axon growth 
on extracellular matrices and cell surfaces. Dev. Neurosci. 11, 332-347.
Reid, I.R., Civitelli, R., Avioli, C.V., and Hruska, K.A. (1988). Parathyroid hormone 
depresses cytosolic pH and DNA synthesis in osteoblast-like cells. Am. J. Physiol. 225, 
E9-E16.
Reid, I.R., Lowe, C., and Cornish, J. (1989). Luekaemia inhibitory factor: a novel 
cytokine which stimulates bone resorption in vitro. J. Bone Miner. Res. 4, S150.(Abstract)
187
Reinholt, F.P., Hultenby, K., Oldberg, A., and Heinegard, D. (1990). Osteopontin-a 
possible anchor of osteoclasts to bone. Proc. Natl. Acad. Sci. USA 87, 4473-4475.
Reynolds, J.J., Pavlovitch, H., and Balsan, S. (1976). 1,25 dihydroxycholecalciferol 
increases bone resorption in thyroparathyroidectomised mice. Calcif. Tissue Int. 21, 207- 
212.
Rigby, W.F.C., Shen, L., Ball, E.D., and Fanger, M.W. (1985). 1,25 dihydroxyvitamin 
D3  induces a myelomonocytic phenotype with enhanced effector cell function in the HL-60 
promyelocytic leukaemia cell line. Mol. Immunol. 22,567-572.
Riggs, B.L., Jowsey, J., Goldsmith, R.S., Kelly, P.J., Hoffmann, D.L., and Amaud, 
C.D. (1972). Short and long term effects of oestrogen and synthetic anabolic hormones in 
post menopausal osteoporosis. J. Clin. Invest. 51, 1659-1663.
Roberts, A.B., McCune, B.K., and Spom, M.B. (1992). TGF-p: regulation of 
extracellular matrix. Kidney Int. 41, 557-559.
Roberts, C J, Birkenmier, T.M., McQuillan, J.J., Akiyama, S.K., Yamada, S.S., Chen, 
W-T., Yamada, K.M., and McDonald, J.A. (1988). Transforming growth factor p 
stimulates the expression of fibronectin and both subunits of the human fibronectin receptor 
by cultured lung fibroblasts. J. Biol. Chem. 263, 4586-4592.
Rodan, G.A. and Rodan, S.B. (1984). Expression of the osteoblastic phenotype. In Bone 
and Mineral Research. Volume 2, W.A. Peck, ed. (Amsterdam: Elsevier), pp. 244-285.
Romberg, R.W., Wemess, P.G., Riggs, B.L., and Mann, K.G. (1986). Inhibition of 
hydroxyapatite crystal growth by bone specific and other calcium binding proteins. 
Biochemistry 25, 1176-1180.
Roodman, G.D., Ibbotson, K.J., MacDonald, B.R., Kuehl, T.J., and Mundy, G.R.
(1985). 1,25 Dihydroxyvitamin D3 causes formation of multinucleated cells with several 
osteoclast characteristics in cultures of primate marrow. Proc. Natl. Acad. Sci. USA 82, 
8213-8217.
Rosenberg, L.C., Choi, H.U., Tang, L.H., Johnson, T.L., and Pal, S. (1985). Isolation 
of dermatan sulphate proteoglycans from mature bovine articular cartilage. J. Biol. Chem. 
260, 6304-6313.
Rouleau, M.F., Warshawsky, H., and Goltzman, D. (1986). Parathyroid hormone 
binding in vivo to renal, hepatic and skeletal tissues of the rat using a radioautographic 
approach. Endocrinology 118, 919-931.
Rubin, C.T. and Lanyon, L.E. (1985). Regulation of bone mass by mechanical strain 
magnitude. Calcif. Tissue Int. 37, 411-417.
Ruoslahti, E., Hayman, E.G., Pierschbacher, M., and Engvall, E. (1982). Fibronectin: 
Purification, immunochemical properties and biological activites. In Methods in 
Enzymology. Volume 82: Strucutral and contractile proteins. Part A, L.W. Cunningham 
and D.W. Frederiksen, eds. (New York: Academic Press),
Ruoslahti, E. and Pierschbacher, M.D. (1987). New perspectives in cell adhesion. RGD 
and integrins. Science 238,491-497.
188
Sakamoto, S. and Sakamoto, M. (1985). Biochemical and immunohistological studies on 
collagenase in resorbing bone in tissue culture. Peridont. Res. 17,523-526.
Sandberg, M., Vuorio, T., Hirvonen, H., Alitalo, K., and Vuorio, E. (1988). Enhanced 
expression of TGF-p and c-fos mRNA's in the growth plates of developing human long 
bones. Dev. 102, 461-470.
Santala, P. and Heino, J. (1991). Regulation of integrin-type cell adhesion receptors by 
cytokines . J. Biol. Chem. 266, 23505-23509.
Savill, J., Dransfield, I., Hogg, N., and Haslett, C. (1990). Vitronectin receptor mediated 
phagocytosis of cells undergoing apoptosis. Nature 343,170-173.
Schaller, M.D., Borgman, C.A., Cobb, B.S., Vines, R.R., Reynolds, A.B., and 
Parsons, J.T. (1992). ppl25fak, a structurally unique protein tyrosine kinase associated 
with focal adhesion. Proc. Natl. Acad. Sci. USA 89, 5192-5196.
Schiro, J.A., Chan, B.M.C., Roswit, W.T., Kassner, P.D., Pentland, A.P., Hemler, 
M.E., Eisen, A.Z., and Kupper, T.S. (1991). Integrin a2pl (VLA-2) mediates re­
organisation and contraction of collagen matrices by human cells . Cell 67,403-410.
Schmid, C., Steiner, T., and Froesch, E.R. (1983). Insulin-like growth factors stimulate 
synthesis of nucleic acids and glycogen in cultured calvaria cells. Calcif. Tissue Int. 35, 
578-585.
Schmid, C., Guler, H.P., Rowe, D., and Froesch, E.R. (1989). Insulin like growth factor 
I regulates type I pro-collagen mRNA steady state levels in bone of rats. Endocrinology 
125, 1575-1580.
Schmidhauser, C., Casperson, G.F., Myers, C.A., Sanzo, K.T., Bolten, S., and Bissell, 
M.J. (1992). A novel transcriptional enhancer is involved in the prolactin and extracellular 
dependent regulation of p-Casein gene expression. Mol Biol. Cell 3, 699-709.
Schneider, H-G., Michelangeli, V.P., Frampton, R.J., Grogan, J.L., Ikeda, K., Martin, 
T.J., and Findlay, D.M. (1992). Transforming growth factor p modulates receptor binding 
of calcitropic hormones and G protein-mediated adenylate cyclase response in osteoblast 
like cells. Endocrinology 131,1383-1389.
Schotland, S., Foelmer, O., Basic, M.M., Kleeman, C.R., and Green, J. (1992). Effect 
of extracellular matrices on proliferation and differentiation of osteoblast-like cells. J. Bone 
Miner. Res. 7 suppl 1, S271.(Abstract)
Seftor, R.E.B., Seftor, E.A., Gehlsen, K.R., Stetler-Stevenson, W.G., Brown, P.D., 
Ruoslahti, E., and Hendrix, MJ.C. (1992). Role of the aVp3 integrin in human melanoma 
cell invasion. Proc. Natl. Acad. Sci. USA 89, 1557-1561.
Seyedin, S.M. and Rosen, D.M. (1990). Matrix proteins of the skeleton. Curr. Opin. Cell 
Biol. 2, 914-919.
Shattil, S.J., Hoxie, J.A., Cunningham, M., and Brass, L.F. (1985). Changes in the 
platelet membrane glycoprotein Ilb.nia complex during platelet activation. J. Biol. Chem. 
260, 11107-11114.
189
Silve, C.H., Hradek, G.T., Jones, A.L., and Amaud, C.D. (1982). Parathyroid hormone 
receptor in intact embryonic chicken bone: characterisation and cellular localisation. J. Cell 
Biol. 94, 379-386.
Singer, I.I., Scott, S., Kawka, D.W., Kazazis, D.M., Gailit, J., and Ruoslahti, E.R. 
(1988). Cell surface distribution of fibronectin and vitronectin receptors depends on 
substrate composition and extracellular matrix accumulation. J. Cell Biol. 106,2171-2182.
Skerry, T.M., Bitensky, L., Chayen, J., and Lanyon, L.E. (1989). Early strain related 
changes in enzyme activity in osteocytes following bone loading in vivo. J. Bone Miner. 
Res. 4, 783-788.
Skerry, T.M., Suswillo, R., El Haj, A.J., Ali, N.N., Dodds, R.A., and Lanyon, L.E. 
(1990). Load induced proteoglycan orientation in bone tissue in vivo and in vitro. Calcif. 
Tissue Int. 46, 318-326.
Skjodt, H., Gallagher, J.A., Beresford, J.N., Couch, M., Poser, J.W., and Russell, 
R.G.G. (1985). Vitamin D metabolites regulate osteocalcin synthesis and proliferation of 
human bone cells in vitro. J. Endocrinol. 105, 391-396.
Smith, D.D., Gowen, M., and Mundy, G.R. (1987). Effects of interferon-y and other 
cytokines on collagen synthesis in fetal rat bone cultures. Endocrinology 120, 2494-2499.
Sodek, J., Domemicucu, C., Zung, P., Kurvata, F., and Wasi, S. (1986). Biosynthesis, 
properties and distribution of osteonectin. In Cell mediated calcifications and matrix 
vesicles, A. Yousut, ed. (Elsevier Science Publishers), pp. 135-141.
Solowska, J., Edelman, J.M., Albelda, S.M., and Buck, C.A. (1991). Cytoplasmic and 
transmembrane domains of integrin pi and p3 subunits are functionally interchangeable. J. 
Cell Biol. 114, 1079-1088.
Somerman, M.J., Fisher, L.W., Foster, R.A., and Sauk, J.J. (1988). Human bone 
sialoprotein I and II enhance fibroblast attachment in vitro. Calcif. Tissue Int. 43, 50-53.
Sonnenberg, A., Calafat, J., Janssen, H., Daams, H., van der Raaij-Hemler, L.M., 
Falcioni, R., Kennel, S.J., Alpin, J.D., Baker, J., Loizidou, M., and Garrod, D. (1991). 
Integrin ot6p4 complex is located in hemidesmosomes suggesting a major role in epithelial 
cell basement membrane adhesion. J. Cell Biol. 113, 907-917.
Soriano, P., Montgomery, C., Geske, R., and Bradley, A. (1991). Targeted disruption of 
the c-src proto-oncogene leads to osteoporosis in mice. Cell 64,693-702.
Spom, M.B., Roberts, A.B., Wakefield, L.M., and Assoian, R.K. (1986). Transforming 
growth factor p: Biological function and chemical structure. Science 233, 532-534.
Spom, M.B., Roberts, A.B., Lalage, M., Wakefield, L.M., and Beniot de Crombrugghe,
(1987). Some recent advances in the chemistry and biology of transforming growth factor- 
beta. J. Cell Biol. 105, 1039-1045.
Springer, T.A., Dustin, M.L., Kishimoto, T.K., Marlin, S.D. (1987). The lymphocyte 
function-associated LFA-1, CD2, and LFA-3 molecules: Cell adhesion receptors of die 
immune system. Ann. Rev. Immunol. 5, 223-252
Springer, T.A. (1990). Adhesion receptors of the immune system. Nature 346, 425-434.
1 90
Staatz, W.D., Rajpara, S.M., Wayner, E.A., Carter, W.G., and Santoro, S.A. (1989). 
The membrane glycoprotein Ia-IIa (VLA-2) complex mediates the Mg2+ dependent 
adhesion of platelets to collagen. J. Cell Biol. 108,1917-1924.
Staatz, W.D., Fok, K.F., Zutter, M.M., Adams, S.P., Rodriguez, B.A., and Santoro, 
S.A. (1991). Identification of a tetrapeptide recognition sequence for the ot2pi integrin in 
collagen. J. Biol. Chem. 266, 7363-7367.
Stanka, P. (1975). The occurence of cell junctions and microfilaments in osteoblasts. Cell 
Tissue Res. 159, 413-422.
Stashenko, P., Dewhirst, F.E., Peros, W.J., Kent, R.L., and Argo, J.M. (1987a). 
Synergistic interactions between IL-1, tumour necrosis factor and lymphotoxin in bone 
resorption. J. Immunol. 138, 1464-1468.
Stashenko, P., Dewhirst, F.E., Rooney, M.L., Desjardins, L.A., and Heeley, J.D. 
(1987b). Interleukin lp is a potent inhibitor of bone formation in vitro. J. Bone Miner.
Res. 2, 559-565.
Stepp, M.A., Spurr-Michaud, S., Tisdale, A., Elwell, J., and Gipson, I.K. (1990). a6p4 
integrin heterodimer is a component of hemidesmosomes. Proc. Natl. Acad. Sci. USA 87, 
8970-8974.
Streuli, C.H., Bailey, N., and Bissell, M.J. (1991). Control of mammary epithelial 
differentiation: basement membrane induces tissue specific gene expression in the absence 
of cell-cell interaction and morphological polarity. J. Cell Biol. 115, 1383-1395.
Strom, S.C. and Michalopoulos, G. (1982). Collagen as a substrate for cell growth and 
differentiation. In Methods in Enzymology. Volume 82. Structural and contractile 
proteins. Part A, L.W. Cunningham and D.W. Frederiksen, eds. (New York: Academic 
Press), pp. 544-555.
Strong, D.D., Beachler, A.L., Wergedal, J.E., and Linkhart, T.A. (1991). Insulin like 
growth factor II and tranforming growth factor p regulate collagen expression in human 
osteoblast-like cells in vitro. J. Bone Miner. Res. 6 , 15-23.
Tanaka, S., Takahashi, N., Udagawa, N., Sasaki, T., Fukui, Y., Kurokawa, T., and 
Suda, T. (1992). Osteoclasts express high levels of ppbO08510, prefentially on ruffled border 
membranes. FEBS Lett. 313, 85-89.
Tashjian, A.H., Voekel, E.F., Lazzaro, M., Singer, F.R., Roberts, A.B., Derynck, R., 
Winkler, M.E., and Levine, L. (1985). a  and p transforming growth factors stimulate 
prostaglandin production and bone resorption in cultured mouse calvaria. Proc. Natl. Acad. 
Sci. USA 82, 4535-4538.
Tashjian, A.H., Voelkel, E.F., Lazzaro, D.G., Bosma, T., and Levine, L. (1987). 
Tumour necrosis factor a  (cachectin) stimulates bone resorption in mouse calvaria via a 
prostaglandin mediated mechanism. Endocrinology 120,2029-2036.
Teitelbaum, S.L. (1990). Skeletal growth and development. In Primer on the metabolic 
bone diseases and disorders of mineral metabolism, M J. Favus, ed. (Kelseyville: 
American Society for Bone and Mineral Research), pp. 7-11.
191
Tezuka, K., Sato, T., Kamioka, H., Nijweide, P.J., Tanaka, K., Matsuo, T., Ohta, M., 
Kurihara, N., Hakeda, Y., and Kumegawa, M. (1992). Identification of osteopontin in 
isolated rat osteoclasts. Biochem. Biophys. Res. Commun. 186, 911-917.
Thomson, B.M., Saklatvala, J., and Chambers, T.J. (1986). Osteoblasts mediate 
interleukin 1 stimulation of bone resorption by rat osteoclasts. J. Exp. Med. 164,104-112.
Trueta, J. (1963). The role of the vessels in osteogenesis. J. Bone Joint Surg. 45B, 402- 
411.
Tusznski, G.P. (1987). Response-metabolism relationships. In Platelet responses and 
metabolism. Volume II, H. Holmsen, ed. (Boca Raton, FL: CRC Press Inc.), pp. 187- 
205.
Vaes, G. (1988). Cellular biology and biochemical mechanism of bone resorption. Clin. 
Orthop. 231, 239-271.
von der Mark, K., Mollenhauer, J., Pfaffle, M., van Menxel, M., and Muller, P.K.
(1986). Role of anchorin CII in the interaction of chondrocytes with extracellular collagen. 
In Articular Cartilage Biochemistry, K. Kuettner and et al, eds. (New York: Raven Press), 
pp. 125-141.
von der Mark, K., von der Mark, H., and Goodman, S. (1992). Cellular responses to 
extracellular matrix. Kidney Int. 41, 632-640.
Vukicevic, S., Luyten, F.P., Kleinman, H.K., and Reddi, A.H. (1990). Differentiation of 
cannalicular cell processes in bone cells by basement membrane matrix components. 
Regulation by distinct domains of laminin. Cell 63,437-445.
Wang, E.A., Rosen, V., Cordes, P., Hawick, R.M., Kriz, M.J., Luxenberg, D.P., 
Sibley, B.S., and Wosney, J.M. (1988). Purification and characterisation of other distinct 
bone inducing factors. Proc. Natl. Acad. Sci. USA 85, 9484-9487.
Warshawsky, H., Goltzman, D., Rouleau, M.F., and Bergeron, J.J.M. (1980). Direct in 
vivo demonstration by autoradiography of specific binding sites for calcitonin in skeletal 
renal tissues of the rat. J. Cell Biol. 85, 682-694.
Wayner, E.A., Orlando, R.A., and Cheresh, D.A. (1991). Integrins aVp3 and aVp5 
contribute to cell attachment to vitronectin but differentially distribute on the cell surface. J. 
Cell Biol. 113,919-929.
Weiss, R.E. and Reddi, A.H. (1980). Synthesis and localisation of fibronectin during 
collagenous matrix mesenchymal cell interaction and differentiation of cartilage and bone in 
vivo. Proc. Natl. Acad. Sci. USA 77, 2074-2078.
Weiss, R.E. and Reddi, A.H. (1981). Appearance of fibronectin during the differentiation 
of cartilage and bone marrow. J. Cell Biol. 88, 630-636.
Welch, M.P., Odland, G.F., and Clark, R.F. (1990). Temporal relationship of F-actin 
bundle formation, collagen and fibronectin matrix assembly and fibronectin receptor 
expression in wound contraction. J. Cell Biol. 110,133-145.
1 92
Werb, Z., Tremble, P.M., Behrendsten, O., Crowley, E., and Damsky, C.,H. (1989). 
Signal transduction through the fibronectin receptor induces collagenase and stromolysin 
gene expression. J. Cell Biol. 109, 877-889.
Whyte, M.P. (1990). Genetic, developmental and dysplastic skeletal disorders. In Primer 
on the metabolic bone diseases and disorders of mineral homeostasis, M.J. Favus, ed. 
(Kelseyville: American Society for Bone and Mineral Research), pp. 188-190.
Wrana, J.L., Maeno, M., Hawrylyshyn, B., Yao, K-L., Domenicucci, C., and Sodek, J.
(1988). Differential effects of transforming growth factor (5 on the synthesis of extracellular 
matrix proteins by normal fetal rat calvarial bone cell populations. J. Cell Biol. 106,915- 
924.
